+关注
sgrs
暂无个人介绍
IP属地:未知
2
关注
9
粉丝
0
主题
0
勋章
主贴
热门
sgrs
2021-12-20
Oh no
Intercept Pharma Shares Stumble After Delay in Trial Data
sgrs
2021-12-18
Ooo
Wall Street ends down after mostly negative week
sgrs
2021-12-17
Nice
Earnings Scheduled For December 17, 2021
sgrs
2021-12-13
:(
EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3%
sgrs
2021-12-13
Ohno
Rivian,Adobe,FedEx,Lennar,Campbell Soup,and Other Stocks to Watch This Week
sgrs
2021-12-09
Great!
Wall St closes higher as vaccine update feeds optimism
sgrs
2021-12-08
Nicee
抱歉,原内容已删除
sgrs
2021-12-07
Nicee
3 High-Growth Stocks Wall Street Thinks Could Soar 30% or More
sgrs
2021-12-05
Ooooo
Peloton stock is a buy, but with an 'asterisk', analyst says
sgrs
2021-12-03
Interesting
Vaccine makers should plan to adjust COVID-19 jabs - WHO
sgrs
2021-12-01
I see
Bionano Genomics Proves Not Everything Genetic is Gold
sgrs
2021-11-28
Nice
Did Qualcomm Just Reveal One of Meta's Biggest Secrets?
sgrs
2021-11-26
Hmm
Worried About A Market Crash? Here Are 3 Things You Can Do
sgrs
2021-11-23
Oh no
Medtronic stock drops toward 8-month low after revenue miss and lowered full-year growth outlook
sgrs
2021-11-20
Oo
Nasdaq ends atop 16,000 mark for the first time on tech strength
sgrs
2021-11-18
:)
After-Hours Stock Movers: NVIDIA, Sonos, Victoria's Secret and more
sgrs
2021-11-17
Oooo
Pfizer asks US officials to OK promising COVID-19 pill
sgrs
2021-11-16
Wow
70 Biggest Movers From Yesterday
sgrs
2021-11-14
Hehe
These are the next three mega-cap tech stocks you’ll be hearing more about
sgrs
2021-11-09
Wow
Kimbal Musk cashed out $109 million of Tesla stock just before Elon's tweets whacked the share price
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582199304143416","uuid":"3582199304143416","gmtCreate":1619281203868,"gmtModify":1619281203868,"name":"sgrs","pinyin":"sgrs","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":2,"tweetSize":83,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.05","exceedPercentage":"60.95%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":693603001,"gmtCreate":1640009853269,"gmtModify":1640009853629,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693603001","repostId":"1134420562","repostType":4,"repost":{"id":"1134420562","kind":"news","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1640009445,"share":"https://www.laohu8.com/m/news/1134420562?lang=&edition=full","pubTime":"2021-12-20 22:10","market":"us","language":"en","title":"Intercept Pharma Shares Stumble After Delay in Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1134420562","media":"Dow Jones","summary":"Intercept Pharmaceuticals Inc.'s shares look set for a weak open Monday after the biopharmaceutical ","content":"<p>Intercept Pharmaceuticals Inc.'s shares look set for a weak open Monday after the biopharmaceutical company said top-line data from its late-stage trial of patients with compensated cirrhosis will be delayed.</p>\n<p>Intercept said the data is now expected in the first quarter of next year, rather than near the end of this year as previously anticipated.</p>\n<p>In premarket trading, the shares were 4.3% lower after ending Friday at $17.14, down more than 30% since the end of last year.</p>\n<p>Michelle Berrey, the company's chief medical officer and president of research and development, said Intercept teams continue to receive data and are working toward locking the database for the study.</p>\n<p>\"As a result of the magnitude and complexity of these analyses and recognizing that we are relying on external parties for information and services, we expect these analyses, including the completion of biopsy readings and safety adjudications, to continue into the first quarter of 2022,\" she said.</p>\n<p>The company said Reverse is the only active late-stage Phase 3 study in patients with compensated cirrhosis due to NASH, a serious disease for which there are no approved pharmacologic therapies. The liver biopsy samples from Reverse are being evaluated utilizing a new consensus methodology, it said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intercept Pharma Shares Stumble After Delay in Trial Data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntercept Pharma Shares Stumble After Delay in Trial Data\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-20 22:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Intercept Pharmaceuticals Inc.'s shares look set for a weak open Monday after the biopharmaceutical company said top-line data from its late-stage trial of patients with compensated cirrhosis will be delayed.</p>\n<p>Intercept said the data is now expected in the first quarter of next year, rather than near the end of this year as previously anticipated.</p>\n<p>In premarket trading, the shares were 4.3% lower after ending Friday at $17.14, down more than 30% since the end of last year.</p>\n<p>Michelle Berrey, the company's chief medical officer and president of research and development, said Intercept teams continue to receive data and are working toward locking the database for the study.</p>\n<p>\"As a result of the magnitude and complexity of these analyses and recognizing that we are relying on external parties for information and services, we expect these analyses, including the completion of biopsy readings and safety adjudications, to continue into the first quarter of 2022,\" she said.</p>\n<p>The company said Reverse is the only active late-stage Phase 3 study in patients with compensated cirrhosis due to NASH, a serious disease for which there are no approved pharmacologic therapies. The liver biopsy samples from Reverse are being evaluated utilizing a new consensus methodology, it said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ICPT":"Intercept Pharmaceuticals"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134420562","content_text":"Intercept Pharmaceuticals Inc.'s shares look set for a weak open Monday after the biopharmaceutical company said top-line data from its late-stage trial of patients with compensated cirrhosis will be delayed.\nIntercept said the data is now expected in the first quarter of next year, rather than near the end of this year as previously anticipated.\nIn premarket trading, the shares were 4.3% lower after ending Friday at $17.14, down more than 30% since the end of last year.\nMichelle Berrey, the company's chief medical officer and president of research and development, said Intercept teams continue to receive data and are working toward locking the database for the study.\n\"As a result of the magnitude and complexity of these analyses and recognizing that we are relying on external parties for information and services, we expect these analyses, including the completion of biopsy readings and safety adjudications, to continue into the first quarter of 2022,\" she said.\nThe company said Reverse is the only active late-stage Phase 3 study in patients with compensated cirrhosis due to NASH, a serious disease for which there are no approved pharmacologic therapies. The liver biopsy samples from Reverse are being evaluated utilizing a new consensus methodology, it said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699583369,"gmtCreate":1639839290058,"gmtModify":1639839290225,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Ooo","listText":"Ooo","text":"Ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699583369","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","kind":"news","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p>\n<p>All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p>\n<p>Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.</p>\n<p>The S&P 500 growth index lost 0.7% and the value index declined 1.4%.</p>\n<p>All of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p>\n<p>Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p>\n<p>Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p>\n<p>\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p>\n<p>Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.</p>\n<p>In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.</p>\n<p>The Nasdaq Composite dropped 0.07% to 15,169.68.</p>\n<p>On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p>\n<p>With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p>\n<p>For the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p>\n<p>In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p>\n<p>FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 07:59 GMT+8 <a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699934042,"gmtCreate":1639733808690,"gmtModify":1639733808810,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699934042","repostId":"1180441380","repostType":4,"repost":{"id":"1180441380","kind":"news","pubTimestamp":1639733119,"share":"https://www.laohu8.com/m/news/1180441380?lang=&edition=full","pubTime":"2021-12-17 17:25","market":"us","language":"en","title":"Earnings Scheduled For December 17, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1180441380","media":"Benzinga","summary":"Companies Reporting Before The Bell\n• Darden Restaurants (NYSE:DRI) is projected to report quarterly","content":"<p>Companies Reporting Before The Bell</p>\n<p>• Darden Restaurants (NYSE:DRI) is projected to report quarterly earnings at $1.43 per share on revenue of $2.23 billion.</p>\n<p>• Winnebago Industries (NYSE:WGO) is estimated to report quarterly earnings at $2.25 per share on revenue of $1.01 billion.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Earnings Scheduled For December 17, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEarnings Scheduled For December 17, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 17:25 GMT+8 <a href=https://www.benzinga.com/news/earnings/21/12/24664262/earnings-scheduled-for-december-17-2021><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Companies Reporting Before The Bell\n• Darden Restaurants (NYSE:DRI) is projected to report quarterly earnings at $1.43 per share on revenue of $2.23 billion.\n• Winnebago Industries (NYSE:WGO) is ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/12/24664262/earnings-scheduled-for-december-17-2021\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WGO":"温尼巴格实业","DRI":"达登饭店"},"source_url":"https://www.benzinga.com/news/earnings/21/12/24664262/earnings-scheduled-for-december-17-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180441380","content_text":"Companies Reporting Before The Bell\n• Darden Restaurants (NYSE:DRI) is projected to report quarterly earnings at $1.43 per share on revenue of $2.23 billion.\n• Winnebago Industries (NYSE:WGO) is estimated to report quarterly earnings at $2.25 per share on revenue of $1.01 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":892,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604598444,"gmtCreate":1639408885987,"gmtModify":1639409717414,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":":(","listText":":(","text":":(","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/604598444","repostId":"1125628300","repostType":4,"repost":{"id":"1125628300","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639408702,"share":"https://www.laohu8.com/m/news/1125628300?lang=&edition=full","pubTime":"2021-12-13 23:18","market":"us","language":"en","title":"EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125628300","media":"Tiger Newspress","summary":"EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling aro","content":"<p>EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3%.<img src=\"https://static.tigerbbs.com/339c507942577109dbbbb0437dd2eb2d\" tg-width=\"537\" tg-height=\"197\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3% </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3% \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 23:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3%.<img src=\"https://static.tigerbbs.com/339c507942577109dbbbb0437dd2eb2d\" tg-width=\"537\" tg-height=\"197\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","LI":"理想汽车","TSLA":"特斯拉","F":"福特汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125628300","content_text":"EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":752,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604598145,"gmtCreate":1639408857686,"gmtModify":1639409714286,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Ohno","listText":"Ohno","text":"Ohno","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604598145","repostId":"1171271872","repostType":4,"repost":{"id":"1171271872","kind":"news","pubTimestamp":1639348466,"share":"https://www.laohu8.com/m/news/1171271872?lang=&edition=full","pubTime":"2021-12-13 06:34","market":"us","language":"en","title":"Rivian,Adobe,FedEx,Lennar,Campbell Soup,and Other Stocks to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1171271872","media":"Barrons","summary":"The main event for investors this week will be the Federal Reserve’s rate-setting committee’s last meeting of 2021. Recent commentary from officials has leaned more hawkish, setting up a potential announcement of plans to accelerate monthly asset purchase tapering.The Federal Open Market Committee’s two-day meeting takes place on Tuesday and Wednesday.Earnings reports this week are few, but will include Campbell Soup on Tuesday;Lennar,Accenture,FedEx,Rivian Automotive, and Adobe on Thursday; and","content":"<p>The main event for investors this week will be the Federal Reserve’s rate-setting committee’s last meeting of 2021. Recent commentary from officials has leaned more hawkish, setting up a potential announcement of plans to accelerate monthly asset purchase tapering.</p>\n<p>The Federal Open Market Committee’s two-day meeting takes place on Tuesday and Wednesday.</p>\n<p>Earnings reports this week are few, but will include Campbell Soup on Tuesday;Lennar,Accenture,FedEx,Rivian Automotive, and Adobe on Thursday; and Darden Restaurants on Friday.</p>\n<p>Economic data coming out this week includes the Bureau of Labor Statistics’ producer price index for November on Tuesday. Economists expect a 0.55% month-over-month rise for the headline index and a 0.4% gain for the core PPI. Those would both roughly match October’s pace of producer inflation.</p>\n<p>Other data releases include the National Federation of Independent Businesses’ sentiment index on Tuesday, November retail-sales spending from the Census Bureau on Wednesday, and the November housing starts on Thursday.</p>\n<p><b>Monday 12/13</b></p>\n<p>J.Jill and PHX Minerals host earnings conference calls.</p>\n<p><b>Tuesday 12/14</b></p>\n<p>Campbell Soup, Barnes Group, and Avaya Holdings host investor days.</p>\n<p><b>The Bureau of Labor</b> Statistics releases the producer price index for November. Consensus estimate is for a 0.55% month-over-month rise, and for the core PPI, which excludes food and energy, to gain 0.4%. This compares with increases of 0.6% and 0.4%, respectively, in October.</p>\n<p><b>The National Federation</b> of Independent Businesses reports its index, which surveys about 5,000 small-business owners across the country, for November. Expectations call for a reading of 98.3, compared with 98.2 in October.</p>\n<p><b>Wednesday 12/15</b></p>\n<p><b>The Federal Open Market Committee</b> concludes its two-day meeting, when policy makers will discuss accelerating the timetable for tapering monthly securities purchases.</p>\n<p><b>The BLS reports</b> export and import price data for November. Expectations are for a 0.5% month-over-month rise in export prices, while import prices are seen increasing 0.5%. This compares with gains of 1.5% and 1.2%, respectively, in October.</p>\n<p><b>The National Association</b> of Home Builders releases its NAHB/Wells Fargo Housing Market Index for December. Consensus estimate is for an 84 reading, compared with an 83 reading in November. The index peaked at 90 late last year, and home builders remain bullish on the housing market.</p>\n<p><b>The Census Bureau</b> reports on retail-sales spending for November. Expectations are for a seasonally adjusted 0.7% month-over-month increase in retail sales, compared with a 1.7% rise in October. Excluding autos, spending is seen rising 0.8%, compared with 1.7% in the previous period.</p>\n<p><b>Thursday 12/16</b></p>\n<p>Heico,Lennar, Accenture, FedEx, Jabil, Adobe, Rivian Automotive, and Nordson are among companies hosting earnings conference calls.</p>\n<p><b>The Census Bureau</b>releases its New Residential Construction report for November. The seasonally adjusted annual rate of housing starts is expected to be 1.563 million units, compared with 1.52 million in October. A housing start is counted when excavation begins on a home. Permits issued for new-home construction are expected to be 1.655 million, compared with 1.653 million in October.</p>\n<p><b>The Bank of England</b> announces its interest-rate decision and publishes the minutes of the meeting.</p>\n<p><b>The Federal Reserve</b> releases industrial production data for November. Economists are looking for a 0.6% rise, after a 1.6% increase in October. Capacity utilization is expected at 76.8, roughly in line with October’s 76.4%.</p>\n<p><b>Friday 12/17</b></p>\n<p>Steelcase,Darden Restaurants, and Quanex Building Products host earnings conference calls.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rivian,Adobe,FedEx,Lennar,Campbell Soup,and Other Stocks to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRivian,Adobe,FedEx,Lennar,Campbell Soup,and Other Stocks to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 06:34 GMT+8 <a href=https://www.barrons.com/articles/stocks-to-watch-this-week-fedex-rivian-lennar-campbell-adobe-51639330550?mod=hp_LEAD_3><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The main event for investors this week will be the Federal Reserve’s rate-setting committee’s last meeting of 2021. Recent commentary from officials has leaned more hawkish, setting up a potential ...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-to-watch-this-week-fedex-rivian-lennar-campbell-adobe-51639330550?mod=hp_LEAD_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEN":"莱纳建筑公司","DRI":"达登饭店","CPB":"金宝汤","FDX":"联邦快递",".SPX":"S&P 500 Index","JILL":"J.Jill Inc.","RIVN":"Rivian Automotive, Inc.",".IXIC":"NASDAQ Composite","ACN":"埃森哲",".DJI":"道琼斯","HEI":"海科航空","PHX":"潘汉德尔油气","SCS":"Steelcase Inc.","ADBE":"Adobe"},"source_url":"https://www.barrons.com/articles/stocks-to-watch-this-week-fedex-rivian-lennar-campbell-adobe-51639330550?mod=hp_LEAD_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171271872","content_text":"The main event for investors this week will be the Federal Reserve’s rate-setting committee’s last meeting of 2021. Recent commentary from officials has leaned more hawkish, setting up a potential announcement of plans to accelerate monthly asset purchase tapering.\nThe Federal Open Market Committee’s two-day meeting takes place on Tuesday and Wednesday.\nEarnings reports this week are few, but will include Campbell Soup on Tuesday;Lennar,Accenture,FedEx,Rivian Automotive, and Adobe on Thursday; and Darden Restaurants on Friday.\nEconomic data coming out this week includes the Bureau of Labor Statistics’ producer price index for November on Tuesday. Economists expect a 0.55% month-over-month rise for the headline index and a 0.4% gain for the core PPI. Those would both roughly match October’s pace of producer inflation.\nOther data releases include the National Federation of Independent Businesses’ sentiment index on Tuesday, November retail-sales spending from the Census Bureau on Wednesday, and the November housing starts on Thursday.\nMonday 12/13\nJ.Jill and PHX Minerals host earnings conference calls.\nTuesday 12/14\nCampbell Soup, Barnes Group, and Avaya Holdings host investor days.\nThe Bureau of Labor Statistics releases the producer price index for November. Consensus estimate is for a 0.55% month-over-month rise, and for the core PPI, which excludes food and energy, to gain 0.4%. This compares with increases of 0.6% and 0.4%, respectively, in October.\nThe National Federation of Independent Businesses reports its index, which surveys about 5,000 small-business owners across the country, for November. Expectations call for a reading of 98.3, compared with 98.2 in October.\nWednesday 12/15\nThe Federal Open Market Committee concludes its two-day meeting, when policy makers will discuss accelerating the timetable for tapering monthly securities purchases.\nThe BLS reports export and import price data for November. Expectations are for a 0.5% month-over-month rise in export prices, while import prices are seen increasing 0.5%. This compares with gains of 1.5% and 1.2%, respectively, in October.\nThe National Association of Home Builders releases its NAHB/Wells Fargo Housing Market Index for December. Consensus estimate is for an 84 reading, compared with an 83 reading in November. The index peaked at 90 late last year, and home builders remain bullish on the housing market.\nThe Census Bureau reports on retail-sales spending for November. Expectations are for a seasonally adjusted 0.7% month-over-month increase in retail sales, compared with a 1.7% rise in October. Excluding autos, spending is seen rising 0.8%, compared with 1.7% in the previous period.\nThursday 12/16\nHeico,Lennar, Accenture, FedEx, Jabil, Adobe, Rivian Automotive, and Nordson are among companies hosting earnings conference calls.\nThe Census Bureaureleases its New Residential Construction report for November. The seasonally adjusted annual rate of housing starts is expected to be 1.563 million units, compared with 1.52 million in October. A housing start is counted when excavation begins on a home. Permits issued for new-home construction are expected to be 1.655 million, compared with 1.653 million in October.\nThe Bank of England announces its interest-rate decision and publishes the minutes of the meeting.\nThe Federal Reserve releases industrial production data for November. Economists are looking for a 0.6% rise, after a 1.6% increase in October. Capacity utilization is expected at 76.8, roughly in line with October’s 76.4%.\nFriday 12/17\nSteelcase,Darden Restaurants, and Quanex Building Products host earnings conference calls.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1052,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602254203,"gmtCreate":1639032338716,"gmtModify":1639032338826,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602254203","repostId":"2190169579","repostType":4,"repost":{"id":"2190169579","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639001174,"share":"https://www.laohu8.com/m/news/2190169579?lang=&edition=full","pubTime":"2021-12-09 06:06","market":"us","language":"en","title":"Wall St closes higher as vaccine update feeds optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2190169579","media":"Reuters","summary":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third st","content":"<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St closes higher as vaccine update feeds optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St closes higher as vaccine update feeds optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-09 06:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QQQ":"纳指100ETF","BK4517":"邮轮概念","UDOW":"道指三倍做多ETF-ProShares","PFE":"辉瑞","QID":"纳指两倍做空ETF","TQQQ":"纳指三倍做多ETF","BK4142":"酒店、度假村与豪华游轮","DJX":"1/100道琼斯","NCLH":"挪威邮轮","SWK":"美国史丹利公司","BK4161":"工业机械","PSQ":"纳指反向ETF","DXD":"道指两倍做空ETF","QLD":"纳指两倍做多ETF","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4566":"资本集团","DDM":"道指两倍做多ETF",".DJI":"道琼斯","DOG":"道指反向ETF","CCL":"嘉年华邮轮","SQQQ":"纳指三倍做空ETF","BK4568":"美国抗疫概念",".IXIC":"NASDAQ Composite","BK4550":"红杉资本持仓","SDOW":"道指三倍做空ETF-ProShares",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190169579","content_text":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.\nPfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.\nInvestors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.\nMarkets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.\nIn a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.\nWhile Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.\nWith Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"\n\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.\nThe Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.\nThe S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.\n\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.\nSector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.\nWHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.\nSo-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.\nGoodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".\nStanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.\nOn U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602343337,"gmtCreate":1638975935231,"gmtModify":1638975935231,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Nicee","listText":"Nicee","text":"Nicee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602343337","repostId":"1100353648","repostType":4,"isVote":1,"tweetType":1,"viewCount":614,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606201331,"gmtCreate":1638880267101,"gmtModify":1638880267214,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Nicee","listText":"Nicee","text":"Nicee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606201331","repostId":"2189398466","repostType":4,"repost":{"id":"2189398466","kind":"highlight","pubTimestamp":1638880110,"share":"https://www.laohu8.com/m/news/2189398466?lang=&edition=full","pubTime":"2021-12-07 20:28","market":"us","language":"en","title":"3 High-Growth Stocks Wall Street Thinks Could Soar 30% or More","url":"https://stock-news.laohu8.com/highlight/detail?id=2189398466","media":"Motley Fool","summary":"Analyst estimates suggest the stock market isn't giving these stocks the attention they deserve.","content":"<p>When it rains, it pours. A market scorned for tech stocks, in general, has been particularly rough on the biotechnology industry and a slew of companies that provide software as a service (SaaS).</p>\n<p>Wall Street analysts who follow these companies don't think they've lost their sparkle. The average target on each <a href=\"https://laohu8.com/S/AONE.U\">one</a> is still at least 30% above their recent prices.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a3dc6b5af684b3586af06831b8c96c8\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p>If you're already holding these stocks in your portfolio, now could be a good time to average down. If you missed the boat the first time around, here's another chance to get in at a relatively low price.</p>\n<h2>1. Veeva Systems</h2>\n<p><b>Veeva Systems</b> (NYSE:VEEV) stock fell about 22% over the past month. Now, this stock is around 27% below the peak it reached over the summer.</p>\n<p>Wall Street analysts are expecting a swift rebound for Veeva Systems in 2022. The consensus price target for this stock represents a 30% premium over recent prices.</p>\n<p>Veeva Systems is a cloud service provider to the biopharmaceutical industry. Fiscal third-quarter earnings results came in slightly above expectations, but analysts on Wall Street have gotten used to this company beating estimates by a wide margin.</p>\n<p>A couple of quarters with less than amazing financial results hardly seem like a reason to avoid this well-positioned SaaS stock. The biopharmaceutical industry increasingly relies on Veeva Systems' suite of subscription-based services.</p>\n<p>Customer relationship management is just the tip of the spear for Veeva Systems. Its subscribers can also warehouse waves of data thrown off in the course of developing new drugs in a way that helps them meet the expectations of regulators all over the world.</p>\n<p>Despite the recent drop, Veeva Systems' stock isn't exactly cheap. The shares have been trading at around 68 times the company's earnings expectations for the year. With super sticky subscriber revenue, though, this stock has a good chance to grow into its valuation.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ae1bb868442e00c2b966f9357851d00c\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>2. Global-E Online</h2>\n<p>Shares of international e-commerce facilitator <b>Global-E Online</b> (NASDAQ:GLBE) shot up after its IPO this spring, but the gains didn't last long. The stock's down around 31% from the peak it reached in early September.</p>\n<p>The average analyst following Global-E Online expects it to bounce right back. The consensus price target suggests around 36% of upside ahead for this provider of end-to-end international e-commerce services.</p>\n<p>Despite the sell-off, Global-E Online stock still looks pricey at 32.6 times trailing sales. Expectations are high, but a recent partnership deal with <b>Shopify</b> (NASDAQ:SHOP) gives Global-E Online a chance to grow past its optimistic valuation.</p>\n<p>A majority of Shopify merchants operate out of North America, but they don't sell to countries on different continents nearly as often as they would like to. The tie-up gives Global-E Online access to around 1.7 million Shopify merchants eager to reach a larger audience.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d75544ca9267ab4ebb394449490deefc\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>3. Twist Bioscience</h2>\n<p><b>Twist Bioscience</b> (NASDAQ:TWST) is a DNA synthesis leader that has fallen around 40% over the past month. Investment bank analysts who follow the company think it can recover those losses soon. The consensus target for Twist Bioscience is around 38% higher than its recent price.</p>\n<p>At its peak this year, Twist Bioscience's market cap rose past $10 billion. During the company's fiscal year ended Sept. 30, 2021, total revenue reached just $132.3 million. That was an impressive 16% gain over the previous year, but hardly enough to justify such an enormous valuation.</p>\n<p>Copying a strand of DNA that already exists isn't nearly as difficult as it used to be. Accurately producing totally new bits of DNA code at scale, though, is usually prohibitively expensive. Twist Bioscience's proprietary DNA synthesis platform allows the company to synthesize DNA at a fraction of the cost of its nearest competitor, and its lead is expanding.</p>\n<p>Producing custom DNA strands to help drugmakers develop new drugs is Twist Bioscience's largest source of revenue at the moment, but it's probably just the tip of the iceberg. Twist Biosciences is doing for DNA synthesis what <b>Microsoft</b>'s Windows operating system did for personal computers in the 1990s.</p>\n<p>Since DNA is relatively stable over long periods of time, data storage is one potential new application. It's hard to know exactly what direction Twist Biosciences' customer base will expand in. We can be sure that patient investors who buy this high-growth stock now are in for an interesting ride.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 High-Growth Stocks Wall Street Thinks Could Soar 30% or More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 High-Growth Stocks Wall Street Thinks Could Soar 30% or More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 20:28 GMT+8 <a href=https://www.fool.com/investing/2021/12/07/3-high-growth-stocks-wall-street-thinks-could-soar/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When it rains, it pours. A market scorned for tech stocks, in general, has been particularly rough on the biotechnology industry and a slew of companies that provide software as a service (SaaS).\nWall...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/07/3-high-growth-stocks-wall-street-thinks-could-soar/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","BK4122":"互联网与直销零售","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4539":"次新股","BK4504":"桥水持仓","BK4528":"SaaS概念","GLBE":"Global-E Online Ltd.","VEEV":"Veeva Systems Inc.","BK4167":"医疗保健技术"},"source_url":"https://www.fool.com/investing/2021/12/07/3-high-growth-stocks-wall-street-thinks-could-soar/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189398466","content_text":"When it rains, it pours. A market scorned for tech stocks, in general, has been particularly rough on the biotechnology industry and a slew of companies that provide software as a service (SaaS).\nWall Street analysts who follow these companies don't think they've lost their sparkle. The average target on each one is still at least 30% above their recent prices.\nImage source: Getty Images.\nIf you're already holding these stocks in your portfolio, now could be a good time to average down. If you missed the boat the first time around, here's another chance to get in at a relatively low price.\n1. Veeva Systems\nVeeva Systems (NYSE:VEEV) stock fell about 22% over the past month. Now, this stock is around 27% below the peak it reached over the summer.\nWall Street analysts are expecting a swift rebound for Veeva Systems in 2022. The consensus price target for this stock represents a 30% premium over recent prices.\nVeeva Systems is a cloud service provider to the biopharmaceutical industry. Fiscal third-quarter earnings results came in slightly above expectations, but analysts on Wall Street have gotten used to this company beating estimates by a wide margin.\nA couple of quarters with less than amazing financial results hardly seem like a reason to avoid this well-positioned SaaS stock. The biopharmaceutical industry increasingly relies on Veeva Systems' suite of subscription-based services.\nCustomer relationship management is just the tip of the spear for Veeva Systems. Its subscribers can also warehouse waves of data thrown off in the course of developing new drugs in a way that helps them meet the expectations of regulators all over the world.\nDespite the recent drop, Veeva Systems' stock isn't exactly cheap. The shares have been trading at around 68 times the company's earnings expectations for the year. With super sticky subscriber revenue, though, this stock has a good chance to grow into its valuation.\nImage source: Getty Images.\n2. Global-E Online\nShares of international e-commerce facilitator Global-E Online (NASDAQ:GLBE) shot up after its IPO this spring, but the gains didn't last long. The stock's down around 31% from the peak it reached in early September.\nThe average analyst following Global-E Online expects it to bounce right back. The consensus price target suggests around 36% of upside ahead for this provider of end-to-end international e-commerce services.\nDespite the sell-off, Global-E Online stock still looks pricey at 32.6 times trailing sales. Expectations are high, but a recent partnership deal with Shopify (NASDAQ:SHOP) gives Global-E Online a chance to grow past its optimistic valuation.\nA majority of Shopify merchants operate out of North America, but they don't sell to countries on different continents nearly as often as they would like to. The tie-up gives Global-E Online access to around 1.7 million Shopify merchants eager to reach a larger audience.\nImage source: Getty Images.\n3. Twist Bioscience\nTwist Bioscience (NASDAQ:TWST) is a DNA synthesis leader that has fallen around 40% over the past month. Investment bank analysts who follow the company think it can recover those losses soon. The consensus target for Twist Bioscience is around 38% higher than its recent price.\nAt its peak this year, Twist Bioscience's market cap rose past $10 billion. During the company's fiscal year ended Sept. 30, 2021, total revenue reached just $132.3 million. That was an impressive 16% gain over the previous year, but hardly enough to justify such an enormous valuation.\nCopying a strand of DNA that already exists isn't nearly as difficult as it used to be. Accurately producing totally new bits of DNA code at scale, though, is usually prohibitively expensive. Twist Bioscience's proprietary DNA synthesis platform allows the company to synthesize DNA at a fraction of the cost of its nearest competitor, and its lead is expanding.\nProducing custom DNA strands to help drugmakers develop new drugs is Twist Bioscience's largest source of revenue at the moment, but it's probably just the tip of the iceberg. Twist Biosciences is doing for DNA synthesis what Microsoft's Windows operating system did for personal computers in the 1990s.\nSince DNA is relatively stable over long periods of time, data storage is one potential new application. It's hard to know exactly what direction Twist Biosciences' customer base will expand in. We can be sure that patient investors who buy this high-growth stock now are in for an interesting ride.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1094,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608683241,"gmtCreate":1638711890532,"gmtModify":1638711890639,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Ooooo","listText":"Ooooo","text":"Ooooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/608683241","repostId":"2189576203","repostType":4,"repost":{"id":"2189576203","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638691560,"share":"https://www.laohu8.com/m/news/2189576203?lang=&edition=full","pubTime":"2021-12-05 16:06","market":"us","language":"en","title":"Peloton stock is a buy, but with an 'asterisk', analyst says","url":"https://stock-news.laohu8.com/highlight/detail?id=2189576203","media":"Dow Jones","summary":"Deutsche Bank's Chris Woronka said his 'unemotional analysis' suggests the at-home fitness company's","content":"<p>Deutsche Bank's Chris Woronka said his 'unemotional analysis' suggests the at-home fitness company's stock is worth owning for investors with 'patience'</p>\n<p>Investors should buy Peloton Interactive Inc.'s stock, says Deutsche Bank analyst Chris Woronka, but only those who have the patience to ride out potential volatility, which could last a \"few quarters.\"</p>\n<p>The at-home fitness company's stock <a href=\"https://laohu8.com/S/PTON\">$(PTON)$</a> slumped 2.0% to close Monday at $43.55, reversing an earlier intraday gain of as much as 4.6%.</p>\n<p>Peloton was viewed as a hot COVID-19-pandemic play last year, with the stock rocketing more than fivefold (up 434%), as gym closures fueled an explosion in the \"work-in\" trend. It's been an entirely different play in 2021, however, as the stock has plunged 71% year to date. It closed Wednesday at $42.25, the lowest price since May 27, 2020.</p>\n<p>In comparison, shares of fitness center operator <a href=\"https://laohu8.com/S/PLNT\">Planet Fitness Inc</a>. (PLNT) have gained 3.8% this year and the S&P 500 index has rallied 21%.</p>\n<p>While the stock has suffered a \"tough ride\" this year, and the going could still be a bit rough for a while, Deutsche Bank's Woronka said he is bullish on Peloton's fundamentals over the longer term.</p>\n<p>He initiated coverage of Peloton with a buy rating and a 12-month stock price target of $76, which implies nearly about 75% upside from current levels. Woronka said his view is based on an \"unemotional analysis\" of the company's earnings power in a \"normalized, fully-reopened\" economic environment.</p>\n<p>\"[W]hile it's never fun to lead off a buy report with a 'patience required' asterisk of sorts, that's exactly what we find ourselves doing here,\" Woronka wrote in a note to clients.</p>\n<p>As a fundamental analyst, Woronka said he is most interested in looking for \"asymmetrical risk/reward scenarios,\" and that's what he believes Pelton's stock provides at current levels. While there are scenarios in which the stock can still go lower, he believes there are more scenarios that result in even greater upside.</p>\n<p>\"Right now, we believe the market is looking at fitness stocks as an 'either/or' sector; either consumers stay at home to work out or they go back to their favorite pre-COVID-19 fitness facility,\" Woronka wrote. \"In our opinion, that's an oversimplified view of the world; we think the hybrid work model extends to fitness, too, and that [Peloton] has plenty of momentum to regain operationally.\"</p>\n<p>He realizes that sentiment on the stock isn't likely to reflect his bullish view \"until a few quarters of improved execution\" are in the books. But that's where the opportunity for reward lies over a 12-month time horizon.</p>\n<p>Once the stock starts trading on fundamentals again, Woronka believes \"it has quite a bit of room to run.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peloton stock is a buy, but with an 'asterisk', analyst says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeloton stock is a buy, but with an 'asterisk', analyst says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-05 16:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Deutsche Bank's Chris Woronka said his 'unemotional analysis' suggests the at-home fitness company's stock is worth owning for investors with 'patience'</p>\n<p>Investors should buy Peloton Interactive Inc.'s stock, says Deutsche Bank analyst Chris Woronka, but only those who have the patience to ride out potential volatility, which could last a \"few quarters.\"</p>\n<p>The at-home fitness company's stock <a href=\"https://laohu8.com/S/PTON\">$(PTON)$</a> slumped 2.0% to close Monday at $43.55, reversing an earlier intraday gain of as much as 4.6%.</p>\n<p>Peloton was viewed as a hot COVID-19-pandemic play last year, with the stock rocketing more than fivefold (up 434%), as gym closures fueled an explosion in the \"work-in\" trend. It's been an entirely different play in 2021, however, as the stock has plunged 71% year to date. It closed Wednesday at $42.25, the lowest price since May 27, 2020.</p>\n<p>In comparison, shares of fitness center operator <a href=\"https://laohu8.com/S/PLNT\">Planet Fitness Inc</a>. (PLNT) have gained 3.8% this year and the S&P 500 index has rallied 21%.</p>\n<p>While the stock has suffered a \"tough ride\" this year, and the going could still be a bit rough for a while, Deutsche Bank's Woronka said he is bullish on Peloton's fundamentals over the longer term.</p>\n<p>He initiated coverage of Peloton with a buy rating and a 12-month stock price target of $76, which implies nearly about 75% upside from current levels. Woronka said his view is based on an \"unemotional analysis\" of the company's earnings power in a \"normalized, fully-reopened\" economic environment.</p>\n<p>\"[W]hile it's never fun to lead off a buy report with a 'patience required' asterisk of sorts, that's exactly what we find ourselves doing here,\" Woronka wrote in a note to clients.</p>\n<p>As a fundamental analyst, Woronka said he is most interested in looking for \"asymmetrical risk/reward scenarios,\" and that's what he believes Pelton's stock provides at current levels. While there are scenarios in which the stock can still go lower, he believes there are more scenarios that result in even greater upside.</p>\n<p>\"Right now, we believe the market is looking at fitness stocks as an 'either/or' sector; either consumers stay at home to work out or they go back to their favorite pre-COVID-19 fitness facility,\" Woronka wrote. \"In our opinion, that's an oversimplified view of the world; we think the hybrid work model extends to fitness, too, and that [Peloton] has plenty of momentum to regain operationally.\"</p>\n<p>He realizes that sentiment on the stock isn't likely to reflect his bullish view \"until a few quarters of improved execution\" are in the books. But that's where the opportunity for reward lies over a 12-month time horizon.</p>\n<p>Once the stock starts trading on fundamentals again, Woronka believes \"it has quite a bit of room to run.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4551":"寇图资本持仓","BK4216":"消闲设施","BK4190":"消闲用品","BK4566":"资本集团","PTON":"Peloton Interactive, Inc.","BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189576203","content_text":"Deutsche Bank's Chris Woronka said his 'unemotional analysis' suggests the at-home fitness company's stock is worth owning for investors with 'patience'\nInvestors should buy Peloton Interactive Inc.'s stock, says Deutsche Bank analyst Chris Woronka, but only those who have the patience to ride out potential volatility, which could last a \"few quarters.\"\nThe at-home fitness company's stock $(PTON)$ slumped 2.0% to close Monday at $43.55, reversing an earlier intraday gain of as much as 4.6%.\nPeloton was viewed as a hot COVID-19-pandemic play last year, with the stock rocketing more than fivefold (up 434%), as gym closures fueled an explosion in the \"work-in\" trend. It's been an entirely different play in 2021, however, as the stock has plunged 71% year to date. It closed Wednesday at $42.25, the lowest price since May 27, 2020.\nIn comparison, shares of fitness center operator Planet Fitness Inc. (PLNT) have gained 3.8% this year and the S&P 500 index has rallied 21%.\nWhile the stock has suffered a \"tough ride\" this year, and the going could still be a bit rough for a while, Deutsche Bank's Woronka said he is bullish on Peloton's fundamentals over the longer term.\nHe initiated coverage of Peloton with a buy rating and a 12-month stock price target of $76, which implies nearly about 75% upside from current levels. Woronka said his view is based on an \"unemotional analysis\" of the company's earnings power in a \"normalized, fully-reopened\" economic environment.\n\"[W]hile it's never fun to lead off a buy report with a 'patience required' asterisk of sorts, that's exactly what we find ourselves doing here,\" Woronka wrote in a note to clients.\nAs a fundamental analyst, Woronka said he is most interested in looking for \"asymmetrical risk/reward scenarios,\" and that's what he believes Pelton's stock provides at current levels. While there are scenarios in which the stock can still go lower, he believes there are more scenarios that result in even greater upside.\n\"Right now, we believe the market is looking at fitness stocks as an 'either/or' sector; either consumers stay at home to work out or they go back to their favorite pre-COVID-19 fitness facility,\" Woronka wrote. \"In our opinion, that's an oversimplified view of the world; we think the hybrid work model extends to fitness, too, and that [Peloton] has plenty of momentum to regain operationally.\"\nHe realizes that sentiment on the stock isn't likely to reflect his bullish view \"until a few quarters of improved execution\" are in the books. But that's where the opportunity for reward lies over a 12-month time horizon.\nOnce the stock starts trading on fundamentals again, Woronka believes \"it has quite a bit of room to run.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":1402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601213073,"gmtCreate":1638533968624,"gmtModify":1638533968736,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601213073","repostId":"1177709350","repostType":4,"repost":{"id":"1177709350","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638533783,"share":"https://www.laohu8.com/m/news/1177709350?lang=&edition=full","pubTime":"2021-12-03 20:16","market":"us","language":"en","title":"Vaccine makers should plan to adjust COVID-19 jabs - WHO","url":"https://stock-news.laohu8.com/highlight/detail?id=1177709350","media":"Reuters","summary":"GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the \"likelihood\" of needing","content":"<p>GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the \"likelihood\" of needing to adjust their products to protect against the Omicron variant, the World Health Organization's (WHO) spokesperson said on Friday.</p>\n<p>Christian Lindmeier, speaking at a U.N. briefing in Geneva, said the agency was studying the transmissibility and severity of the variant first detected in southern Africa last month.</p>\n<p>\"It is very recommendable that vaccine manufacturers already start planning ahead and plan for the likelihood for having to adjust the existing vaccine,\" he said.</p>\n<p>\"That's good not just to wait until the final alarm bell rings,\" he said.</p>\n<p>Germany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the emergence of the Omicron variant, its CEO Ugur Sahin told the Reuters Next conference on Friday.</p>\n<p>South African scientists studying the Omicron outbreak believe symptoms are less severe for those reinfected with COVID-19 by the new variant or infected after vaccination, a top scientist said on Thursday.</p>\n<p>Maria van Kerkhove, the WHO's technical lead on COVID-19, said on Wednesday that the body expected to have more information on the transmissibility of the new Omicron variant \"within days\".</p>\n<p>\"It will still take some time and let's not rush into conclusions here,\" Lindmeier said on Friday.</p>\n<p>\"Preliminary data, and we have said that now since awhile, show that there is higher transmissibility. But that's all that we basically have so far,\" he said.</p>\n<p>Delta remains the dominant variant globally, accounting for more than 90% of infections, Lindmeier said.</p>\n<p>\"So Omicron may be on the rise, and we may come to point where it takes over to be the dominant variant, but at this point the very dominant variant remains Delta,\" he said.</p>\n<p>\"The restrictions that were put into place in many countries just two weeks ago, economic closures again, lockdowns in some areas, closure of Christmas markets in parts of Europe, this was done before Omicron because of a rise in Delta cases.</p>\n<p>Let's not lose sight of this,\" he added.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine makers should plan to adjust COVID-19 jabs - WHO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine makers should plan to adjust COVID-19 jabs - WHO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-03 20:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the \"likelihood\" of needing to adjust their products to protect against the Omicron variant, the World Health Organization's (WHO) spokesperson said on Friday.</p>\n<p>Christian Lindmeier, speaking at a U.N. briefing in Geneva, said the agency was studying the transmissibility and severity of the variant first detected in southern Africa last month.</p>\n<p>\"It is very recommendable that vaccine manufacturers already start planning ahead and plan for the likelihood for having to adjust the existing vaccine,\" he said.</p>\n<p>\"That's good not just to wait until the final alarm bell rings,\" he said.</p>\n<p>Germany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the emergence of the Omicron variant, its CEO Ugur Sahin told the Reuters Next conference on Friday.</p>\n<p>South African scientists studying the Omicron outbreak believe symptoms are less severe for those reinfected with COVID-19 by the new variant or infected after vaccination, a top scientist said on Thursday.</p>\n<p>Maria van Kerkhove, the WHO's technical lead on COVID-19, said on Wednesday that the body expected to have more information on the transmissibility of the new Omicron variant \"within days\".</p>\n<p>\"It will still take some time and let's not rush into conclusions here,\" Lindmeier said on Friday.</p>\n<p>\"Preliminary data, and we have said that now since awhile, show that there is higher transmissibility. But that's all that we basically have so far,\" he said.</p>\n<p>Delta remains the dominant variant globally, accounting for more than 90% of infections, Lindmeier said.</p>\n<p>\"So Omicron may be on the rise, and we may come to point where it takes over to be the dominant variant, but at this point the very dominant variant remains Delta,\" he said.</p>\n<p>\"The restrictions that were put into place in many countries just two weeks ago, economic closures again, lockdowns in some areas, closure of Christmas markets in parts of Europe, this was done before Omicron because of a rise in Delta cases.</p>\n<p>Let's not lose sight of this,\" he added.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNY":"赛诺菲安万特","MRK":"默沙东","JNJ":"强生","AZN":"阿斯利康","LLY":"礼来","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177709350","content_text":"GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the \"likelihood\" of needing to adjust their products to protect against the Omicron variant, the World Health Organization's (WHO) spokesperson said on Friday.\nChristian Lindmeier, speaking at a U.N. briefing in Geneva, said the agency was studying the transmissibility and severity of the variant first detected in southern Africa last month.\n\"It is very recommendable that vaccine manufacturers already start planning ahead and plan for the likelihood for having to adjust the existing vaccine,\" he said.\n\"That's good not just to wait until the final alarm bell rings,\" he said.\nGermany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the emergence of the Omicron variant, its CEO Ugur Sahin told the Reuters Next conference on Friday.\nSouth African scientists studying the Omicron outbreak believe symptoms are less severe for those reinfected with COVID-19 by the new variant or infected after vaccination, a top scientist said on Thursday.\nMaria van Kerkhove, the WHO's technical lead on COVID-19, said on Wednesday that the body expected to have more information on the transmissibility of the new Omicron variant \"within days\".\n\"It will still take some time and let's not rush into conclusions here,\" Lindmeier said on Friday.\n\"Preliminary data, and we have said that now since awhile, show that there is higher transmissibility. But that's all that we basically have so far,\" he said.\nDelta remains the dominant variant globally, accounting for more than 90% of infections, Lindmeier said.\n\"So Omicron may be on the rise, and we may come to point where it takes over to be the dominant variant, but at this point the very dominant variant remains Delta,\" he said.\n\"The restrictions that were put into place in many countries just two weeks ago, economic closures again, lockdowns in some areas, closure of Christmas markets in parts of Europe, this was done before Omicron because of a rise in Delta cases.\nLet's not lose sight of this,\" he added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":817,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603947489,"gmtCreate":1638358841076,"gmtModify":1638358841313,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"I see","listText":"I see","text":"I see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603947489","repostId":"1159950155","repostType":4,"repost":{"id":"1159950155","kind":"news","pubTimestamp":1638358466,"share":"https://www.laohu8.com/m/news/1159950155?lang=&edition=full","pubTime":"2021-12-01 19:34","market":"us","language":"en","title":"Bionano Genomics Proves Not Everything Genetic is Gold","url":"https://stock-news.laohu8.com/highlight/detail?id=1159950155","media":"InvestorPlace","summary":"Genomics is the coming thing, but BNGO stock investors want to see the money","content":"<p>The tech underpinning <b>Bionano Genomics</b>(NASDAQ:<b><u>BNGO</u></b>) stock is a cool genomics sequencing device called Saphyr. It claims to do genomic mapping faster, and better, than ever before possible. The machine costs$150,000, but it’s offered as a service for as little as $950 per sample.</p>\n<p>Bionano’s third-quarter report showed 141 Saphyr devices had been installed as of the end of September,24 in the third quarter alone. New hires in the sales department made future prospects look good.</p>\n<p>Buy, buy, buy,<i>right</i>? Nope. Sell, sell, sell. Since a speculative spike in February sent the stock to $15.57, it has gone nowhere but down. It closed out November at $3.91 a share. That’s still up on the year, but the trend is not in your favor.</p>\n<p><b>Seeking Value in BNGO Stock</b></p>\n<p>Even at its current price, Bionano is an expensive stock.</p>\n<p>Sales for the first three quarters of 2021 were up 250% from a year ago. But they totaled less than $11.7 million. Operating losses were also up 76%, to over $48 million. The company was still putting $6.5 million into research expenses during the third quarter. Sales and general administrative expenses have nearly doubled from a year ago.</p>\n<p>There is promise here. Our Chris Tyler remains bullish.So doesLouis Navellier. The stock may be down, but the science is sound.</p>\n<p>Trouble is, if all that is true, why won’t Cathie Woods’ ARK Invest buy in? I checked the <b>ARK Genomic Revolution ETF</b>(NYSEARCA:<b><u>ARKG</u></b>) before writing this. It has no investments in BNGO stock. That’s bad. What’s worse is that ARKG shares themselves are down nearly a third since June. They were trading at $63.37 on Nov. 30 from $93.01 in late June.</p>\n<p>What investors seem to be saying is: Don’t show us the tech, show us the money.</p>\n<p><b>The Market Reality</b></p>\n<p>I have been pounding the table for two years now on DNA as a programming language. It’s a coming thing.</p>\n<p>But devices like the Saphyr aren’t where the money is. Big equipment purchases are carefully considered against hospital and research institution budgets. An institution is going to do a lot of tests before it makes the capital commitment. Even after you buy the Saphyr system, you’re going to be spending $450/test for reagents. In the near term, it’s Bionano’s services business that holds the most promise. Even at $1,000 per test, it takes a lot of tests to justify a market cap of $1.15 billion.</p>\n<p>All the analysts tracked by <i>TipRanks</i> say “buy.”. The problem is there are only three of them. The analysis to me looks one-sided. Analysts are in the business of selling stock. A legitimate company like Bionano isn’t going to have people talking it down until there’s real news.</p>\n<p>That’s why writers like our Joseph Nograles are advising caution.Speculators are fleeing the sector. Even the current stock price makes no sense, from the point of view of value. Hope can be found in some recent hires from <b>Illumina</b>(NASDAQ:<b><u>ILMN</u></b>), a mature genetics testing outfitwith a market capitalization of nearly $58 billion and positive earnings. But that’s just hope.</p>\n<p><b>The Bionano Bottom Line</b></p>\n<p>Bionano is not going to be a quick hit. It’s not going to make you rich in the next year unless there’s another flood of speculation in the sector.</p>\n<p>But this is a solid technology with good growth prospects.If you like the sector, keep an eye on it. Keep an eye on exchange-traded funds like ARKG, as well. When the ETF makes a decisive move higher, that’s when you can look at Bionano. Until then I think you’re overpaying.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bionano Genomics Proves Not Everything Genetic is Gold</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBionano Genomics Proves Not Everything Genetic is Gold\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 19:34 GMT+8 <a href=https://investorplace.com/2021/12/bionano-genomics-proves-not-everything-genetic-is-gold/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The tech underpinning Bionano Genomics(NASDAQ:BNGO) stock is a cool genomics sequencing device called Saphyr. It claims to do genomic mapping faster, and better, than ever before possible. The machine...</p>\n\n<a href=\"https://investorplace.com/2021/12/bionano-genomics-proves-not-everything-genetic-is-gold/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://investorplace.com/2021/12/bionano-genomics-proves-not-everything-genetic-is-gold/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159950155","content_text":"The tech underpinning Bionano Genomics(NASDAQ:BNGO) stock is a cool genomics sequencing device called Saphyr. It claims to do genomic mapping faster, and better, than ever before possible. The machine costs$150,000, but it’s offered as a service for as little as $950 per sample.\nBionano’s third-quarter report showed 141 Saphyr devices had been installed as of the end of September,24 in the third quarter alone. New hires in the sales department made future prospects look good.\nBuy, buy, buy,right? Nope. Sell, sell, sell. Since a speculative spike in February sent the stock to $15.57, it has gone nowhere but down. It closed out November at $3.91 a share. That’s still up on the year, but the trend is not in your favor.\nSeeking Value in BNGO Stock\nEven at its current price, Bionano is an expensive stock.\nSales for the first three quarters of 2021 were up 250% from a year ago. But they totaled less than $11.7 million. Operating losses were also up 76%, to over $48 million. The company was still putting $6.5 million into research expenses during the third quarter. Sales and general administrative expenses have nearly doubled from a year ago.\nThere is promise here. Our Chris Tyler remains bullish.So doesLouis Navellier. The stock may be down, but the science is sound.\nTrouble is, if all that is true, why won’t Cathie Woods’ ARK Invest buy in? I checked the ARK Genomic Revolution ETF(NYSEARCA:ARKG) before writing this. It has no investments in BNGO stock. That’s bad. What’s worse is that ARKG shares themselves are down nearly a third since June. They were trading at $63.37 on Nov. 30 from $93.01 in late June.\nWhat investors seem to be saying is: Don’t show us the tech, show us the money.\nThe Market Reality\nI have been pounding the table for two years now on DNA as a programming language. It’s a coming thing.\nBut devices like the Saphyr aren’t where the money is. Big equipment purchases are carefully considered against hospital and research institution budgets. An institution is going to do a lot of tests before it makes the capital commitment. Even after you buy the Saphyr system, you’re going to be spending $450/test for reagents. In the near term, it’s Bionano’s services business that holds the most promise. Even at $1,000 per test, it takes a lot of tests to justify a market cap of $1.15 billion.\nAll the analysts tracked by TipRanks say “buy.”. The problem is there are only three of them. The analysis to me looks one-sided. Analysts are in the business of selling stock. A legitimate company like Bionano isn’t going to have people talking it down until there’s real news.\nThat’s why writers like our Joseph Nograles are advising caution.Speculators are fleeing the sector. Even the current stock price makes no sense, from the point of view of value. Hope can be found in some recent hires from Illumina(NASDAQ:ILMN), a mature genetics testing outfitwith a market capitalization of nearly $58 billion and positive earnings. But that’s just hope.\nThe Bionano Bottom Line\nBionano is not going to be a quick hit. It’s not going to make you rich in the next year unless there’s another flood of speculation in the sector.\nBut this is a solid technology with good growth prospects.If you like the sector, keep an eye on it. Keep an eye on exchange-traded funds like ARKG, as well. When the ETF makes a decisive move higher, that’s when you can look at Bionano. Until then I think you’re overpaying.","news_type":1},"isVote":1,"tweetType":1,"viewCount":364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600932704,"gmtCreate":1638034058766,"gmtModify":1638034058841,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600932704","repostId":"1138332509","repostType":4,"repost":{"id":"1138332509","kind":"news","pubTimestamp":1637978067,"share":"https://www.laohu8.com/m/news/1138332509?lang=&edition=full","pubTime":"2021-11-27 09:54","market":"us","language":"en","title":"Did Qualcomm Just Reveal One of Meta's Biggest Secrets?","url":"https://stock-news.laohu8.com/highlight/detail?id=1138332509","media":"Motley Fool","summary":"Meta Platforms, the tech giant formerly known as Facebook, has never revealed any exact shipment figures for its Oculus virtual reality headsets. But it's dropped plenty of hints along the way.Two years ago, CEO Mark Zuckerberg set a long-term goal of hitting 10 million VR users to become a sustainable software platform for developers. This August, Meta's AR and VR chief Andrew Bosworth said he was \"convinced\" it would hit that threshold earlier than it \"had initially expected.\". In a subsequen","content":"<p><b>Meta Platforms</b>(NASDAQ:FB), the tech giant formerly known as Facebook, has never revealed any exact shipment figures for its Oculus virtual reality (VR) headsets. But it's dropped plenty of hints along the way.</p>\n<p>Two years ago, CEO Mark Zuckerberg set a long-term goal of hitting 10 million VR users to become a sustainable software platform for developers. This August, Meta's AR and VR chief Andrew Bosworth said he was \"convinced\" it would hit that threshold earlier than it \"had initially expected.\"</p>\n<p>Meta didn't say anything else about hitting that target during last quarter's conference call, but it attributed the 195% year-over-year growth of its \"others\" segment to \"strong Quest 2 sales.\" However,<b>Qualcomm</b>(NASDAQ:QCOM) seemingly let the cat of the bag in a recent investor day presentation, when CEO Cristiano Amon casually noted that Oculus had shipped 10 million Quest 2 headsets since its launch last October.</p>\n<p>In a subsequent statement, Qualcomm said that figure was actually based on third-party estimates and wasn't \"meant as an official disclosure of sales numbers by Meta or Qualcomm.\" But even if those numbers weren't official, they give investors a much clearer view of Meta's opaque Oculus segment.</p>\n<p>Why does Meta want to sell 10 million headsets?</p>\n<p>Meta bought Oculus VR in 2014, and it launched its first commercial headset, the Oculus Rift, in 2016. However, the Rift remained a niche gaming device that needed to be tethered to a high-end PC.</p>\n<p>To address those limitations, Meta launched its first wireless VR headset, the Oculus Go, in 2018. It wasn't as powerful as the Rift, but it didn't need to be tethered to a PC or mobile device. It followed up the Go with the more powerful Oculus Quest in 2019, and it launched the Quest 2 -- which was even more powerful, lighter, and had better controllers -- last year.</p>\n<p>The success of the Quest headsets enabled Meta to sell more VR games and experiences on the platform. Last May, it said the Quest platform had surpassed $100 million in VR content sales. This January, it said that over 60 Oculus Quest titles had surpassed $1 million in revenue. This October, it said <i>Beat Saber</i>-- the hit VR rhythm game it acquired in late 2019 -- had exceeded $100 million in lifetime sales on the Quest platform alone.</p>\n<p>Those sales figures are tiny compared to Meta's estimated revenue of $117.8 billion this year. Ten million headsets might also sound paltry compared to other gaming platforms.<b>Nintendo</b>, for example, has shipped nearly 95 million Switch devices since 2017.</p>\n<p>However, the Quest has still set up the foundations for Meta's push into the \"metaverse\" -- which already includes new augmented reality (AR) devices like its new Ray-Ban smartglasses and Horizon Workrooms, which enable remote workers to hold VR meetings with digital avatars. The expansion of that ecosystem could gradually tie together its social networking, AR, and VR platforms, while significantly extending its reach beyond PCs and mobile devices.</p>\n<p>Why is Qualcomm talking about VR headsets?</p>\n<p>Qualcomm's chipsets power the Oculus Go, Quest, and Quest 2 headsets. The Go and first-generation Quest both used Snapdragon mobile system on chips (SoCs), which were commonly used in mobile phones.</p>\n<p>However, the second-generation Quest used the new Snapdragon XR2 SoC, which was specifically designed with VR and AR devices in mind. The chipset can be tethered to seven concurrent cameras to track a user's motions and gestures, supports 8K 360-degree videos, provides 3D audio, and supports AI processing features for voice commands.</p>\n<p>Qualcomm is selling more VR/AR chips to diversify its core business away from the smartphone market. That market is heavily commoditized, and it's facing intense competition from rivals like <b>MediaTek</b> as well as first-party chipsets from original equipment manufacturers (OEMs) like <b>Apple</b>,<b>Samsung</b>, and <b>Huawei</b>.</p>\n<p>That's also why Qualcomm has been rolling out new specialized chipsets for wearables, cars, drones, and other Internet of Things (IoT) devices in recent years. None of these chipsets are significantly reducing its dependence on the smartphone market yet, but that could change over the next few years.</p>\n<p>For example, the global AR and VR market could grow at a compound annual growth rate (CAGR) of 46% between 2021 and 2025, according to Technavio. But the global smartphone market might only grow at a CAGR of 1.7% between 2021 and 2026, according to Mordor Intelligence.</p>\n<p>We should take those estimates with a grain of salt, but it's easy to see why Qualcomm is so keen to develop new VR chips for Meta. If VR headset sales tale off over the next few years, Qualcomm could dominate that platform with its chips in the same way it became the market leader in smartphone chips.</p>\n<p>Setting up the foundations of the future</p>\n<p>Qualcomm's revelation, official or not, indicates Meta's VR business is growing rapidly. It isn't as large as the top gaming consoles yet, but it's gaining momentum and forming the foundations of its metaverse business.</p>\n<p>Investors shouldn't expect Meta and Qualcomm to generate significant revenue from those efforts in the near future. But over the long term, they could significantly transform the business models of both companies.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Did Qualcomm Just Reveal One of Meta's Biggest Secrets?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDid Qualcomm Just Reveal One of Meta's Biggest Secrets?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-27 09:54 GMT+8 <a href=https://www.fool.com/investing/2021/11/26/did-qualcomm-just-reveal-meta-biggest-secret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meta Platforms(NASDAQ:FB), the tech giant formerly known as Facebook, has never revealed any exact shipment figures for its Oculus virtual reality (VR) headsets. But it's dropped plenty of hints along...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/26/did-qualcomm-just-reveal-meta-biggest-secret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QCOM":"高通"},"source_url":"https://www.fool.com/investing/2021/11/26/did-qualcomm-just-reveal-meta-biggest-secret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138332509","content_text":"Meta Platforms(NASDAQ:FB), the tech giant formerly known as Facebook, has never revealed any exact shipment figures for its Oculus virtual reality (VR) headsets. But it's dropped plenty of hints along the way.\nTwo years ago, CEO Mark Zuckerberg set a long-term goal of hitting 10 million VR users to become a sustainable software platform for developers. This August, Meta's AR and VR chief Andrew Bosworth said he was \"convinced\" it would hit that threshold earlier than it \"had initially expected.\"\nMeta didn't say anything else about hitting that target during last quarter's conference call, but it attributed the 195% year-over-year growth of its \"others\" segment to \"strong Quest 2 sales.\" However,Qualcomm(NASDAQ:QCOM) seemingly let the cat of the bag in a recent investor day presentation, when CEO Cristiano Amon casually noted that Oculus had shipped 10 million Quest 2 headsets since its launch last October.\nIn a subsequent statement, Qualcomm said that figure was actually based on third-party estimates and wasn't \"meant as an official disclosure of sales numbers by Meta or Qualcomm.\" But even if those numbers weren't official, they give investors a much clearer view of Meta's opaque Oculus segment.\nWhy does Meta want to sell 10 million headsets?\nMeta bought Oculus VR in 2014, and it launched its first commercial headset, the Oculus Rift, in 2016. However, the Rift remained a niche gaming device that needed to be tethered to a high-end PC.\nTo address those limitations, Meta launched its first wireless VR headset, the Oculus Go, in 2018. It wasn't as powerful as the Rift, but it didn't need to be tethered to a PC or mobile device. It followed up the Go with the more powerful Oculus Quest in 2019, and it launched the Quest 2 -- which was even more powerful, lighter, and had better controllers -- last year.\nThe success of the Quest headsets enabled Meta to sell more VR games and experiences on the platform. Last May, it said the Quest platform had surpassed $100 million in VR content sales. This January, it said that over 60 Oculus Quest titles had surpassed $1 million in revenue. This October, it said Beat Saber-- the hit VR rhythm game it acquired in late 2019 -- had exceeded $100 million in lifetime sales on the Quest platform alone.\nThose sales figures are tiny compared to Meta's estimated revenue of $117.8 billion this year. Ten million headsets might also sound paltry compared to other gaming platforms.Nintendo, for example, has shipped nearly 95 million Switch devices since 2017.\nHowever, the Quest has still set up the foundations for Meta's push into the \"metaverse\" -- which already includes new augmented reality (AR) devices like its new Ray-Ban smartglasses and Horizon Workrooms, which enable remote workers to hold VR meetings with digital avatars. The expansion of that ecosystem could gradually tie together its social networking, AR, and VR platforms, while significantly extending its reach beyond PCs and mobile devices.\nWhy is Qualcomm talking about VR headsets?\nQualcomm's chipsets power the Oculus Go, Quest, and Quest 2 headsets. The Go and first-generation Quest both used Snapdragon mobile system on chips (SoCs), which were commonly used in mobile phones.\nHowever, the second-generation Quest used the new Snapdragon XR2 SoC, which was specifically designed with VR and AR devices in mind. The chipset can be tethered to seven concurrent cameras to track a user's motions and gestures, supports 8K 360-degree videos, provides 3D audio, and supports AI processing features for voice commands.\nQualcomm is selling more VR/AR chips to diversify its core business away from the smartphone market. That market is heavily commoditized, and it's facing intense competition from rivals like MediaTek as well as first-party chipsets from original equipment manufacturers (OEMs) like Apple,Samsung, and Huawei.\nThat's also why Qualcomm has been rolling out new specialized chipsets for wearables, cars, drones, and other Internet of Things (IoT) devices in recent years. None of these chipsets are significantly reducing its dependence on the smartphone market yet, but that could change over the next few years.\nFor example, the global AR and VR market could grow at a compound annual growth rate (CAGR) of 46% between 2021 and 2025, according to Technavio. But the global smartphone market might only grow at a CAGR of 1.7% between 2021 and 2026, according to Mordor Intelligence.\nWe should take those estimates with a grain of salt, but it's easy to see why Qualcomm is so keen to develop new VR chips for Meta. If VR headset sales tale off over the next few years, Qualcomm could dominate that platform with its chips in the same way it became the market leader in smartphone chips.\nSetting up the foundations of the future\nQualcomm's revelation, official or not, indicates Meta's VR business is growing rapidly. It isn't as large as the top gaming consoles yet, but it's gaining momentum and forming the foundations of its metaverse business.\nInvestors shouldn't expect Meta and Qualcomm to generate significant revenue from those efforts in the near future. But over the long term, they could significantly transform the business models of both companies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":343,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877692443,"gmtCreate":1637920950475,"gmtModify":1637920950540,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877692443","repostId":"1100178242","repostType":4,"repost":{"id":"1100178242","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637920008,"share":"https://www.laohu8.com/m/news/1100178242?lang=&edition=full","pubTime":"2021-11-26 17:46","market":"us","language":"en","title":"Worried About A Market Crash? Here Are 3 Things You Can Do","url":"https://stock-news.laohu8.com/highlight/detail?id=1100178242","media":"Benzinga","summary":"COVID-19, a worry that investors had pushed down their list of top concerns in recent months, has so","content":"<p>COVID-19, a worry that investors had pushed down their list of top concerns in recent months, has soared back up to the number one spot as a new variant spreads across South Africa.</p>\n<p>Asia stocks outside Japan slid over 2%, Europe and U.S. stock futures are down sharply, oil prices drops almost 5%, the safe-haven yen is up around three-quarters of a percent, and U.S. Treasury yields are down almost 10 basis points.</p>\n<p>Little is known of the variant, detected in South Africa, Botswana and Hong Kong, but scientists reckon it has an unusual combination of mutations and may be able to evade immune responses or make it more transmissible.</p>\n<p>The news comes as Europe already battles a resurgent COVID-19 outbreak, triggering fresh restrictions that raise uncertainty over the near-term economic outlook.</p>\n<p>Thin liquidity following Thursday's U.S. Thanksgiving Day holiday likely exacerbates price moves for sure, but there's little doubt overnight headlines have taken markets by surprise on Friday.</p>\n<p>It’s been another great year for investors, with the <b>SPDR S&P 500 ETF Trust</b> up another 25.4% on the year. The S&P 500 has also made it more than a year since its last 10% correction, and some investors are growing concerned that a combination of historically high stock valuations, rising inflation, the COVID-19 variant and the possibility that aggressive Federal Reserve tightening could trigger a market crash in the next couple of quarters.</p>\n<p><img src=\"https://static.tigerbbs.com/1f999347452cfb2fdd30570431642cb9\" tg-width=\"685\" tg-height=\"375\" referrerpolicy=\"no-referrer\"></p>\n<p>Historically, the S&P 500 has averaged about one 10% pullback per yearsince 1950. Long-term investors have no reason to fear temporary market pullbacks, but there are ways to prepare for the next stock market crash to reduce your risk and take advantage of the potential buying opportunity. Here are three things to do before the next stock market crash.</p>\n<p><b>1. Diversify Your Portfolio</b></p>\n<p>Not all market sectors and asset classes take the same hit when the stock market crashes, but it’s difficult to predict beforehand which stocks will be hit hardest. The market crash in 2008 hit bank and housing stocks hardest, while the crash in 2020 was particularly bad for travel and retail stocks. Growth stocks also tend to take a harder hit than value stocks during market crashes. By diversifying your portfolio into different types of stocks, bonds, commodities and other investments, you are ensuring that your portfolio won’t be overexposed to the worst parts of the next market crash or underexposed to any investments that may avoid the sell-off.</p>\n<p><b>2. Raise Cash</b></p>\n<p>There have been countless pullbacks, crashes and recessions throughout history. One strategy that has worked every single time for long-term investors during those periods is buying the dip. But to buy the dip, you must have cash or margin available.</p>\n<p>If you are 100% invested, your hands will be tied and your only option may be tosell stockat the worst possible time. Market crashes are nearly impossible to predict, so there’s no need to dump all your stocks now and transition to all cash. But raising the amount of cash in your account to 10%, 20% or whatever level makes you feel more comfortable allows you to be opportunistic when the next crash happens.</p>\n<p><b>3. Maintain A Watch List</b></p>\n<p>Investors tend to not make the best, most rational decisions during the worst of a stock market crash. It’s best if you have a plan of action before the crash so that you aren’t trying to make emotional decisions when it seems like the sky is falling.</p>\n<p>Before the stock market turns south, make a list of stocks you may potentially be interested in buying on the dip. Research these companies and vet them prior to the crash so that all you have to do when the opportunity to buy the dip arises is click that “buy” button.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Worried About A Market Crash? Here Are 3 Things You Can Do</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWorried About A Market Crash? Here Are 3 Things You Can Do\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-26 17:46</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>COVID-19, a worry that investors had pushed down their list of top concerns in recent months, has soared back up to the number one spot as a new variant spreads across South Africa.</p>\n<p>Asia stocks outside Japan slid over 2%, Europe and U.S. stock futures are down sharply, oil prices drops almost 5%, the safe-haven yen is up around three-quarters of a percent, and U.S. Treasury yields are down almost 10 basis points.</p>\n<p>Little is known of the variant, detected in South Africa, Botswana and Hong Kong, but scientists reckon it has an unusual combination of mutations and may be able to evade immune responses or make it more transmissible.</p>\n<p>The news comes as Europe already battles a resurgent COVID-19 outbreak, triggering fresh restrictions that raise uncertainty over the near-term economic outlook.</p>\n<p>Thin liquidity following Thursday's U.S. Thanksgiving Day holiday likely exacerbates price moves for sure, but there's little doubt overnight headlines have taken markets by surprise on Friday.</p>\n<p>It’s been another great year for investors, with the <b>SPDR S&P 500 ETF Trust</b> up another 25.4% on the year. The S&P 500 has also made it more than a year since its last 10% correction, and some investors are growing concerned that a combination of historically high stock valuations, rising inflation, the COVID-19 variant and the possibility that aggressive Federal Reserve tightening could trigger a market crash in the next couple of quarters.</p>\n<p><img src=\"https://static.tigerbbs.com/1f999347452cfb2fdd30570431642cb9\" tg-width=\"685\" tg-height=\"375\" referrerpolicy=\"no-referrer\"></p>\n<p>Historically, the S&P 500 has averaged about one 10% pullback per yearsince 1950. Long-term investors have no reason to fear temporary market pullbacks, but there are ways to prepare for the next stock market crash to reduce your risk and take advantage of the potential buying opportunity. Here are three things to do before the next stock market crash.</p>\n<p><b>1. Diversify Your Portfolio</b></p>\n<p>Not all market sectors and asset classes take the same hit when the stock market crashes, but it’s difficult to predict beforehand which stocks will be hit hardest. The market crash in 2008 hit bank and housing stocks hardest, while the crash in 2020 was particularly bad for travel and retail stocks. Growth stocks also tend to take a harder hit than value stocks during market crashes. By diversifying your portfolio into different types of stocks, bonds, commodities and other investments, you are ensuring that your portfolio won’t be overexposed to the worst parts of the next market crash or underexposed to any investments that may avoid the sell-off.</p>\n<p><b>2. Raise Cash</b></p>\n<p>There have been countless pullbacks, crashes and recessions throughout history. One strategy that has worked every single time for long-term investors during those periods is buying the dip. But to buy the dip, you must have cash or margin available.</p>\n<p>If you are 100% invested, your hands will be tied and your only option may be tosell stockat the worst possible time. Market crashes are nearly impossible to predict, so there’s no need to dump all your stocks now and transition to all cash. But raising the amount of cash in your account to 10%, 20% or whatever level makes you feel more comfortable allows you to be opportunistic when the next crash happens.</p>\n<p><b>3. Maintain A Watch List</b></p>\n<p>Investors tend to not make the best, most rational decisions during the worst of a stock market crash. It’s best if you have a plan of action before the crash so that you aren’t trying to make emotional decisions when it seems like the sky is falling.</p>\n<p>Before the stock market turns south, make a list of stocks you may potentially be interested in buying on the dip. Research these companies and vet them prior to the crash so that all you have to do when the opportunity to buy the dip arises is click that “buy” button.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100178242","content_text":"COVID-19, a worry that investors had pushed down their list of top concerns in recent months, has soared back up to the number one spot as a new variant spreads across South Africa.\nAsia stocks outside Japan slid over 2%, Europe and U.S. stock futures are down sharply, oil prices drops almost 5%, the safe-haven yen is up around three-quarters of a percent, and U.S. Treasury yields are down almost 10 basis points.\nLittle is known of the variant, detected in South Africa, Botswana and Hong Kong, but scientists reckon it has an unusual combination of mutations and may be able to evade immune responses or make it more transmissible.\nThe news comes as Europe already battles a resurgent COVID-19 outbreak, triggering fresh restrictions that raise uncertainty over the near-term economic outlook.\nThin liquidity following Thursday's U.S. Thanksgiving Day holiday likely exacerbates price moves for sure, but there's little doubt overnight headlines have taken markets by surprise on Friday.\nIt’s been another great year for investors, with the SPDR S&P 500 ETF Trust up another 25.4% on the year. The S&P 500 has also made it more than a year since its last 10% correction, and some investors are growing concerned that a combination of historically high stock valuations, rising inflation, the COVID-19 variant and the possibility that aggressive Federal Reserve tightening could trigger a market crash in the next couple of quarters.\n\nHistorically, the S&P 500 has averaged about one 10% pullback per yearsince 1950. Long-term investors have no reason to fear temporary market pullbacks, but there are ways to prepare for the next stock market crash to reduce your risk and take advantage of the potential buying opportunity. Here are three things to do before the next stock market crash.\n1. Diversify Your Portfolio\nNot all market sectors and asset classes take the same hit when the stock market crashes, but it’s difficult to predict beforehand which stocks will be hit hardest. The market crash in 2008 hit bank and housing stocks hardest, while the crash in 2020 was particularly bad for travel and retail stocks. Growth stocks also tend to take a harder hit than value stocks during market crashes. By diversifying your portfolio into different types of stocks, bonds, commodities and other investments, you are ensuring that your portfolio won’t be overexposed to the worst parts of the next market crash or underexposed to any investments that may avoid the sell-off.\n2. Raise Cash\nThere have been countless pullbacks, crashes and recessions throughout history. One strategy that has worked every single time for long-term investors during those periods is buying the dip. But to buy the dip, you must have cash or margin available.\nIf you are 100% invested, your hands will be tied and your only option may be tosell stockat the worst possible time. Market crashes are nearly impossible to predict, so there’s no need to dump all your stocks now and transition to all cash. But raising the amount of cash in your account to 10%, 20% or whatever level makes you feel more comfortable allows you to be opportunistic when the next crash happens.\n3. Maintain A Watch List\nInvestors tend to not make the best, most rational decisions during the worst of a stock market crash. It’s best if you have a plan of action before the crash so that you aren’t trying to make emotional decisions when it seems like the sky is falling.\nBefore the stock market turns south, make a list of stocks you may potentially be interested in buying on the dip. Research these companies and vet them prior to the crash so that all you have to do when the opportunity to buy the dip arises is click that “buy” button.","news_type":1},"isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875557729,"gmtCreate":1637673658837,"gmtModify":1637673658902,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875557729","repostId":"2185381910","repostType":4,"repost":{"id":"2185381910","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1637673540,"share":"https://www.laohu8.com/m/news/2185381910?lang=&edition=full","pubTime":"2021-11-23 21:19","market":"us","language":"en","title":"Medtronic stock drops toward 8-month low after revenue miss and lowered full-year growth outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2185381910","media":"Dow Jones","summary":"MW Medtronic stock drops toward 8-month low after revenue miss and lowered full-year growth outlook\n","content":"<p>MW Medtronic stock drops toward 8-month low after revenue miss and lowered full-year growth outlook</p>\n<p>Shares of Medtronic <a href=\"https://laohu8.com/S/PLC\">PLC</a> <a href=\"https://laohu8.com/S/MDT\">$(MDT)$</a> dropped 1.2% toward an eight-month low in premarket trading Tuesday, after the medical technology company beat fiscal second-quarter profit expectations but missed on revenue, citing the negative impact of the COVID-19 pandemic resurgence and healthcare staffing challenges on medical procedure volumes. Net income for the quarter to Oct. 29 nearly tripled to $1.31 billion, or 97 cents a share, from $489 million, or 36 cents a share, in the year-ago period. Revenue rose 2.6% to $7.85 billion but was below the FactSet consensus of $7.97 billion, while cost of sales fell 7.7%. Cardiovascular revenue rose 3.7% to $2.83 billion, medical surgical revenue increased 0.6% to $2.30 billion, neuroscience revenue fell 0.4% to $1.07 billion and diabetes revenue grew 1.9% to $585 million. For fiscal 2022, the company affirmed its adjusted EPS guidance range of $5.65 to $5.75, but cut its revenue growth outlook to 7% to 8% from 9%. The stock has shed 9.0% over the past three months through Monday, while the SPDR Health Care Select Sector ETF <a href=\"https://laohu8.com/S/XLV\">$(XLV)$</a> has slipped 2.8% and the S&P 500 has gained 4.5%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medtronic stock drops toward 8-month low after revenue miss and lowered full-year growth outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedtronic stock drops toward 8-month low after revenue miss and lowered full-year growth outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-23 21:19</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Medtronic stock drops toward 8-month low after revenue miss and lowered full-year growth outlook</p>\n<p>Shares of Medtronic <a href=\"https://laohu8.com/S/PLC\">PLC</a> <a href=\"https://laohu8.com/S/MDT\">$(MDT)$</a> dropped 1.2% toward an eight-month low in premarket trading Tuesday, after the medical technology company beat fiscal second-quarter profit expectations but missed on revenue, citing the negative impact of the COVID-19 pandemic resurgence and healthcare staffing challenges on medical procedure volumes. Net income for the quarter to Oct. 29 nearly tripled to $1.31 billion, or 97 cents a share, from $489 million, or 36 cents a share, in the year-ago period. Revenue rose 2.6% to $7.85 billion but was below the FactSet consensus of $7.97 billion, while cost of sales fell 7.7%. Cardiovascular revenue rose 3.7% to $2.83 billion, medical surgical revenue increased 0.6% to $2.30 billion, neuroscience revenue fell 0.4% to $1.07 billion and diabetes revenue grew 1.9% to $585 million. For fiscal 2022, the company affirmed its adjusted EPS guidance range of $5.65 to $5.75, but cut its revenue growth outlook to 7% to 8% from 9%. The stock has shed 9.0% over the past three months through Monday, while the SPDR Health Care Select Sector ETF <a href=\"https://laohu8.com/S/XLV\">$(XLV)$</a> has slipped 2.8% and the S&P 500 has gained 4.5%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MDT":"美敦力"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185381910","content_text":"MW Medtronic stock drops toward 8-month low after revenue miss and lowered full-year growth outlook\nShares of Medtronic PLC $(MDT)$ dropped 1.2% toward an eight-month low in premarket trading Tuesday, after the medical technology company beat fiscal second-quarter profit expectations but missed on revenue, citing the negative impact of the COVID-19 pandemic resurgence and healthcare staffing challenges on medical procedure volumes. Net income for the quarter to Oct. 29 nearly tripled to $1.31 billion, or 97 cents a share, from $489 million, or 36 cents a share, in the year-ago period. Revenue rose 2.6% to $7.85 billion but was below the FactSet consensus of $7.97 billion, while cost of sales fell 7.7%. Cardiovascular revenue rose 3.7% to $2.83 billion, medical surgical revenue increased 0.6% to $2.30 billion, neuroscience revenue fell 0.4% to $1.07 billion and diabetes revenue grew 1.9% to $585 million. For fiscal 2022, the company affirmed its adjusted EPS guidance range of $5.65 to $5.75, but cut its revenue growth outlook to 7% to 8% from 9%. The stock has shed 9.0% over the past three months through Monday, while the SPDR Health Care Select Sector ETF $(XLV)$ has slipped 2.8% and the S&P 500 has gained 4.5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872915330,"gmtCreate":1637391093484,"gmtModify":1637391093557,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872915330","repostId":"2184842262","repostType":4,"repost":{"id":"2184842262","kind":"news","pubTimestamp":1637359018,"share":"https://www.laohu8.com/m/news/2184842262?lang=&edition=full","pubTime":"2021-11-20 05:56","market":"us","language":"en","title":"Nasdaq ends atop 16,000 mark for the first time on tech strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2184842262","media":"Reuters","summary":"(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in i","content":"<p>(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in its second-straight record finish powered by technology stocks, while pandemic jitters sent the Dow to its fourth losing session in the last five.</p>\n<p>Both the Nasdaq and S&P 500 index scored a winning week, up 1.2% and 0.3% respectively, after last week's declines snapped a five-week run of higher finishes.</p>\n<p>The Dow Jones Industrial Average's second-successive weekly loss - this one of 1.4% - wiped out the last of its November gains, extending the index's drop from a Nov. 8 record high to 2.3%.</p>\n<p>Friday's fall was caused by banking, energy and airline stocks slumping on fears that European countries, battling a resurgence of COVID-19 cases, could follow Austria in moving towards a full lockdown.</p>\n<p>Banking stocks fell 1.6%, tracking a drop in Treasury yields as investors snapped up safe-haven bonds. The S&P energy index dropped 3.9%, the worst performing sector, as crude prices fell on demand implications.</p>\n<p>Carriers including Delta Air Lines, United Airlines and American Airlines, and cruiseliners Norwegian Cruise Line and Carnival Corp all dropped between 0.6% and 2.8%.</p>\n<p>\"It's a normal time to take risk off. And in this case, there's just so much liquidity that the market doesn't go down - just people take risk off by going into safe havens,\" said Jay Hatfield, chief executive of Infrastructure Capital Management in New York.</p>\n<p>Falling yields and safe-haven demand supported major technology stocks, which in turn lifted the Nasdaq.</p>\n<p>FAANG stocks, which have largely persevered through economic shocks since 2020, traded broadly higher. Netflix Inc gained along with other stay-at-home stocks.</p>\n<p>Chipmaker Nvidia Corp rose 4.1% to its third straight closing high, and the Philadelphia semiconductor index , up 0.3%, hit its third record closing high in four.</p>\n<p>The Dow Jones Industrial Average fell 268.97 points, or 0.75%, to 35,601.98; the S&P 500 lost 6.58 points, or 0.14%, at 4,697.96; and the Nasdaq Composite added 63.73 points, or 0.4%, to 16,057.44.</p>\n<p>The S&P 500 gyrated on Friday before slipping into negative territory, after a week in which retailers pushed it to a record finish the previous day.</p>\n<p>The S&P consumer discretionary sector rose 0.3% to a closing peak for a second day in a row, after breaking its lifetime intraday high on Friday. This follows strong retail earnings this week and positive signs for holiday shopping.</p>\n<p>Lowe's Companies rose 0.9% to its third successive record close after reporting third-quarter results on Wednesday. Etsy Inc, which posted earnings earlier this month, achieved the same closing feat after finishing up 1.4%.</p>\n<p>\"Out of the Q3 earnings, one of the trends we have seen is the resounding strength of the U.S. consumer,\" said Jessica Bemer, portfolio manager at Easterly Investment Partners.</p>\n<p>\"We've heard it all through this week from retailers talking about the consumer coming back into the store, enjoying the shopping experience and getting ready for the holidays. It makes sense but it was really validated during earnings season.\"</p>\n<p>Profit-taking in names which gained earlier in the week led to drops of between 2.9% and 8.8% in Macy's Inc, Kohls Corp and Gap Inc.</p>\n<p>The information technology segment, up 0.8%, was the best performer on the S&P 500.</p>\n<p>It was buoyed by Intuit Inc, which jumped 10.1% as brokerages lifted their price targets on the income tax software company after it beat quarterly estimates and raised forecasts.</p>\n<p>Volume on U.S. exchanges was 10.68 billion shares, compared with the 11.12 billion average for the full session over the last 20 trading days.</p>\n<p>The S&P 500 posted 45 new 52-week highs and nine new lows; the Nasdaq Composite recorded 100 new highs and 309 new lows.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq ends atop 16,000 mark for the first time on tech strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq ends atop 16,000 mark for the first time on tech strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-20 05:56 GMT+8 <a href=https://finance.yahoo.com/news/us-stocks-nasdaq-ends-atop-215658565.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in its second-straight record finish powered by technology stocks, while pandemic jitters sent the Dow ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-nasdaq-ends-atop-215658565.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","COMP":"Compass, Inc.",".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/us-stocks-nasdaq-ends-atop-215658565.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2184842262","content_text":"(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in its second-straight record finish powered by technology stocks, while pandemic jitters sent the Dow to its fourth losing session in the last five.\nBoth the Nasdaq and S&P 500 index scored a winning week, up 1.2% and 0.3% respectively, after last week's declines snapped a five-week run of higher finishes.\nThe Dow Jones Industrial Average's second-successive weekly loss - this one of 1.4% - wiped out the last of its November gains, extending the index's drop from a Nov. 8 record high to 2.3%.\nFriday's fall was caused by banking, energy and airline stocks slumping on fears that European countries, battling a resurgence of COVID-19 cases, could follow Austria in moving towards a full lockdown.\nBanking stocks fell 1.6%, tracking a drop in Treasury yields as investors snapped up safe-haven bonds. The S&P energy index dropped 3.9%, the worst performing sector, as crude prices fell on demand implications.\nCarriers including Delta Air Lines, United Airlines and American Airlines, and cruiseliners Norwegian Cruise Line and Carnival Corp all dropped between 0.6% and 2.8%.\n\"It's a normal time to take risk off. And in this case, there's just so much liquidity that the market doesn't go down - just people take risk off by going into safe havens,\" said Jay Hatfield, chief executive of Infrastructure Capital Management in New York.\nFalling yields and safe-haven demand supported major technology stocks, which in turn lifted the Nasdaq.\nFAANG stocks, which have largely persevered through economic shocks since 2020, traded broadly higher. Netflix Inc gained along with other stay-at-home stocks.\nChipmaker Nvidia Corp rose 4.1% to its third straight closing high, and the Philadelphia semiconductor index , up 0.3%, hit its third record closing high in four.\nThe Dow Jones Industrial Average fell 268.97 points, or 0.75%, to 35,601.98; the S&P 500 lost 6.58 points, or 0.14%, at 4,697.96; and the Nasdaq Composite added 63.73 points, or 0.4%, to 16,057.44.\nThe S&P 500 gyrated on Friday before slipping into negative territory, after a week in which retailers pushed it to a record finish the previous day.\nThe S&P consumer discretionary sector rose 0.3% to a closing peak for a second day in a row, after breaking its lifetime intraday high on Friday. This follows strong retail earnings this week and positive signs for holiday shopping.\nLowe's Companies rose 0.9% to its third successive record close after reporting third-quarter results on Wednesday. Etsy Inc, which posted earnings earlier this month, achieved the same closing feat after finishing up 1.4%.\n\"Out of the Q3 earnings, one of the trends we have seen is the resounding strength of the U.S. consumer,\" said Jessica Bemer, portfolio manager at Easterly Investment Partners.\n\"We've heard it all through this week from retailers talking about the consumer coming back into the store, enjoying the shopping experience and getting ready for the holidays. It makes sense but it was really validated during earnings season.\"\nProfit-taking in names which gained earlier in the week led to drops of between 2.9% and 8.8% in Macy's Inc, Kohls Corp and Gap Inc.\nThe information technology segment, up 0.8%, was the best performer on the S&P 500.\nIt was buoyed by Intuit Inc, which jumped 10.1% as brokerages lifted their price targets on the income tax software company after it beat quarterly estimates and raised forecasts.\nVolume on U.S. exchanges was 10.68 billion shares, compared with the 11.12 billion average for the full session over the last 20 trading days.\nThe S&P 500 posted 45 new 52-week highs and nine new lows; the Nasdaq Composite recorded 100 new highs and 309 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878250794,"gmtCreate":1637199706734,"gmtModify":1637199706840,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":":)","listText":":)","text":":)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878250794","repostId":"2184547718","repostType":4,"repost":{"id":"2184547718","kind":"news","pubTimestamp":1637191423,"share":"https://www.laohu8.com/m/news/2184547718?lang=&edition=full","pubTime":"2021-11-18 07:23","market":"us","language":"en","title":"After-Hours Stock Movers: NVIDIA, Sonos, Victoria's Secret and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2184547718","media":"StreetInsider","summary":"$Victoria's Secret & Co. $ 11% HIGHER; reported Q3 EPS of $0.81, $0.10 better than the analyst estimate of $0.71. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.46 billion. Victoria's Secret & Co. sees Q4 2021 EPS of $2.35-$2.65, versus the consensus of $2.80. sales to be in the range of flat to up 3% versus last year’s fourth quarter sales of $2.100 billion. $Cisco Systems $ 6% LOWER; reported Q1 EPS of $0.82, in-line with the analyst estimate of $0.82. Rev","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VSCO\">Victoria's Secret & Co. </a> 11% HIGHER; reported Q3 EPS of $0.81, $0.10 better than the analyst estimate of $0.71. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.46 billion. Victoria's Secret & Co. sees Q4 2021 EPS of $2.35-$2.65, versus the consensus of $2.80. sales to be in the range of flat to up 3% versus last year’s fourth quarter sales of $2.100 billion</p>\n<p><a href=\"https://laohu8.com/S/CSCO\">Cisco Systems </a> 6% LOWER; reported Q1 EPS of $0.82, in-line with the analyst estimate of $0.82. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.03 billion. Cisco Systems sees Q2 2022 EPS of $0.80-$0.82, versus the consensus of $0.82. Revenue: 4.5% to 6.5% growth year over year. Cisco Systems sees FY2022 EPS of $3.38-$3.45, versus the consensus of $3.42.</p>\n<p><a href=\"https://laohu8.com/S/NVDA\">NVIDIA </a> 4.9% HIGHER; reported Q3 EPS of $1.17, $0.06 better than the analyst estimate of $1.11. Revenue for the quarter came in at $7.1 billion versus the consensus estimate of $6.83 billion. NVIDIA sees Q4 2022 revenue of $7.4 billion, versus the consensus of $6.86 billion.</p>\n<p><a href=\"https://laohu8.com/S/SONO\">Sonos </a> 3% HIGHER; reported Q4 EPS of $0.08, $0.14 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $359.5 million versus the consensus estimate of $360.23 million. Sonos sees FY2022 revenue of $1.925-2 billion, versus the consensus of $1.86 billion.</p>\n<p><a href=\"https://laohu8.com/S/KHC\">The Kraft Heinz Company </a> 1.8% LOWER; announced a secondary offering of shares of its common stock (the Offering). In the Offering, which is subject to market and other conditions, certain affiliates of 3G Global Food Holdings LP (the Selling Stockholder) intend to offer 30,596,465 shares of common stock (Common Stock) for sale. The Company will not receive any proceeds from the Offering.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: NVIDIA, Sonos, Victoria's Secret and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: NVIDIA, Sonos, Victoria's Secret and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 07:23 GMT+8 <a href=https://www.streetinsider.com/dr/news.php?id=19236071><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVictoria's Secret & Co. 11% HIGHER; reported Q3 EPS of $0.81, $0.10 better than the analyst estimate of $0.71. Revenue for the quarter came in at $1.44 billion versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19236071\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","SONO":"搜诺思公司","CSCO":"思科","KHC":"卡夫亨氏","VSCO":"维多利亚的秘密"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19236071","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184547718","content_text":"After-Hours Stock Movers:\nVictoria's Secret & Co. 11% HIGHER; reported Q3 EPS of $0.81, $0.10 better than the analyst estimate of $0.71. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.46 billion. Victoria's Secret & Co. sees Q4 2021 EPS of $2.35-$2.65, versus the consensus of $2.80. sales to be in the range of flat to up 3% versus last year’s fourth quarter sales of $2.100 billion\nCisco Systems 6% LOWER; reported Q1 EPS of $0.82, in-line with the analyst estimate of $0.82. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.03 billion. Cisco Systems sees Q2 2022 EPS of $0.80-$0.82, versus the consensus of $0.82. Revenue: 4.5% to 6.5% growth year over year. Cisco Systems sees FY2022 EPS of $3.38-$3.45, versus the consensus of $3.42.\nNVIDIA 4.9% HIGHER; reported Q3 EPS of $1.17, $0.06 better than the analyst estimate of $1.11. Revenue for the quarter came in at $7.1 billion versus the consensus estimate of $6.83 billion. NVIDIA sees Q4 2022 revenue of $7.4 billion, versus the consensus of $6.86 billion.\nSonos 3% HIGHER; reported Q4 EPS of $0.08, $0.14 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $359.5 million versus the consensus estimate of $360.23 million. Sonos sees FY2022 revenue of $1.925-2 billion, versus the consensus of $1.86 billion.\nThe Kraft Heinz Company 1.8% LOWER; announced a secondary offering of shares of its common stock (the Offering). In the Offering, which is subject to market and other conditions, certain affiliates of 3G Global Food Holdings LP (the Selling Stockholder) intend to offer 30,596,465 shares of common stock (Common Stock) for sale. The Company will not receive any proceeds from the Offering.","news_type":1},"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878338208,"gmtCreate":1637147294404,"gmtModify":1637147294404,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Oooo","listText":"Oooo","text":"Oooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/878338208","repostId":"1160710301","repostType":4,"repost":{"id":"1160710301","kind":"news","pubTimestamp":1637147244,"share":"https://www.laohu8.com/m/news/1160710301?lang=&edition=full","pubTime":"2021-11-17 19:07","market":"us","language":"en","title":"Pfizer asks US officials to OK promising COVID-19 pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1160710301","media":"Associated Press","summary":"Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the st","content":"<p>Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.</p>\n<p>The company's filing comes as new infections are rising once again in the United States, driven mainly by hot spots in states where colder weather is driving more Americans indoors.</p>\n<p>Pfizer’s pill has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections. The Food and Drug Administration is already reviewing a competing pill from Merck and several smaller drugmakers are also expected to seek authorization for their own antiviral pills in the coming months.</p>\n<p>“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application,\" said Pfizer CEO Albert Bourla, in a statement.</p>\n<p>Specifically, Pfizer wants the drug available for adults who have mild-to-moderate COVID-19 infections and are at risk of becoming seriously ill. That's similar to how other drugs are currently used to treat the disease. But all FDA-authorized COVID-19 treatments require an IV or injection given by a health professional at a hospital or clinic.</p>\n<p>The FDA is holding a public meeting on the Merck pill later this month to get the opinion of outside experts before making its decision. The agency isn’t required to convene such meetings and it’s not yet known whether Pfizer’s drug will undergo a similar public review.</p>\n<p>Some experts predict COVID-19 treatments eventually will be combined to better protect against the worst effects of the virus.</p>\n<p>Pfizer reported earlier this monththat its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity. If authorized, the FDA will have to weigh making the pill available for vaccinated people dealing with breakthrough infections, since they weren't part of the initial tests.</p>\n<p>For best results, patients need to start taking the pills within three days of symptoms, underscoring the need for speedy testing and diagnosis. That could be a challenge if another COVID-19 surge leads to testing delays and shortages seen last winter.</p>\n<p>Pfizer’s drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body. That's different than the Merck pill, which causes tiny mutations in the coronavirus until the point that it can't reproduce itself.</p>\n<p>On Tuesday,Pfizer signed a deal a with U.N.-backed groupto allow generic drugmakers to produce low-cost versions of the pill for certain countries. Merck has a similar deal for its pill, which was authorized in Britain earlier this month.</p>\n<p>The U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they usually have to be given via time-consuming infusions by health professionals, and limited supplies were strained by the last surge of the delta variant.</p>\n<p>The U.S. government has already committed to purchasing Merck's pill. Federal authorities were in negotiations with Pfizer to buy millions of doses of its pill, according to an official familiar with the matter.</p>","source":"lsy1603278176698","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer asks US officials to OK promising COVID-19 pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer asks US officials to OK promising COVID-19 pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-17 19:07 GMT+8 <a href=https://finance.yahoo.com/news/pfizer-asks-us-officials-ok-190336933.html><strong>Associated Press</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.\nThe company'...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-asks-us-officials-ok-190336933.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-asks-us-officials-ok-190336933.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160710301","content_text":"Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.\nThe company's filing comes as new infections are rising once again in the United States, driven mainly by hot spots in states where colder weather is driving more Americans indoors.\nPfizer’s pill has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections. The Food and Drug Administration is already reviewing a competing pill from Merck and several smaller drugmakers are also expected to seek authorization for their own antiviral pills in the coming months.\n“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application,\" said Pfizer CEO Albert Bourla, in a statement.\nSpecifically, Pfizer wants the drug available for adults who have mild-to-moderate COVID-19 infections and are at risk of becoming seriously ill. That's similar to how other drugs are currently used to treat the disease. But all FDA-authorized COVID-19 treatments require an IV or injection given by a health professional at a hospital or clinic.\nThe FDA is holding a public meeting on the Merck pill later this month to get the opinion of outside experts before making its decision. The agency isn’t required to convene such meetings and it’s not yet known whether Pfizer’s drug will undergo a similar public review.\nSome experts predict COVID-19 treatments eventually will be combined to better protect against the worst effects of the virus.\nPfizer reported earlier this monththat its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity. If authorized, the FDA will have to weigh making the pill available for vaccinated people dealing with breakthrough infections, since they weren't part of the initial tests.\nFor best results, patients need to start taking the pills within three days of symptoms, underscoring the need for speedy testing and diagnosis. That could be a challenge if another COVID-19 surge leads to testing delays and shortages seen last winter.\nPfizer’s drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body. That's different than the Merck pill, which causes tiny mutations in the coronavirus until the point that it can't reproduce itself.\nOn Tuesday,Pfizer signed a deal a with U.N.-backed groupto allow generic drugmakers to produce low-cost versions of the pill for certain countries. Merck has a similar deal for its pill, which was authorized in Britain earlier this month.\nThe U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they usually have to be given via time-consuming infusions by health professionals, and limited supplies were strained by the last surge of the delta variant.\nThe U.S. government has already committed to purchasing Merck's pill. Federal authorities were in negotiations with Pfizer to buy millions of doses of its pill, according to an official familiar with the matter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871636033,"gmtCreate":1637061549497,"gmtModify":1637061549684,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871636033","repostId":"1170699491","repostType":4,"repost":{"id":"1170699491","kind":"news","pubTimestamp":1637060755,"share":"https://www.laohu8.com/m/news/1170699491?lang=&edition=full","pubTime":"2021-11-16 19:05","market":"us","language":"en","title":"70 Biggest Movers From Yesterday","url":"https://stock-news.laohu8.com/highlight/detail?id=1170699491","media":"Benzinga","summary":"Gainers\n\nCasper Sleep Inc. shares jumped 88.5% to close at $6.69 on Monday after the company agreed ","content":"<p><b>Gainers</b></p>\n<ul>\n <li><b>Casper Sleep Inc.</b> shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The company also reported Q3 earnings results.</li>\n <li><b>Creative Realities, Inc.</b> gained 79.5% to settle at $2.62 as the company reported a merger with Reflect Systems on Friday.</li>\n <li><b>Patriot National Bancorp, Inc.</b> climbed 50.4% to settle at $15.04. Patriot National Bancorp and American Challenger Development Corp. agreed to merge.</li>\n <li><b>Trio-Tech International</b> jumped 36% to settle at $6.73 after the company reported Q1 results, posting a 49% year-over-year increase in total revenue.</li>\n <li><b>SCYNEXIS, Inc.</b> rose 25% to close at $6.75. SCYNEXIS, last week, posted a Q3 net loss of C$1.252 million.</li>\n <li><b>Matterport, Inc.</b> gained 22.3% to close at $27.12.</li>\n <li><b>Newegg Commerce, Inc.</b> surged 21.3% to settle at $19.21. After the closing bell, Newegg Commerce’s F-1 filing showed registration for a $300 million common stock offering.</li>\n <li><b>The Vita Coco Company, Inc.</b> jumped 21.2% to close at $17.57. Several analysts initiated coverage on the stock with positive ratings.</li>\n <li><b>Siyata Mobile Inc.</b> gained 21.1% to close at $4.13.</li>\n <li><b>SilverSun Technologies, Inc.</b> shares rose 20.5% to close at $6.70. SilverSun Technologies announced plans to acquire Acumatica division of Dynamic Tech Services, Inc.</li>\n <li><b>Enthusiast Gaming Holdings Inc.</b> surged 19.1% to close at $4.00. HC Wainwright, last week, lowered its price target on the stock from $10 to $7.</li>\n <li><b>Society Pass Incorporated</b> gained 19% to close at $51.83.</li>\n <li><b>Vaxxinity, Inc.</b> rose 18.5% to close at $16.00 on continued volatility following last week's IPO.</li>\n <li><b>Aura Biosciences, Inc.</b> gained 18.4% to close at $20.70.</li>\n <li><b>Decarbonization Plus Acquisition Corporation III</b> surged 18.3% to settle at $14.17.</li>\n <li><b>Scienjoy Holding Corporation</b> gained 17.3% to close at $6.79.</li>\n <li><b>Blink Charging Co.</b> rose 17.1% to settle at $46.85 after HC Wainwright upgraded the stock from Neutral to Buy and announced a $50 price target.</li>\n <li><b>Vivint Smart Home, Inc.</b> jumped 16.8% to settle at $11.40 after the company posted upbeat Q3 sales and raised sales guidance.</li>\n <li><b>Progenity, Inc.</b> gained 16.8% to close at $3.47 after declining 4% on Friday.</li>\n <li><b>Volcon, Inc.</b> surged 16.4% to settle at $13.68.</li>\n <li><b>Tricida, Inc.</b> gained 16.3% to close at $6.35. Tricida, last week, posted a Q3 loss of $0.79 per share.</li>\n <li><b>Manning & Napier, Inc.</b> shares surged 16.1% to close at $9.36. Manning & Napier, last week, reported preliminary assets under management as of October 31, 2021 of $22.5 billion.</li>\n <li><b>Xeris Biopharma Holdings, Inc.</b> jumped 15.9% to close at $2.48. Xeris Biopharma Holdings’ Paul Edick acquired a total of 200000 shares at an average price of $2.08. The company, last week, posted a wider-than-expected quarterly loss.</li>\n <li><b>Backblaze, Inc.</b> gained 15.7% to close at $25.50. The company, last week, priced its IPO at $16 a share.</li>\n <li><b>Gores Guggenheim, Inc.</b> jumped 15.4% to close at $14.78 after jumping around 16% on Friday.</li>\n <li><b>The Real Good Food Company, Inc.</b> surged 15.4% to settle at $11.50. The company recently priced its IPO at $12 per share.</li>\n <li><b>Milestone Pharmaceuticals Inc.</b> gained 15.3% to settle at $6.95.</li>\n <li><b>Rivian Automotive, Inc.</b> jumped 14.9% to close at $149.36 on continued post-IPO volatility.</li>\n <li><b>Dollar Tree, Inc.</b> gained 14.3% to settle at $129.23 following Dow Jones report activist investor Mantle Ridge has taken a $1.8 billion stake in the company. Deutsche Bank upgraded the stock from Hold to Buy and raised its price target from $96 to $148.</li>\n <li><b>Weave Communications, Inc.</b> surged 14.2% to close at $21.13. The company, last week, priced its IPO at $24 a share.</li>\n <li><b>PureCycle Technologies, Inc.</b> rose 14.2% to settle at $10.86.</li>\n <li><b>The Real Brokerage Inc.</b> jumped 13.7% to close at $3.24. The Real Brokerage named Raj Naik as Chief Operating Officer.</li>\n <li><b>Everspin Technologies, Inc.</b> rose 13.6% to settle at $12.20. Everspin Technologies recently reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.</li>\n <li><b>Akerna Corp.</b> gained 12.8% to close at $3.26. Akerna, last week, reported quarterly sales of $5.10 million.</li>\n <li><b>a.k.a. Brands Holding Corp.</b> climbed 12.1% to settle at $14.27.</li>\n <li><b>BM Technologies, Inc.</b> rose 11.6% to close at $12.23. BM Technologies announced plans to acquire First Sound Bank for $23 million in cash. The company also released Q3 results.</li>\n <li><b>The Glimpse Group, Inc.</b> gained 9.3% to settle at $15.23.</li>\n <li><b>HeadHunter Group PLC</b> rose 8.5% to settle at $62.66 following strong quarterly sales.</li>\n <li><b>The9 Limited</b> rose 7.4% to close at $13.55 after the company said its new NFT community and trading platform NFTSTAR signed an exclusive license agreement with the American Football star, CHRISTIAN McCAFFREY.</li>\n <li><b>CareMax, Inc.</b> rose 5.3% to settle at $8.95 following narrower-than-expected quarterly loss.</li>\n</ul>\n<p><b>Losers</b></p>\n<ul>\n <li><b>Bit Brother Limited</b> fell 28.7% to close at $1.89 after jumping more than 32% on Friday.</li>\n <li><b>Telos Corporation</b> shares tumbled 28.1% to close at $17.54 on Monday after the company reported worse-than-expected Q3 results and cut guidance.</li>\n <li><b>Marathon Digital Holdings, Inc.</b> fell 27% to settle at $55.40 after the company announced it received a subpoena to produce documents and communications concerning the Hardin, Montana data center facility. The company also announced a proposed convertible senior notes offering.</li>\n <li><b>PetVivo Holdings, Inc.</b> dipped 25.9% to close at $3.12 after the company reported worse-than-expected Q2 EPS.</li>\n <li><b>Midwest Holding Inc.</b> fell 24.1% to settle at $24.34.</li>\n <li><b>Rocket Pharmaceuticals, Inc.</b> declined 23.7% to close at $25.90 after the company provided an update from its Phase 1 Clinical Trial of RP-A501, saying it will no longer administer the high-dose to study patients and will focus on the low-dose cohort moving forward.</li>\n <li><b>UroGen Pharma Ltd.</b> fell 23% to close at $14.74 after the company reported worse-than-expected Q3 results.</li>\n <li><b>BioXcel Therapeutics, Inc.</b> dropped 21.2% to settle at $27.21 after Goldman Sachs downgraded the stock from Buy to Sell and lowered its price target from $55 to $24.</li>\n <li><b>Oatly Group AB</b> fell 20.8% to close at $9.36 after the company reported worse-than-expected Q3 sales results and issued FY21 sales guidance.</li>\n <li><b>Bluejay Diagnostics, Inc.</b> shares fell 20.7% to close at $3.63. The company recently priced its IPO at $10 per unit.</li>\n <li><b>Aerovate Therapeutics, Inc.</b> dropped 18.9% to settle at $17.46 after the company reported Q3 results.</li>\n <li><b>PhaseBio Pharmaceuticals, Inc.</b> dipped 18.4% to close at $3.02 after the company announced interim results from the REVERSE-IT Phase 3 trial of bentracimab. 91% of patients reported a treatment-emergent side effect, the most common was pain associated with the surgical procedure.</li>\n <li><b>Splunk Inc.</b> fell 18.1% to close at $137.38. Splunk said its CEO Doug Merritt will step down. Splunk said it sees Q3 revenue of $660 million.</li>\n <li><b>Aptevo Therapeutics Inc.</b> dropped 16.5% to close at $9.72. Aptevo Therapeutics announced presentation of 2 abstracts at upcoming American Society of Hematology Annual Meeting.</li>\n <li><b>REGENXBIO Inc.</b> fell 16.1% to close at $31.72.</li>\n <li><b>Hudson Technologies, Inc.</b> dipped 16% to close at $3.95.</li>\n <li><b>CNFinance Holdings Limited</b> fell 15.5% to settle at $4.30</li>\n <li><b>TG Therapeutics, Inc.</b> fell 14.9% to settle at $27.05 after Goldman Sachs downgraded the stock from Neutral to Sell and lowered its price target from $33 to $26.</li>\n <li><b>Sohu.com Limited</b> dropped 14.3% to close at $18.49. Sohu.com reported third-quarter FY21 revenue growth of 37% year-on-year to $216 million. Revenue improved 6% quarter-over-quarter.</li>\n <li><b>EVgo, Inc.</b> fell 14.3% to close at $16.19 following negative analyst coverage from Credit Suisse.</li>\n <li><b>Atai Life Sciences N.V.</b> dropped 13.8% to close at $12.85 following Q3 results.</li>\n <li><b>Butterfly Network, Inc.</b> dipped 12.6% to close at $7.52 after the company posted downbeat Q3 sales and issued weak FY21 sales forecast.</li>\n <li><b>Moving iMage Technologies, Inc.</b> shares fell 12.5% to close at $2.87. Moving iMage Technologies shares jumped around 22% on Friday after the company posted a narrower Q3 loss.</li>\n <li><b>NuZee, Inc.</b> shares fell 12% to close at $4.53. NuZee manufacturing partner, Cuvee Coffee, recently reported an expansion into select Walmart stores nationwide.</li>\n <li><b>Koninklijke Philips N.V.</b> fell 11.5% to settle at $42.16 after the company said it is in discussions with the FDA after a new inspection of one of its facilities.</li>\n <li><b>JAKKS Pacific, Inc.</b> fell 10% to close at $12.38.</li>\n <li><b>F45 Training Holdings Inc.</b> dropped 9.7% to close at $11.72. F45 Training Holdings recently reported worse-than-expected Q3 results.</li>\n <li><b>AvePoint, Inc.</b> fell 9.6% to close at $8.33. AvePoint reported third-quarter FY21 revenue growth of 36% year-on-year to $53.9 million, beating the consensus of $52.6 million.</li>\n <li><b>Better Therapeutics, Inc.</b> fell 9.1% to close at $8.73.</li>\n <li><b>RumbleON, Inc.</b> fell 5.9% to close at $45.54 following weak quarterly sales.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>70 Biggest Movers From Yesterday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n70 Biggest Movers From Yesterday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-16 19:05 GMT+8 <a href=https://www.benzinga.com/news/21/11/24115477/70-biggest-movers-from-yesterday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCasper Sleep Inc. shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The company also reported Q3 earnings results.\n...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24115477/70-biggest-movers-from-yesterday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","OTLY":"Oatly Group AB"},"source_url":"https://www.benzinga.com/news/21/11/24115477/70-biggest-movers-from-yesterday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170699491","content_text":"Gainers\n\nCasper Sleep Inc. shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The company also reported Q3 earnings results.\nCreative Realities, Inc. gained 79.5% to settle at $2.62 as the company reported a merger with Reflect Systems on Friday.\nPatriot National Bancorp, Inc. climbed 50.4% to settle at $15.04. Patriot National Bancorp and American Challenger Development Corp. agreed to merge.\nTrio-Tech International jumped 36% to settle at $6.73 after the company reported Q1 results, posting a 49% year-over-year increase in total revenue.\nSCYNEXIS, Inc. rose 25% to close at $6.75. SCYNEXIS, last week, posted a Q3 net loss of C$1.252 million.\nMatterport, Inc. gained 22.3% to close at $27.12.\nNewegg Commerce, Inc. surged 21.3% to settle at $19.21. After the closing bell, Newegg Commerce’s F-1 filing showed registration for a $300 million common stock offering.\nThe Vita Coco Company, Inc. jumped 21.2% to close at $17.57. Several analysts initiated coverage on the stock with positive ratings.\nSiyata Mobile Inc. gained 21.1% to close at $4.13.\nSilverSun Technologies, Inc. shares rose 20.5% to close at $6.70. SilverSun Technologies announced plans to acquire Acumatica division of Dynamic Tech Services, Inc.\nEnthusiast Gaming Holdings Inc. surged 19.1% to close at $4.00. HC Wainwright, last week, lowered its price target on the stock from $10 to $7.\nSociety Pass Incorporated gained 19% to close at $51.83.\nVaxxinity, Inc. rose 18.5% to close at $16.00 on continued volatility following last week's IPO.\nAura Biosciences, Inc. gained 18.4% to close at $20.70.\nDecarbonization Plus Acquisition Corporation III surged 18.3% to settle at $14.17.\nScienjoy Holding Corporation gained 17.3% to close at $6.79.\nBlink Charging Co. rose 17.1% to settle at $46.85 after HC Wainwright upgraded the stock from Neutral to Buy and announced a $50 price target.\nVivint Smart Home, Inc. jumped 16.8% to settle at $11.40 after the company posted upbeat Q3 sales and raised sales guidance.\nProgenity, Inc. gained 16.8% to close at $3.47 after declining 4% on Friday.\nVolcon, Inc. surged 16.4% to settle at $13.68.\nTricida, Inc. gained 16.3% to close at $6.35. Tricida, last week, posted a Q3 loss of $0.79 per share.\nManning & Napier, Inc. shares surged 16.1% to close at $9.36. Manning & Napier, last week, reported preliminary assets under management as of October 31, 2021 of $22.5 billion.\nXeris Biopharma Holdings, Inc. jumped 15.9% to close at $2.48. Xeris Biopharma Holdings’ Paul Edick acquired a total of 200000 shares at an average price of $2.08. The company, last week, posted a wider-than-expected quarterly loss.\nBackblaze, Inc. gained 15.7% to close at $25.50. The company, last week, priced its IPO at $16 a share.\nGores Guggenheim, Inc. jumped 15.4% to close at $14.78 after jumping around 16% on Friday.\nThe Real Good Food Company, Inc. surged 15.4% to settle at $11.50. The company recently priced its IPO at $12 per share.\nMilestone Pharmaceuticals Inc. gained 15.3% to settle at $6.95.\nRivian Automotive, Inc. jumped 14.9% to close at $149.36 on continued post-IPO volatility.\nDollar Tree, Inc. gained 14.3% to settle at $129.23 following Dow Jones report activist investor Mantle Ridge has taken a $1.8 billion stake in the company. Deutsche Bank upgraded the stock from Hold to Buy and raised its price target from $96 to $148.\nWeave Communications, Inc. surged 14.2% to close at $21.13. The company, last week, priced its IPO at $24 a share.\nPureCycle Technologies, Inc. rose 14.2% to settle at $10.86.\nThe Real Brokerage Inc. jumped 13.7% to close at $3.24. The Real Brokerage named Raj Naik as Chief Operating Officer.\nEverspin Technologies, Inc. rose 13.6% to settle at $12.20. Everspin Technologies recently reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.\nAkerna Corp. gained 12.8% to close at $3.26. Akerna, last week, reported quarterly sales of $5.10 million.\na.k.a. Brands Holding Corp. climbed 12.1% to settle at $14.27.\nBM Technologies, Inc. rose 11.6% to close at $12.23. BM Technologies announced plans to acquire First Sound Bank for $23 million in cash. The company also released Q3 results.\nThe Glimpse Group, Inc. gained 9.3% to settle at $15.23.\nHeadHunter Group PLC rose 8.5% to settle at $62.66 following strong quarterly sales.\nThe9 Limited rose 7.4% to close at $13.55 after the company said its new NFT community and trading platform NFTSTAR signed an exclusive license agreement with the American Football star, CHRISTIAN McCAFFREY.\nCareMax, Inc. rose 5.3% to settle at $8.95 following narrower-than-expected quarterly loss.\n\nLosers\n\nBit Brother Limited fell 28.7% to close at $1.89 after jumping more than 32% on Friday.\nTelos Corporation shares tumbled 28.1% to close at $17.54 on Monday after the company reported worse-than-expected Q3 results and cut guidance.\nMarathon Digital Holdings, Inc. fell 27% to settle at $55.40 after the company announced it received a subpoena to produce documents and communications concerning the Hardin, Montana data center facility. The company also announced a proposed convertible senior notes offering.\nPetVivo Holdings, Inc. dipped 25.9% to close at $3.12 after the company reported worse-than-expected Q2 EPS.\nMidwest Holding Inc. fell 24.1% to settle at $24.34.\nRocket Pharmaceuticals, Inc. declined 23.7% to close at $25.90 after the company provided an update from its Phase 1 Clinical Trial of RP-A501, saying it will no longer administer the high-dose to study patients and will focus on the low-dose cohort moving forward.\nUroGen Pharma Ltd. fell 23% to close at $14.74 after the company reported worse-than-expected Q3 results.\nBioXcel Therapeutics, Inc. dropped 21.2% to settle at $27.21 after Goldman Sachs downgraded the stock from Buy to Sell and lowered its price target from $55 to $24.\nOatly Group AB fell 20.8% to close at $9.36 after the company reported worse-than-expected Q3 sales results and issued FY21 sales guidance.\nBluejay Diagnostics, Inc. shares fell 20.7% to close at $3.63. The company recently priced its IPO at $10 per unit.\nAerovate Therapeutics, Inc. dropped 18.9% to settle at $17.46 after the company reported Q3 results.\nPhaseBio Pharmaceuticals, Inc. dipped 18.4% to close at $3.02 after the company announced interim results from the REVERSE-IT Phase 3 trial of bentracimab. 91% of patients reported a treatment-emergent side effect, the most common was pain associated with the surgical procedure.\nSplunk Inc. fell 18.1% to close at $137.38. Splunk said its CEO Doug Merritt will step down. Splunk said it sees Q3 revenue of $660 million.\nAptevo Therapeutics Inc. dropped 16.5% to close at $9.72. Aptevo Therapeutics announced presentation of 2 abstracts at upcoming American Society of Hematology Annual Meeting.\nREGENXBIO Inc. fell 16.1% to close at $31.72.\nHudson Technologies, Inc. dipped 16% to close at $3.95.\nCNFinance Holdings Limited fell 15.5% to settle at $4.30\nTG Therapeutics, Inc. fell 14.9% to settle at $27.05 after Goldman Sachs downgraded the stock from Neutral to Sell and lowered its price target from $33 to $26.\nSohu.com Limited dropped 14.3% to close at $18.49. Sohu.com reported third-quarter FY21 revenue growth of 37% year-on-year to $216 million. Revenue improved 6% quarter-over-quarter.\nEVgo, Inc. fell 14.3% to close at $16.19 following negative analyst coverage from Credit Suisse.\nAtai Life Sciences N.V. dropped 13.8% to close at $12.85 following Q3 results.\nButterfly Network, Inc. dipped 12.6% to close at $7.52 after the company posted downbeat Q3 sales and issued weak FY21 sales forecast.\nMoving iMage Technologies, Inc. shares fell 12.5% to close at $2.87. Moving iMage Technologies shares jumped around 22% on Friday after the company posted a narrower Q3 loss.\nNuZee, Inc. shares fell 12% to close at $4.53. NuZee manufacturing partner, Cuvee Coffee, recently reported an expansion into select Walmart stores nationwide.\nKoninklijke Philips N.V. fell 11.5% to settle at $42.16 after the company said it is in discussions with the FDA after a new inspection of one of its facilities.\nJAKKS Pacific, Inc. fell 10% to close at $12.38.\nF45 Training Holdings Inc. dropped 9.7% to close at $11.72. F45 Training Holdings recently reported worse-than-expected Q3 results.\nAvePoint, Inc. fell 9.6% to close at $8.33. AvePoint reported third-quarter FY21 revenue growth of 36% year-on-year to $53.9 million, beating the consensus of $52.6 million.\nBetter Therapeutics, Inc. fell 9.1% to close at $8.73.\nRumbleON, Inc. fell 5.9% to close at $45.54 following weak quarterly sales.","news_type":1},"isVote":1,"tweetType":1,"viewCount":377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873179443,"gmtCreate":1636899490880,"gmtModify":1636899490982,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Hehe","listText":"Hehe","text":"Hehe","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873179443","repostId":"1103944030","repostType":4,"repost":{"id":"1103944030","kind":"news","pubTimestamp":1636857439,"share":"https://www.laohu8.com/m/news/1103944030?lang=&edition=full","pubTime":"2021-11-14 10:37","market":"us","language":"en","title":"These are the next three mega-cap tech stocks you’ll be hearing more about","url":"https://stock-news.laohu8.com/highlight/detail?id=1103944030","media":"MarketWatch","summary":"AMD is among companies poised to eclipse $200 billion in market value\nAMD Chief Executive Lisa Su is","content":"<p>AMD is among companies poised to eclipse $200 billion in market value</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8977785546ccb691b11117bea0aa1480\" tg-width=\"1320\" tg-height=\"742\" referrerpolicy=\"no-referrer\"><span>AMD Chief Executive Lisa Su is seen in 2017. AFP via Getty Images</span></p>\n<p>As technology stocks have led the market for the better part of a dozen years, there are now 15 companies in the sector that have risen to mega-cap status — those valued at $200 billion or more.</p>\n<p>Five are valued at more than $1 trillion, including electric-vehicle maker Tesla,which I consider a tech company.</p>\n<p>Bets have been placed on which companies will rise to a trillion next, with Meta Platforms — aka Facebook — at the top of most lists and Nvidia,sitting on top of mine as a call I made 14 months ago.</p>\n<p>Perhaps harder than rising from north of half a trillion to a trillion is rising from less than $200 billion to break the threshold into mega-cap status.</p>\n<p>However, a few companies look destined for this outcome precisely, and I believe three have an incredibly compelling case to get there within the next 12 to 18 months — if not sooner.</p>\n<p><b>1. ServiceNow:</b> ServiceNow has been on an incredible run for more than a decade. From 2010 to 2020, revenues grew at a 59.2% average annual rate, while its stock rose at 44% a year. The company finished the 2020 calendar year at about $4.5 billion in revenue, and its trailing 12 months have surged close to $5.5 billion.</p>\n<p>The company now has more than 1,266 customers with a million or more dollars in recurring revenue, and is seeing this number grow at a substantial rate, including 25% in its most recent quarter.</p>\n<p>Beyond the numbers, the company’s technology, which enables companies to automate and implement digital workflows, continues to prove robust and best of breed. The most recent release of its Rome platform, three additional acquisitions to expand its portfolio and a deepened partnership with Microsoft are just a few recent highlights that provide the company a pathway to growth that should accelerate based on trends including app modernization, hybrid work, workflow automation, and even enterprise ESG initiatives.</p>\n<p>It’s hard to see ServiceNow not providing the robust growth that will take its market cap above $200 billion. The company’s market value is about $138 billion as of Monday.</p>\n<p><b>2. Qualcomm:</b>Qualcomm’s strong earnings report released last week — earnings per share jumped 76% year over year and revenue rose 43% — helped drive the stock to over $160 from the low $120s in mid-October.</p>\n<p>Consequently, that took the company’s market cap from about $145 billion to over $180 billion in just a matter of days. It serves as a timely reminder of how quickly a tech company in the right markets can produce momentum.</p>\n<p>Qualcomm, while best known as a chip provider for mobile handsets, is rapidly becoming a much bigger force in many categories, including the internet of things (IoT), automotive and wireless RFFE. With IoT and wireless RFFE surpassing a billion dollars a quarter in revenue, and automotive reaching nearly a billion in annual revenue with a $10 billion design pipeline, the company is becoming increasingly diversified. Thirty-eight percent of revenue in its QCT semiconductor business is now unrelated to handsets.</p>\n<p>Perhaps these adjacent business successes alone could catapult the company’s market value to over $200 billion, but what Qualcomm also has going for it is an undisputable global market leadership in 5G, which will continue to accelerate its handset business, as well as all of its adjacencies and massive licensing business.</p>\n<p><b>3. AMD:</b> I’ve been critical at times of Advanced Micro Devices,and sometimes you have to lean into calls you get wrong. While Intel under new CEO Pat Gelsinger shows more ambition and clear direction, AMD under Lisa Su has been on an absolute tear.</p>\n<p>In August, Mercury Research reported that AMD’s 22.5% x86 market share was its best in 14 years. With 4.2% year-over-year market share growth in its second quarter and another 54% overall revenue growth in the third quarter, the company’s market share gains look likely to continue.</p>\n<p>While I do think Intel is quickly patching its gaps and going to be a much more robust competitor, I believe the overall demand for CPUs (central processing units), GPUs (graphics processing units) and FPGAs (field-programmable gate arrays) will drive a larger total addressable market, and AMD’s going to grow revenues even if market share gains level off.</p>\n<p>Speaking of FPGA’s, the impending Xilinx deal, which I believe will gain regulatory approval, hasn’t been accounted for by many investors.</p>\n<p>AMD’s market value rose to over $180 billion Monday after the stock surged more than 10%. The company on Monday announced a range of news, including the fact that Meta will use its Epyc processors in its data center computers.</p>\n<p>After those three, I would add Micron Technology as an honorable mention. The company sits at closer to $85 billion in market cap. Still, as our thirst for compute continues to grow, the need for memory technology will scale dramatically, making Micron a significant beneficiary along with the likes of Samsung, which already sits well inside mega-cap territory.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These are the next three mega-cap tech stocks you’ll be hearing more about</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese are the next three mega-cap tech stocks you’ll be hearing more about\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-14 10:37 GMT+8 <a href=https://www.marketwatch.com/story/these-are-the-next-three-mega-cap-tech-stocks-youll-be-hearing-more-about-11636392083?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AMD is among companies poised to eclipse $200 billion in market value\nAMD Chief Executive Lisa Su is seen in 2017. AFP via Getty Images\nAs technology stocks have led the market for the better part of ...</p>\n\n<a href=\"https://www.marketwatch.com/story/these-are-the-next-three-mega-cap-tech-stocks-youll-be-hearing-more-about-11636392083?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司","NVDA":"英伟达","NOW":"ServiceNow","QCOM":"高通"},"source_url":"https://www.marketwatch.com/story/these-are-the-next-three-mega-cap-tech-stocks-youll-be-hearing-more-about-11636392083?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103944030","content_text":"AMD is among companies poised to eclipse $200 billion in market value\nAMD Chief Executive Lisa Su is seen in 2017. AFP via Getty Images\nAs technology stocks have led the market for the better part of a dozen years, there are now 15 companies in the sector that have risen to mega-cap status — those valued at $200 billion or more.\nFive are valued at more than $1 trillion, including electric-vehicle maker Tesla,which I consider a tech company.\nBets have been placed on which companies will rise to a trillion next, with Meta Platforms — aka Facebook — at the top of most lists and Nvidia,sitting on top of mine as a call I made 14 months ago.\nPerhaps harder than rising from north of half a trillion to a trillion is rising from less than $200 billion to break the threshold into mega-cap status.\nHowever, a few companies look destined for this outcome precisely, and I believe three have an incredibly compelling case to get there within the next 12 to 18 months — if not sooner.\n1. ServiceNow: ServiceNow has been on an incredible run for more than a decade. From 2010 to 2020, revenues grew at a 59.2% average annual rate, while its stock rose at 44% a year. The company finished the 2020 calendar year at about $4.5 billion in revenue, and its trailing 12 months have surged close to $5.5 billion.\nThe company now has more than 1,266 customers with a million or more dollars in recurring revenue, and is seeing this number grow at a substantial rate, including 25% in its most recent quarter.\nBeyond the numbers, the company’s technology, which enables companies to automate and implement digital workflows, continues to prove robust and best of breed. The most recent release of its Rome platform, three additional acquisitions to expand its portfolio and a deepened partnership with Microsoft are just a few recent highlights that provide the company a pathway to growth that should accelerate based on trends including app modernization, hybrid work, workflow automation, and even enterprise ESG initiatives.\nIt’s hard to see ServiceNow not providing the robust growth that will take its market cap above $200 billion. The company’s market value is about $138 billion as of Monday.\n2. Qualcomm:Qualcomm’s strong earnings report released last week — earnings per share jumped 76% year over year and revenue rose 43% — helped drive the stock to over $160 from the low $120s in mid-October.\nConsequently, that took the company’s market cap from about $145 billion to over $180 billion in just a matter of days. It serves as a timely reminder of how quickly a tech company in the right markets can produce momentum.\nQualcomm, while best known as a chip provider for mobile handsets, is rapidly becoming a much bigger force in many categories, including the internet of things (IoT), automotive and wireless RFFE. With IoT and wireless RFFE surpassing a billion dollars a quarter in revenue, and automotive reaching nearly a billion in annual revenue with a $10 billion design pipeline, the company is becoming increasingly diversified. Thirty-eight percent of revenue in its QCT semiconductor business is now unrelated to handsets.\nPerhaps these adjacent business successes alone could catapult the company’s market value to over $200 billion, but what Qualcomm also has going for it is an undisputable global market leadership in 5G, which will continue to accelerate its handset business, as well as all of its adjacencies and massive licensing business.\n3. AMD: I’ve been critical at times of Advanced Micro Devices,and sometimes you have to lean into calls you get wrong. While Intel under new CEO Pat Gelsinger shows more ambition and clear direction, AMD under Lisa Su has been on an absolute tear.\nIn August, Mercury Research reported that AMD’s 22.5% x86 market share was its best in 14 years. With 4.2% year-over-year market share growth in its second quarter and another 54% overall revenue growth in the third quarter, the company’s market share gains look likely to continue.\nWhile I do think Intel is quickly patching its gaps and going to be a much more robust competitor, I believe the overall demand for CPUs (central processing units), GPUs (graphics processing units) and FPGAs (field-programmable gate arrays) will drive a larger total addressable market, and AMD’s going to grow revenues even if market share gains level off.\nSpeaking of FPGA’s, the impending Xilinx deal, which I believe will gain regulatory approval, hasn’t been accounted for by many investors.\nAMD’s market value rose to over $180 billion Monday after the stock surged more than 10%. The company on Monday announced a range of news, including the fact that Meta will use its Epyc processors in its data center computers.\nAfter those three, I would add Micron Technology as an honorable mention. The company sits at closer to $85 billion in market cap. Still, as our thirst for compute continues to grow, the need for memory technology will scale dramatically, making Micron a significant beneficiary along with the likes of Samsung, which already sits well inside mega-cap territory.","news_type":1},"isVote":1,"tweetType":1,"viewCount":346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847914327,"gmtCreate":1636471698060,"gmtModify":1636471724906,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582199304143416","idStr":"3582199304143416"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/847914327","repostId":"1127189501","repostType":4,"repost":{"id":"1127189501","kind":"news","pubTimestamp":1636470995,"share":"https://www.laohu8.com/m/news/1127189501?lang=&edition=full","pubTime":"2021-11-09 23:16","market":"us","language":"en","title":"Kimbal Musk cashed out $109 million of Tesla stock just before Elon's tweets whacked the share price","url":"https://stock-news.laohu8.com/highlight/detail?id=1127189501","media":"businessinsider","summary":"Tesla board member Kimbal Musk sold around $109 million of the electric-car maker's stock shortly be","content":"<p>Tesla board member Kimbal Musk sold around $109 million of the electric-car maker's stock shortly before his brother Elon knocked the share price by asking Twitter if he should sell a big chunk of his holdings.</p>\n<p>Kimbal, an entrepreneur who sits on Tesla's board of directors, made a number of transactions on Friday according to a Securities and Exchange Commission filing.</p>\n<p>He exercised his stock options to buy 25,000 shares at just $74.17 a pop. Kimbal then sold 88,500 shares in a number of tranches at an average price of around $1,230, making him roughly $108.9 million.</p>\n<p>Elon's younger brother also donated 25,000 shares - which closed at $1,222.09 on Friday - to charity.</p>\n<p>Kimbal has not been the only director to take advantage of the Tesla's blistering rally, which has seen the stock price rise around 1,600% over the last two years.</p>\n<p>Filings from the end of October showed that directors Ira Ehrenpreis, Robyn Denholm and Antonio Gracias sold shares worth hundreds of millions of dollars.</p>\n<p>Tesla shares once fell nearly 10% in morning trading.</p>","source":"lsy1636471102575","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kimbal Musk cashed out $109 million of Tesla stock just before Elon's tweets whacked the share price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKimbal Musk cashed out $109 million of Tesla stock just before Elon's tweets whacked the share price\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-09 23:16 GMT+8 <a href=https://markets.businessinsider.com/news/stocks/kimbal-musk-elon-tesla-stock-share-sale-twitter-poll-2021-11><strong>businessinsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla board member Kimbal Musk sold around $109 million of the electric-car maker's stock shortly before his brother Elon knocked the share price by asking Twitter if he should sell a big chunk of his...</p>\n\n<a href=\"https://markets.businessinsider.com/news/stocks/kimbal-musk-elon-tesla-stock-share-sale-twitter-poll-2021-11\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://markets.businessinsider.com/news/stocks/kimbal-musk-elon-tesla-stock-share-sale-twitter-poll-2021-11","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127189501","content_text":"Tesla board member Kimbal Musk sold around $109 million of the electric-car maker's stock shortly before his brother Elon knocked the share price by asking Twitter if he should sell a big chunk of his holdings.\nKimbal, an entrepreneur who sits on Tesla's board of directors, made a number of transactions on Friday according to a Securities and Exchange Commission filing.\nHe exercised his stock options to buy 25,000 shares at just $74.17 a pop. Kimbal then sold 88,500 shares in a number of tranches at an average price of around $1,230, making him roughly $108.9 million.\nElon's younger brother also donated 25,000 shares - which closed at $1,222.09 on Friday - to charity.\nKimbal has not been the only director to take advantage of the Tesla's blistering rally, which has seen the stock price rise around 1,600% over the last two years.\nFilings from the end of October showed that directors Ira Ehrenpreis, Robyn Denholm and Antonio Gracias sold shares worth hundreds of millions of dollars.\nTesla shares once fell nearly 10% in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":309,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":878338208,"gmtCreate":1637147294404,"gmtModify":1637147294404,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Oooo","listText":"Oooo","text":"Oooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/878338208","repostId":"1160710301","repostType":4,"repost":{"id":"1160710301","kind":"news","pubTimestamp":1637147244,"share":"https://www.laohu8.com/m/news/1160710301?lang=&edition=full","pubTime":"2021-11-17 19:07","market":"us","language":"en","title":"Pfizer asks US officials to OK promising COVID-19 pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1160710301","media":"Associated Press","summary":"Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the st","content":"<p>Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.</p>\n<p>The company's filing comes as new infections are rising once again in the United States, driven mainly by hot spots in states where colder weather is driving more Americans indoors.</p>\n<p>Pfizer’s pill has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections. The Food and Drug Administration is already reviewing a competing pill from Merck and several smaller drugmakers are also expected to seek authorization for their own antiviral pills in the coming months.</p>\n<p>“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application,\" said Pfizer CEO Albert Bourla, in a statement.</p>\n<p>Specifically, Pfizer wants the drug available for adults who have mild-to-moderate COVID-19 infections and are at risk of becoming seriously ill. That's similar to how other drugs are currently used to treat the disease. But all FDA-authorized COVID-19 treatments require an IV or injection given by a health professional at a hospital or clinic.</p>\n<p>The FDA is holding a public meeting on the Merck pill later this month to get the opinion of outside experts before making its decision. The agency isn’t required to convene such meetings and it’s not yet known whether Pfizer’s drug will undergo a similar public review.</p>\n<p>Some experts predict COVID-19 treatments eventually will be combined to better protect against the worst effects of the virus.</p>\n<p>Pfizer reported earlier this monththat its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity. If authorized, the FDA will have to weigh making the pill available for vaccinated people dealing with breakthrough infections, since they weren't part of the initial tests.</p>\n<p>For best results, patients need to start taking the pills within three days of symptoms, underscoring the need for speedy testing and diagnosis. That could be a challenge if another COVID-19 surge leads to testing delays and shortages seen last winter.</p>\n<p>Pfizer’s drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body. That's different than the Merck pill, which causes tiny mutations in the coronavirus until the point that it can't reproduce itself.</p>\n<p>On Tuesday,Pfizer signed a deal a with U.N.-backed groupto allow generic drugmakers to produce low-cost versions of the pill for certain countries. Merck has a similar deal for its pill, which was authorized in Britain earlier this month.</p>\n<p>The U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they usually have to be given via time-consuming infusions by health professionals, and limited supplies were strained by the last surge of the delta variant.</p>\n<p>The U.S. government has already committed to purchasing Merck's pill. Federal authorities were in negotiations with Pfizer to buy millions of doses of its pill, according to an official familiar with the matter.</p>","source":"lsy1603278176698","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer asks US officials to OK promising COVID-19 pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer asks US officials to OK promising COVID-19 pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-17 19:07 GMT+8 <a href=https://finance.yahoo.com/news/pfizer-asks-us-officials-ok-190336933.html><strong>Associated Press</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.\nThe company'...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-asks-us-officials-ok-190336933.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-asks-us-officials-ok-190336933.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160710301","content_text":"Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.\nThe company's filing comes as new infections are rising once again in the United States, driven mainly by hot spots in states where colder weather is driving more Americans indoors.\nPfizer’s pill has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections. The Food and Drug Administration is already reviewing a competing pill from Merck and several smaller drugmakers are also expected to seek authorization for their own antiviral pills in the coming months.\n“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application,\" said Pfizer CEO Albert Bourla, in a statement.\nSpecifically, Pfizer wants the drug available for adults who have mild-to-moderate COVID-19 infections and are at risk of becoming seriously ill. That's similar to how other drugs are currently used to treat the disease. But all FDA-authorized COVID-19 treatments require an IV or injection given by a health professional at a hospital or clinic.\nThe FDA is holding a public meeting on the Merck pill later this month to get the opinion of outside experts before making its decision. The agency isn’t required to convene such meetings and it’s not yet known whether Pfizer’s drug will undergo a similar public review.\nSome experts predict COVID-19 treatments eventually will be combined to better protect against the worst effects of the virus.\nPfizer reported earlier this monththat its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity. If authorized, the FDA will have to weigh making the pill available for vaccinated people dealing with breakthrough infections, since they weren't part of the initial tests.\nFor best results, patients need to start taking the pills within three days of symptoms, underscoring the need for speedy testing and diagnosis. That could be a challenge if another COVID-19 surge leads to testing delays and shortages seen last winter.\nPfizer’s drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body. That's different than the Merck pill, which causes tiny mutations in the coronavirus until the point that it can't reproduce itself.\nOn Tuesday,Pfizer signed a deal a with U.N.-backed groupto allow generic drugmakers to produce low-cost versions of the pill for certain countries. Merck has a similar deal for its pill, which was authorized in Britain earlier this month.\nThe U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they usually have to be given via time-consuming infusions by health professionals, and limited supplies were strained by the last surge of the delta variant.\nThe U.S. government has already committed to purchasing Merck's pill. Federal authorities were in negotiations with Pfizer to buy millions of doses of its pill, according to an official familiar with the matter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":171910072,"gmtCreate":1626701984796,"gmtModify":1633924821609,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Ohno","listText":"Ohno","text":"Ohno","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/171910072","repostId":"1155543383","repostType":4,"repost":{"id":"1155543383","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626701304,"share":"https://www.laohu8.com/m/news/1155543383?lang=&edition=full","pubTime":"2021-07-19 21:28","market":"us","language":"en","title":"US stocks sink at open on renewed virus fears","url":"https://stock-news.laohu8.com/highlight/detail?id=1155543383","media":"Tiger Newspress","summary":"(July 19) US stocks open lower on Monday; The DOW lost 1.42%, the S&P 500 dipped 1.30%, and the Nasd","content":"<p>(July 19) US stocks open lower on Monday; The DOW lost 1.42%, the S&P 500 dipped 1.30%, and the Nasdaq Composite shed 1.31%.</p>\n<p><img src=\"https://static.tigerbbs.com/9f8cb9434b60260c80a3bbbebc82750e\" tg-width=\"1242\" tg-height=\"577\" referrerpolicy=\"no-referrer\"></p>\n<p>The S&P 500 declined for a third day. Travel-related stocks including United Airlines Holdings Inc. and Carnival Corp. were among the worst performers, falling more than 4%. Energy stocks tumbled as crude prices dropped to the lowest since early June after OPEC+ struck a deal to increase output. All 24 stocks in the KBW Bank Index declined. Ten-year U.S. Treasury yields fell to the lowest since February.</p>\n<p><img src=\"https://static.tigerbbs.com/e90e2b06bafc1691f797fadaa59457dc\" tg-width=\"278\" tg-height=\"372\" referrerpolicy=\"no-referrer\"></p>\n<p>A rising number of Covid-19 cases as the delta variant spreads around the world is prompting investors to move money into safer assets on concern that new restrictions could sap an economic rebound that helped push all of the major U.S. equity benchmarks to record highs this month. The decline in Treasury yields may be a sign of cracks in the global recovery, putting the onus back on the Federal Reserve and other central banks to support ailing economies even as inflation remains elevated.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US stocks sink at open on renewed virus fears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS stocks sink at open on renewed virus fears\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-19 21:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(July 19) US stocks open lower on Monday; The DOW lost 1.42%, the S&P 500 dipped 1.30%, and the Nasdaq Composite shed 1.31%.</p>\n<p><img src=\"https://static.tigerbbs.com/9f8cb9434b60260c80a3bbbebc82750e\" tg-width=\"1242\" tg-height=\"577\" referrerpolicy=\"no-referrer\"></p>\n<p>The S&P 500 declined for a third day. Travel-related stocks including United Airlines Holdings Inc. and Carnival Corp. were among the worst performers, falling more than 4%. Energy stocks tumbled as crude prices dropped to the lowest since early June after OPEC+ struck a deal to increase output. All 24 stocks in the KBW Bank Index declined. Ten-year U.S. Treasury yields fell to the lowest since February.</p>\n<p><img src=\"https://static.tigerbbs.com/e90e2b06bafc1691f797fadaa59457dc\" tg-width=\"278\" tg-height=\"372\" referrerpolicy=\"no-referrer\"></p>\n<p>A rising number of Covid-19 cases as the delta variant spreads around the world is prompting investors to move money into safer assets on concern that new restrictions could sap an economic rebound that helped push all of the major U.S. equity benchmarks to record highs this month. The decline in Treasury yields may be a sign of cracks in the global recovery, putting the onus back on the Federal Reserve and other central banks to support ailing economies even as inflation remains elevated.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155543383","content_text":"(July 19) US stocks open lower on Monday; The DOW lost 1.42%, the S&P 500 dipped 1.30%, and the Nasdaq Composite shed 1.31%.\n\nThe S&P 500 declined for a third day. Travel-related stocks including United Airlines Holdings Inc. and Carnival Corp. were among the worst performers, falling more than 4%. Energy stocks tumbled as crude prices dropped to the lowest since early June after OPEC+ struck a deal to increase output. All 24 stocks in the KBW Bank Index declined. Ten-year U.S. Treasury yields fell to the lowest since February.\n\nA rising number of Covid-19 cases as the delta variant spreads around the world is prompting investors to move money into safer assets on concern that new restrictions could sap an economic rebound that helped push all of the major U.S. equity benchmarks to record highs this month. The decline in Treasury yields may be a sign of cracks in the global recovery, putting the onus back on the Federal Reserve and other central banks to support ailing economies even as inflation remains elevated.","news_type":1},"isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":604598444,"gmtCreate":1639408885987,"gmtModify":1639409717414,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":":(","listText":":(","text":":(","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/604598444","repostId":"1125628300","repostType":4,"repost":{"id":"1125628300","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639408702,"share":"https://www.laohu8.com/m/news/1125628300?lang=&edition=full","pubTime":"2021-12-13 23:18","market":"us","language":"en","title":"EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125628300","media":"Tiger Newspress","summary":"EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling aro","content":"<p>EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3%.<img src=\"https://static.tigerbbs.com/339c507942577109dbbbb0437dd2eb2d\" tg-width=\"537\" tg-height=\"197\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3% </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3% \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 23:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3%.<img src=\"https://static.tigerbbs.com/339c507942577109dbbbb0437dd2eb2d\" tg-width=\"537\" tg-height=\"197\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","LI":"理想汽车","TSLA":"特斯拉","F":"福特汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125628300","content_text":"EV stocks slid in morning trading, with Tesla falling over 4%,and Li,General motors,Ford falling around 3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":752,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602343337,"gmtCreate":1638975935231,"gmtModify":1638975935231,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Nicee","listText":"Nicee","text":"Nicee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602343337","repostId":"1100353648","repostType":4,"repost":{"id":"1100353648","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638975407,"share":"https://www.laohu8.com/m/news/1100353648?lang=&edition=full","pubTime":"2021-12-08 22:56","market":"us","language":"en","title":"Airlines and cruise line stocks jumped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1100353648","media":"Tiger Newspress","summary":"Airlines and cruise line stocks jumped in morning trading.","content":"<p>Airlines and cruise line stocks jumped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/994b55083be6d042bbbfb1c0599d47cd\" tg-width=\"407\" tg-height=\"483\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/0947f84e60588e489e2e964fe5a018dc\" tg-width=\"405\" tg-height=\"189\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Airlines and cruise line stocks jumped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAirlines and cruise line stocks jumped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 22:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Airlines and cruise line stocks jumped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/994b55083be6d042bbbfb1c0599d47cd\" tg-width=\"407\" tg-height=\"483\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/0947f84e60588e489e2e964fe5a018dc\" tg-width=\"405\" tg-height=\"189\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LUV":"西南航空","SAVE":"Spirit Airlines","UAL":"联合大陆航空","AAL":"美国航空","BA":"波音","JBLU":"捷蓝航空","CCL":"嘉年华邮轮","DAL":"达美航空","NCLH":"挪威邮轮","RCL":"皇家加勒比邮轮"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100353648","content_text":"Airlines and cruise line stocks jumped in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":614,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":803521435,"gmtCreate":1627450077427,"gmtModify":1633764863788,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Ooo","listText":"Ooo","text":"Ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/803521435","repostId":"1107532514","repostType":4,"isVote":1,"tweetType":1,"viewCount":118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177620051,"gmtCreate":1627212603473,"gmtModify":1633767135011,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Interesting!","listText":"Interesting!","text":"Interesting!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/177620051","repostId":"2153936352","repostType":4,"repost":{"id":"2153936352","kind":"highlight","pubTimestamp":1627180340,"share":"https://www.laohu8.com/m/news/2153936352?lang=&edition=full","pubTime":"2021-07-25 10:32","market":"us","language":"en","title":"Will Square Be Worth More Than PayPal by 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2153936352","media":"Motley Fool","summary":"Could the ambitious fintech company overtake the market leader?","content":"<p><b>Square</b> (NYSE:SQ) and <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a></b> (NASDAQ:PYPL) have both generated massive returns for patient investors over the past few years. Square went public at $9 per share in late 2015, and it's now trading at around $260. PayPal, which was spun off from<b> <a href=\"https://laohu8.com/S/EBAY\">eBay</a> </b>(NASDAQ:EBAY) earlier that year, has advanced more than 720% since its debut to over $300 per share.</p>\n<p>Square is worth nearly $120 billion as of this writing, while PayPal is worth over $350 billion. That isn't surprising, since PayPal still serves a much larger audience and operates in more countries than Square. But gazing into the future, could Square eventually match -- or even surpass -- PayPal's valuation by 2025? Let's examine both fintech companies' growth trajectories and valuations to find out.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a3384d45efb17ed54b398c7dbcc043fb\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><b>Wild ambitions vs. stable growth</b></h2>\n<p>Square and PayPal's core business models are similar. Both companies charge businesses flat fees, which vary by platform and transaction type, to process payments. Both companies offer small business loans. Square's Cash App and PayPal's Venmo both enable consumers to make peer-to-peer payments, and both companies provide branded debit cards that are linked to users' online accounts.</p>\n<p>But Square has been willing to take bolder risks than PayPal over the past few years. It expanded its services ecosystem with online payroll management services and analytics tools, and recently launched a full suite of online banking services. Square also added <b>Bitcoin</b> (CRYPTO:BTC) purchases to its Cash App in 2018, added free stock trades to the app to challenge Robinhood in 2019, and plans to add Credit Karma's tax filing services to its ecosystem in the near future.</p>\n<p>PayPal only started offering cryptocurrency trades last October, and it doesn't have any near-term plans to launch stock trading tools or dedicated tax filing services, or expand into a full-blown online bank like Square. Simply put, Square seems to have wilder and grander ambitions than PayPal.</p>\n<h2>Which company is growing faster?</h2>\n<p>Between 2015 and 2020, Square grew its annual revenue at a CAGR of 49.6%. Excluding its massive gain in Bitcoin revenue last year, it would still have grown its revenue at a CAGR of 31.2% over the past five years. PayPal's annual revenue grew at a CAGR of 18.5% between 2015 and 2020. Let's take a look at Wall Street's expectations for both companies over the next two years.</p>\n<table border=\"1\" width=\"600\">\n <colgroup></colgroup>\n <tbody>\n <tr valign=\"TOP\">\n <th width=\"118\"><p>Company</p></th>\n <th width=\"213\"><p>Estimated Sales Growth (FY 2021)</p></th>\n <th width=\"225\"><p>Estimated Sales Growth(FY 2022)</p></th>\n </tr>\n <tr valign=\"TOP\">\n <td width=\"118\"><p><b>Square</b></p></td>\n <td width=\"213\"><p>110.6%</p></td>\n <td width=\"225\"><p>14.1%</p></td>\n </tr>\n <tr valign=\"TOP\">\n <td width=\"118\"><p><b>PayPal</b></p></td>\n <td width=\"213\"><p>20.6%</p></td>\n <td width=\"225\"><p>21.5%</p></td>\n </tr>\n </tbody>\n</table>\n<p>Source: Yahoo Finance, July 22.</p>\n<p>Analysts expect Square's Bitcoin revenue to continue rising this year before cooling off next year. They also expect its growth in transaction-based and seller service revenue, which slowed down during the pandemic, to recover as more businesses reopen. The Cash App, which grew its monthly active users 50% to 36 million in 2020, should also keep expanding as Square adds new services.</p>\n<p>Cathie Wood's ARK Invest expects Square's transaction-based and seller service revenues to grow at a CAGR of 19% through 2025. It also expects the Cash App's MAUs to more than double to 75 million, for Square to monetize roughly 40% of those users, and for its average revenue per Cash App user to grow from $25 in 2019 to $260 in 2025 -- which would represent a whopping CAGR of 49%.</p>\n<p>PayPal's growth should remain more predictable, since it doesn't generate significant revenue from cryptocurrencies yet. Instead, it will mainly rely on its growth in active accounts, which rose 21% year-over-year to 392 million last quarter, to generate stable revenue from its processing fees.</p>\n<p>PayPal expects to nearly double its active accounts to 750 million and <i>more than double</i> its annual revenue to over $50 billion by 2025. It also plans to grow its earnings at a CAGR of 22% from 2020 to 2025. It believes the rising acceptance of QR codes and NFC payments, the expansion of its financial services, and higher engagement rates for its apps will all drive that long-term growth.</p>\n<h2>Will Square be worth more than PayPal by 2025?</h2>\n<p>In a best-case scenario, ARK Invest believes Square's stock could hit $500 per share by 2025 if it hits its growth targets. But unlike PayPal, Square hasn't provided any concrete targets of its own yet.</p>\n<p>If Square hits $500 and its valuations hold steady, it could be worth just over $200 billion by 2025. Meanwhile, if PayPal achieves its goals of more than doubling its annual revenue and growing its EPS at a CAGR of 22% through 2025, its stock could easily double and boost its market cap to $700 billion.</p>\n<p>Therefore, it's doubtful that Square -- which already trades at higher valuations than PayPal -- will be the more valuable company by 2025. But that doesn't mean PayPal is necessarily a better growth stock than Square. I personally own Square instead of PayPal, because I admire its ambitious and forward-thinking strategies. Both stocks are still great long-term investments on the booming fintech market, so investors shouldn't fret too much over which company has the higher market cap.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Square Be Worth More Than PayPal by 2025?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Square Be Worth More Than PayPal by 2025?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-25 10:32 GMT+8 <a href=https://www.fool.com/investing/2021/07/24/will-square-be-worth-more-than-paypal-by-2025/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Square (NYSE:SQ) and PayPal (NASDAQ:PYPL) have both generated massive returns for patient investors over the past few years. Square went public at $9 per share in late 2015, and it's now trading at ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/24/will-square-be-worth-more-than-paypal-by-2025/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SQ":"Block","PYPL":"PayPal"},"source_url":"https://www.fool.com/investing/2021/07/24/will-square-be-worth-more-than-paypal-by-2025/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153936352","content_text":"Square (NYSE:SQ) and PayPal (NASDAQ:PYPL) have both generated massive returns for patient investors over the past few years. Square went public at $9 per share in late 2015, and it's now trading at around $260. PayPal, which was spun off from eBay (NASDAQ:EBAY) earlier that year, has advanced more than 720% since its debut to over $300 per share.\nSquare is worth nearly $120 billion as of this writing, while PayPal is worth over $350 billion. That isn't surprising, since PayPal still serves a much larger audience and operates in more countries than Square. But gazing into the future, could Square eventually match -- or even surpass -- PayPal's valuation by 2025? Let's examine both fintech companies' growth trajectories and valuations to find out.\nImage source: Getty Images.\nWild ambitions vs. stable growth\nSquare and PayPal's core business models are similar. Both companies charge businesses flat fees, which vary by platform and transaction type, to process payments. Both companies offer small business loans. Square's Cash App and PayPal's Venmo both enable consumers to make peer-to-peer payments, and both companies provide branded debit cards that are linked to users' online accounts.\nBut Square has been willing to take bolder risks than PayPal over the past few years. It expanded its services ecosystem with online payroll management services and analytics tools, and recently launched a full suite of online banking services. Square also added Bitcoin (CRYPTO:BTC) purchases to its Cash App in 2018, added free stock trades to the app to challenge Robinhood in 2019, and plans to add Credit Karma's tax filing services to its ecosystem in the near future.\nPayPal only started offering cryptocurrency trades last October, and it doesn't have any near-term plans to launch stock trading tools or dedicated tax filing services, or expand into a full-blown online bank like Square. Simply put, Square seems to have wilder and grander ambitions than PayPal.\nWhich company is growing faster?\nBetween 2015 and 2020, Square grew its annual revenue at a CAGR of 49.6%. Excluding its massive gain in Bitcoin revenue last year, it would still have grown its revenue at a CAGR of 31.2% over the past five years. PayPal's annual revenue grew at a CAGR of 18.5% between 2015 and 2020. Let's take a look at Wall Street's expectations for both companies over the next two years.\n\n\n\n\nCompany\nEstimated Sales Growth (FY 2021)\nEstimated Sales Growth(FY 2022)\n\n\nSquare\n110.6%\n14.1%\n\n\nPayPal\n20.6%\n21.5%\n\n\n\nSource: Yahoo Finance, July 22.\nAnalysts expect Square's Bitcoin revenue to continue rising this year before cooling off next year. They also expect its growth in transaction-based and seller service revenue, which slowed down during the pandemic, to recover as more businesses reopen. The Cash App, which grew its monthly active users 50% to 36 million in 2020, should also keep expanding as Square adds new services.\nCathie Wood's ARK Invest expects Square's transaction-based and seller service revenues to grow at a CAGR of 19% through 2025. It also expects the Cash App's MAUs to more than double to 75 million, for Square to monetize roughly 40% of those users, and for its average revenue per Cash App user to grow from $25 in 2019 to $260 in 2025 -- which would represent a whopping CAGR of 49%.\nPayPal's growth should remain more predictable, since it doesn't generate significant revenue from cryptocurrencies yet. Instead, it will mainly rely on its growth in active accounts, which rose 21% year-over-year to 392 million last quarter, to generate stable revenue from its processing fees.\nPayPal expects to nearly double its active accounts to 750 million and more than double its annual revenue to over $50 billion by 2025. It also plans to grow its earnings at a CAGR of 22% from 2020 to 2025. It believes the rising acceptance of QR codes and NFC payments, the expansion of its financial services, and higher engagement rates for its apps will all drive that long-term growth.\nWill Square be worth more than PayPal by 2025?\nIn a best-case scenario, ARK Invest believes Square's stock could hit $500 per share by 2025 if it hits its growth targets. But unlike PayPal, Square hasn't provided any concrete targets of its own yet.\nIf Square hits $500 and its valuations hold steady, it could be worth just over $200 billion by 2025. Meanwhile, if PayPal achieves its goals of more than doubling its annual revenue and growing its EPS at a CAGR of 22% through 2025, its stock could easily double and boost its market cap to $700 billion.\nTherefore, it's doubtful that Square -- which already trades at higher valuations than PayPal -- will be the more valuable company by 2025. But that doesn't mean PayPal is necessarily a better growth stock than Square. I personally own Square instead of PayPal, because I admire its ambitious and forward-thinking strategies. Both stocks are still great long-term investments on the booming fintech market, so investors shouldn't fret too much over which company has the higher market cap.","news_type":1},"isVote":1,"tweetType":1,"viewCount":165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148919385,"gmtCreate":1625913700947,"gmtModify":1633936144304,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Woah!","listText":"Woah!","text":"Woah!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/148919385","repostId":"1159307278","repostType":4,"repost":{"id":"1159307278","kind":"news","pubTimestamp":1625873648,"share":"https://www.laohu8.com/m/news/1159307278?lang=&edition=full","pubTime":"2021-07-10 07:34","market":"us","language":"en","title":"5 Things to Know About Virgin Galactic and the First Passenger Flight to Space","url":"https://stock-news.laohu8.com/highlight/detail?id=1159307278","media":"Barrons","summary":"Richard Branson’s planned flight to space on Sunday could be a monumental moment for the fledgling s","content":"<p>Richard Branson’s planned flight to space on Sunday could be a monumental moment for the fledgling space tourism industry.</p>\n<p>So long as there are no issues or delays, the flight will take the 70-year-old founder of Virgin Galactic(ticker: SPCE), company mission specialists, and pilots, on the first passenger trip to space, beating Jeff Bezos’s Blue Origin passenger flight by more than a week.</p>\n<p>Here’s what to watch for Sunday, along with some recent history.</p>\n<p><b>When Will the Virgin Galactic Space Flight Take Off?</b></p>\n<p>The Virgin Galactic Unity 22 spaceflight is expected to launch from Virgin’s spaceport in New Mexico around 9 a.m. eastern time. The launch can be streamed live on the company’s website and on Barron’s below.</p>\n<p><b>How High Up in Space Will Passenger Go?</b></p>\n<p>Galactic’s VSS Unity spacecraft will hit speeds of about Mach 3, or three times the speed of sound, and rise to about 300,000 feet, or 57 miles. That’s about 10 times as high as many commercial flights but still considered the edge of space. The suborbital flight will not pass the so-called Karman line, which is what scientists use to define the boundary of outer space. That line is about 62 miles up.</p>\n<p>Blue Origin plans to take its passengers past the Karman line on its flight.</p>\n<p><b>How Much Did Passengers Pay for the Trip?</b></p>\n<p>Nothing. While this flight could be another step forward for space tourism, the expected crew members are Galactic employees and Branson. Joining the company’s founder on board will be two pilots; Beth Moses, chief astronaut instructor; Colin Bennett, lead operations engineer; and Sirisha Bandla, vice president of government affairs and research operations.</p>\n<p>Still, Branson is no stranger to publicity. Canaccord analyst Ken Herbert believes it’s possible that Galactic could surprise viewers by bringing a paying customer on board with Branson. That would generate additional buzz for the company.</p>\n<p>A move like that would best space-tourism competitor Blue Origin in another way. Bezos is expected to take the first paying passenger to space on his flight later this month. That seat was auctioned off for $28 million.</p>\n<p>A ticket on a future Virgin Galactic flight will run about $250,000.</p>\n<p><b>What Does the Flight Mean for Investors?</b></p>\n<p>The continuation of flight tests brings Galactic one step closer to full commercialization, which means sales and, hopefully, earnings down the road.</p>\n<p>Once fully operational, each Galactic spaceship is expected to make roughly 36 flights a year. Most Galactic spaceships have about six seats for sale. At full capacity, that’s about $54 million per spaceship a year.</p>\n<p>Analysts expect Galactic to do about $3 million in 2021 sales, growing to $51 million in 2022 and $555 million by 2025. Earnings and cash flow are expected to turn positive around 2024.</p>\n<p>The flight and associated news coverage also represent publicity for the company.</p>\n<p><b>How Will Virgin Galactic Stock Benefit?</b></p>\n<p>A successful test flight is a clear positive for Galactic, but it might not be so for its stock. The news of the flight and the potential benefits are, for the most part, already priced into shares of Virgin Galactic.</p>\n<p><img src=\"https://static.tigerbbs.com/a4113576958bcf043e56e1c92578d0cc\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>The stock is up roughly 120% year to date and up more than 200% over the past 12 months, giving the start-up a market capitalization of around $11 billion.</p>\n<p>Investors shouldn’t be disappointed if the stock doesn’t gain on Monday following a successful flight. The ultimate value of the company will be determined down the road.</p>\n<p>Analysts loved the stock when it was cheaper. Back in September, all analysts covering Galactic rated shares Buy. Theaverage Buy-ratingratio for S&P 500 stocks is about 55%.</p>\n<p>Shares were $25 in September. Now, only 30% of analysts rate shares Buy as the stock has rocketed north of $50 a share.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Things to Know About Virgin Galactic and the First Passenger Flight to Space</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Things to Know About Virgin Galactic and the First Passenger Flight to Space\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-10 07:34 GMT+8 <a href=https://www.barrons.com/articles/virgin-galactic-richard-branson-space-flight-51625848364?mod=hp_LEAD_4><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Richard Branson’s planned flight to space on Sunday could be a monumental moment for the fledgling space tourism industry.\nSo long as there are no issues or delays, the flight will take the 70-year-...</p>\n\n<a href=\"https://www.barrons.com/articles/virgin-galactic-richard-branson-space-flight-51625848364?mod=hp_LEAD_4\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPCE":"维珍银河"},"source_url":"https://www.barrons.com/articles/virgin-galactic-richard-branson-space-flight-51625848364?mod=hp_LEAD_4","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159307278","content_text":"Richard Branson’s planned flight to space on Sunday could be a monumental moment for the fledgling space tourism industry.\nSo long as there are no issues or delays, the flight will take the 70-year-old founder of Virgin Galactic(ticker: SPCE), company mission specialists, and pilots, on the first passenger trip to space, beating Jeff Bezos’s Blue Origin passenger flight by more than a week.\nHere’s what to watch for Sunday, along with some recent history.\nWhen Will the Virgin Galactic Space Flight Take Off?\nThe Virgin Galactic Unity 22 spaceflight is expected to launch from Virgin’s spaceport in New Mexico around 9 a.m. eastern time. The launch can be streamed live on the company’s website and on Barron’s below.\nHow High Up in Space Will Passenger Go?\nGalactic’s VSS Unity spacecraft will hit speeds of about Mach 3, or three times the speed of sound, and rise to about 300,000 feet, or 57 miles. That’s about 10 times as high as many commercial flights but still considered the edge of space. The suborbital flight will not pass the so-called Karman line, which is what scientists use to define the boundary of outer space. That line is about 62 miles up.\nBlue Origin plans to take its passengers past the Karman line on its flight.\nHow Much Did Passengers Pay for the Trip?\nNothing. While this flight could be another step forward for space tourism, the expected crew members are Galactic employees and Branson. Joining the company’s founder on board will be two pilots; Beth Moses, chief astronaut instructor; Colin Bennett, lead operations engineer; and Sirisha Bandla, vice president of government affairs and research operations.\nStill, Branson is no stranger to publicity. Canaccord analyst Ken Herbert believes it’s possible that Galactic could surprise viewers by bringing a paying customer on board with Branson. That would generate additional buzz for the company.\nA move like that would best space-tourism competitor Blue Origin in another way. Bezos is expected to take the first paying passenger to space on his flight later this month. That seat was auctioned off for $28 million.\nA ticket on a future Virgin Galactic flight will run about $250,000.\nWhat Does the Flight Mean for Investors?\nThe continuation of flight tests brings Galactic one step closer to full commercialization, which means sales and, hopefully, earnings down the road.\nOnce fully operational, each Galactic spaceship is expected to make roughly 36 flights a year. Most Galactic spaceships have about six seats for sale. At full capacity, that’s about $54 million per spaceship a year.\nAnalysts expect Galactic to do about $3 million in 2021 sales, growing to $51 million in 2022 and $555 million by 2025. Earnings and cash flow are expected to turn positive around 2024.\nThe flight and associated news coverage also represent publicity for the company.\nHow Will Virgin Galactic Stock Benefit?\nA successful test flight is a clear positive for Galactic, but it might not be so for its stock. The news of the flight and the potential benefits are, for the most part, already priced into shares of Virgin Galactic.\n\nThe stock is up roughly 120% year to date and up more than 200% over the past 12 months, giving the start-up a market capitalization of around $11 billion.\nInvestors shouldn’t be disappointed if the stock doesn’t gain on Monday following a successful flight. The ultimate value of the company will be determined down the road.\nAnalysts loved the stock when it was cheaper. Back in September, all analysts covering Galactic rated shares Buy. Theaverage Buy-ratingratio for S&P 500 stocks is about 55%.\nShares were $25 in September. Now, only 30% of analysts rate shares Buy as the stock has rocketed north of $50 a share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":608683241,"gmtCreate":1638711890532,"gmtModify":1638711890639,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Ooooo","listText":"Ooooo","text":"Ooooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/608683241","repostId":"2189576203","repostType":4,"repost":{"id":"2189576203","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638691560,"share":"https://www.laohu8.com/m/news/2189576203?lang=&edition=full","pubTime":"2021-12-05 16:06","market":"us","language":"en","title":"Peloton stock is a buy, but with an 'asterisk', analyst says","url":"https://stock-news.laohu8.com/highlight/detail?id=2189576203","media":"Dow Jones","summary":"Deutsche Bank's Chris Woronka said his 'unemotional analysis' suggests the at-home fitness company's","content":"<p>Deutsche Bank's Chris Woronka said his 'unemotional analysis' suggests the at-home fitness company's stock is worth owning for investors with 'patience'</p>\n<p>Investors should buy Peloton Interactive Inc.'s stock, says Deutsche Bank analyst Chris Woronka, but only those who have the patience to ride out potential volatility, which could last a \"few quarters.\"</p>\n<p>The at-home fitness company's stock <a href=\"https://laohu8.com/S/PTON\">$(PTON)$</a> slumped 2.0% to close Monday at $43.55, reversing an earlier intraday gain of as much as 4.6%.</p>\n<p>Peloton was viewed as a hot COVID-19-pandemic play last year, with the stock rocketing more than fivefold (up 434%), as gym closures fueled an explosion in the \"work-in\" trend. It's been an entirely different play in 2021, however, as the stock has plunged 71% year to date. It closed Wednesday at $42.25, the lowest price since May 27, 2020.</p>\n<p>In comparison, shares of fitness center operator <a href=\"https://laohu8.com/S/PLNT\">Planet Fitness Inc</a>. (PLNT) have gained 3.8% this year and the S&P 500 index has rallied 21%.</p>\n<p>While the stock has suffered a \"tough ride\" this year, and the going could still be a bit rough for a while, Deutsche Bank's Woronka said he is bullish on Peloton's fundamentals over the longer term.</p>\n<p>He initiated coverage of Peloton with a buy rating and a 12-month stock price target of $76, which implies nearly about 75% upside from current levels. Woronka said his view is based on an \"unemotional analysis\" of the company's earnings power in a \"normalized, fully-reopened\" economic environment.</p>\n<p>\"[W]hile it's never fun to lead off a buy report with a 'patience required' asterisk of sorts, that's exactly what we find ourselves doing here,\" Woronka wrote in a note to clients.</p>\n<p>As a fundamental analyst, Woronka said he is most interested in looking for \"asymmetrical risk/reward scenarios,\" and that's what he believes Pelton's stock provides at current levels. While there are scenarios in which the stock can still go lower, he believes there are more scenarios that result in even greater upside.</p>\n<p>\"Right now, we believe the market is looking at fitness stocks as an 'either/or' sector; either consumers stay at home to work out or they go back to their favorite pre-COVID-19 fitness facility,\" Woronka wrote. \"In our opinion, that's an oversimplified view of the world; we think the hybrid work model extends to fitness, too, and that [Peloton] has plenty of momentum to regain operationally.\"</p>\n<p>He realizes that sentiment on the stock isn't likely to reflect his bullish view \"until a few quarters of improved execution\" are in the books. But that's where the opportunity for reward lies over a 12-month time horizon.</p>\n<p>Once the stock starts trading on fundamentals again, Woronka believes \"it has quite a bit of room to run.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peloton stock is a buy, but with an 'asterisk', analyst says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeloton stock is a buy, but with an 'asterisk', analyst says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-05 16:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Deutsche Bank's Chris Woronka said his 'unemotional analysis' suggests the at-home fitness company's stock is worth owning for investors with 'patience'</p>\n<p>Investors should buy Peloton Interactive Inc.'s stock, says Deutsche Bank analyst Chris Woronka, but only those who have the patience to ride out potential volatility, which could last a \"few quarters.\"</p>\n<p>The at-home fitness company's stock <a href=\"https://laohu8.com/S/PTON\">$(PTON)$</a> slumped 2.0% to close Monday at $43.55, reversing an earlier intraday gain of as much as 4.6%.</p>\n<p>Peloton was viewed as a hot COVID-19-pandemic play last year, with the stock rocketing more than fivefold (up 434%), as gym closures fueled an explosion in the \"work-in\" trend. It's been an entirely different play in 2021, however, as the stock has plunged 71% year to date. It closed Wednesday at $42.25, the lowest price since May 27, 2020.</p>\n<p>In comparison, shares of fitness center operator <a href=\"https://laohu8.com/S/PLNT\">Planet Fitness Inc</a>. (PLNT) have gained 3.8% this year and the S&P 500 index has rallied 21%.</p>\n<p>While the stock has suffered a \"tough ride\" this year, and the going could still be a bit rough for a while, Deutsche Bank's Woronka said he is bullish on Peloton's fundamentals over the longer term.</p>\n<p>He initiated coverage of Peloton with a buy rating and a 12-month stock price target of $76, which implies nearly about 75% upside from current levels. Woronka said his view is based on an \"unemotional analysis\" of the company's earnings power in a \"normalized, fully-reopened\" economic environment.</p>\n<p>\"[W]hile it's never fun to lead off a buy report with a 'patience required' asterisk of sorts, that's exactly what we find ourselves doing here,\" Woronka wrote in a note to clients.</p>\n<p>As a fundamental analyst, Woronka said he is most interested in looking for \"asymmetrical risk/reward scenarios,\" and that's what he believes Pelton's stock provides at current levels. While there are scenarios in which the stock can still go lower, he believes there are more scenarios that result in even greater upside.</p>\n<p>\"Right now, we believe the market is looking at fitness stocks as an 'either/or' sector; either consumers stay at home to work out or they go back to their favorite pre-COVID-19 fitness facility,\" Woronka wrote. \"In our opinion, that's an oversimplified view of the world; we think the hybrid work model extends to fitness, too, and that [Peloton] has plenty of momentum to regain operationally.\"</p>\n<p>He realizes that sentiment on the stock isn't likely to reflect his bullish view \"until a few quarters of improved execution\" are in the books. But that's where the opportunity for reward lies over a 12-month time horizon.</p>\n<p>Once the stock starts trading on fundamentals again, Woronka believes \"it has quite a bit of room to run.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4551":"寇图资本持仓","BK4216":"消闲设施","BK4190":"消闲用品","BK4566":"资本集团","PTON":"Peloton Interactive, Inc.","BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189576203","content_text":"Deutsche Bank's Chris Woronka said his 'unemotional analysis' suggests the at-home fitness company's stock is worth owning for investors with 'patience'\nInvestors should buy Peloton Interactive Inc.'s stock, says Deutsche Bank analyst Chris Woronka, but only those who have the patience to ride out potential volatility, which could last a \"few quarters.\"\nThe at-home fitness company's stock $(PTON)$ slumped 2.0% to close Monday at $43.55, reversing an earlier intraday gain of as much as 4.6%.\nPeloton was viewed as a hot COVID-19-pandemic play last year, with the stock rocketing more than fivefold (up 434%), as gym closures fueled an explosion in the \"work-in\" trend. It's been an entirely different play in 2021, however, as the stock has plunged 71% year to date. It closed Wednesday at $42.25, the lowest price since May 27, 2020.\nIn comparison, shares of fitness center operator Planet Fitness Inc. (PLNT) have gained 3.8% this year and the S&P 500 index has rallied 21%.\nWhile the stock has suffered a \"tough ride\" this year, and the going could still be a bit rough for a while, Deutsche Bank's Woronka said he is bullish on Peloton's fundamentals over the longer term.\nHe initiated coverage of Peloton with a buy rating and a 12-month stock price target of $76, which implies nearly about 75% upside from current levels. Woronka said his view is based on an \"unemotional analysis\" of the company's earnings power in a \"normalized, fully-reopened\" economic environment.\n\"[W]hile it's never fun to lead off a buy report with a 'patience required' asterisk of sorts, that's exactly what we find ourselves doing here,\" Woronka wrote in a note to clients.\nAs a fundamental analyst, Woronka said he is most interested in looking for \"asymmetrical risk/reward scenarios,\" and that's what he believes Pelton's stock provides at current levels. While there are scenarios in which the stock can still go lower, he believes there are more scenarios that result in even greater upside.\n\"Right now, we believe the market is looking at fitness stocks as an 'either/or' sector; either consumers stay at home to work out or they go back to their favorite pre-COVID-19 fitness facility,\" Woronka wrote. \"In our opinion, that's an oversimplified view of the world; we think the hybrid work model extends to fitness, too, and that [Peloton] has plenty of momentum to regain operationally.\"\nHe realizes that sentiment on the stock isn't likely to reflect his bullish view \"until a few quarters of improved execution\" are in the books. But that's where the opportunity for reward lies over a 12-month time horizon.\nOnce the stock starts trading on fundamentals again, Woronka believes \"it has quite a bit of room to run.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":1402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872915330,"gmtCreate":1637391093484,"gmtModify":1637391093557,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872915330","repostId":"2184842262","repostType":4,"repost":{"id":"2184842262","kind":"news","pubTimestamp":1637359018,"share":"https://www.laohu8.com/m/news/2184842262?lang=&edition=full","pubTime":"2021-11-20 05:56","market":"us","language":"en","title":"Nasdaq ends atop 16,000 mark for the first time on tech strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2184842262","media":"Reuters","summary":"(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in i","content":"<p>(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in its second-straight record finish powered by technology stocks, while pandemic jitters sent the Dow to its fourth losing session in the last five.</p>\n<p>Both the Nasdaq and S&P 500 index scored a winning week, up 1.2% and 0.3% respectively, after last week's declines snapped a five-week run of higher finishes.</p>\n<p>The Dow Jones Industrial Average's second-successive weekly loss - this one of 1.4% - wiped out the last of its November gains, extending the index's drop from a Nov. 8 record high to 2.3%.</p>\n<p>Friday's fall was caused by banking, energy and airline stocks slumping on fears that European countries, battling a resurgence of COVID-19 cases, could follow Austria in moving towards a full lockdown.</p>\n<p>Banking stocks fell 1.6%, tracking a drop in Treasury yields as investors snapped up safe-haven bonds. The S&P energy index dropped 3.9%, the worst performing sector, as crude prices fell on demand implications.</p>\n<p>Carriers including Delta Air Lines, United Airlines and American Airlines, and cruiseliners Norwegian Cruise Line and Carnival Corp all dropped between 0.6% and 2.8%.</p>\n<p>\"It's a normal time to take risk off. And in this case, there's just so much liquidity that the market doesn't go down - just people take risk off by going into safe havens,\" said Jay Hatfield, chief executive of Infrastructure Capital Management in New York.</p>\n<p>Falling yields and safe-haven demand supported major technology stocks, which in turn lifted the Nasdaq.</p>\n<p>FAANG stocks, which have largely persevered through economic shocks since 2020, traded broadly higher. Netflix Inc gained along with other stay-at-home stocks.</p>\n<p>Chipmaker Nvidia Corp rose 4.1% to its third straight closing high, and the Philadelphia semiconductor index , up 0.3%, hit its third record closing high in four.</p>\n<p>The Dow Jones Industrial Average fell 268.97 points, or 0.75%, to 35,601.98; the S&P 500 lost 6.58 points, or 0.14%, at 4,697.96; and the Nasdaq Composite added 63.73 points, or 0.4%, to 16,057.44.</p>\n<p>The S&P 500 gyrated on Friday before slipping into negative territory, after a week in which retailers pushed it to a record finish the previous day.</p>\n<p>The S&P consumer discretionary sector rose 0.3% to a closing peak for a second day in a row, after breaking its lifetime intraday high on Friday. This follows strong retail earnings this week and positive signs for holiday shopping.</p>\n<p>Lowe's Companies rose 0.9% to its third successive record close after reporting third-quarter results on Wednesday. Etsy Inc, which posted earnings earlier this month, achieved the same closing feat after finishing up 1.4%.</p>\n<p>\"Out of the Q3 earnings, one of the trends we have seen is the resounding strength of the U.S. consumer,\" said Jessica Bemer, portfolio manager at Easterly Investment Partners.</p>\n<p>\"We've heard it all through this week from retailers talking about the consumer coming back into the store, enjoying the shopping experience and getting ready for the holidays. It makes sense but it was really validated during earnings season.\"</p>\n<p>Profit-taking in names which gained earlier in the week led to drops of between 2.9% and 8.8% in Macy's Inc, Kohls Corp and Gap Inc.</p>\n<p>The information technology segment, up 0.8%, was the best performer on the S&P 500.</p>\n<p>It was buoyed by Intuit Inc, which jumped 10.1% as brokerages lifted their price targets on the income tax software company after it beat quarterly estimates and raised forecasts.</p>\n<p>Volume on U.S. exchanges was 10.68 billion shares, compared with the 11.12 billion average for the full session over the last 20 trading days.</p>\n<p>The S&P 500 posted 45 new 52-week highs and nine new lows; the Nasdaq Composite recorded 100 new highs and 309 new lows.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq ends atop 16,000 mark for the first time on tech strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq ends atop 16,000 mark for the first time on tech strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-20 05:56 GMT+8 <a href=https://finance.yahoo.com/news/us-stocks-nasdaq-ends-atop-215658565.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in its second-straight record finish powered by technology stocks, while pandemic jitters sent the Dow ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-nasdaq-ends-atop-215658565.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","COMP":"Compass, Inc.",".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/us-stocks-nasdaq-ends-atop-215658565.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2184842262","content_text":"(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in its second-straight record finish powered by technology stocks, while pandemic jitters sent the Dow to its fourth losing session in the last five.\nBoth the Nasdaq and S&P 500 index scored a winning week, up 1.2% and 0.3% respectively, after last week's declines snapped a five-week run of higher finishes.\nThe Dow Jones Industrial Average's second-successive weekly loss - this one of 1.4% - wiped out the last of its November gains, extending the index's drop from a Nov. 8 record high to 2.3%.\nFriday's fall was caused by banking, energy and airline stocks slumping on fears that European countries, battling a resurgence of COVID-19 cases, could follow Austria in moving towards a full lockdown.\nBanking stocks fell 1.6%, tracking a drop in Treasury yields as investors snapped up safe-haven bonds. The S&P energy index dropped 3.9%, the worst performing sector, as crude prices fell on demand implications.\nCarriers including Delta Air Lines, United Airlines and American Airlines, and cruiseliners Norwegian Cruise Line and Carnival Corp all dropped between 0.6% and 2.8%.\n\"It's a normal time to take risk off. And in this case, there's just so much liquidity that the market doesn't go down - just people take risk off by going into safe havens,\" said Jay Hatfield, chief executive of Infrastructure Capital Management in New York.\nFalling yields and safe-haven demand supported major technology stocks, which in turn lifted the Nasdaq.\nFAANG stocks, which have largely persevered through economic shocks since 2020, traded broadly higher. Netflix Inc gained along with other stay-at-home stocks.\nChipmaker Nvidia Corp rose 4.1% to its third straight closing high, and the Philadelphia semiconductor index , up 0.3%, hit its third record closing high in four.\nThe Dow Jones Industrial Average fell 268.97 points, or 0.75%, to 35,601.98; the S&P 500 lost 6.58 points, or 0.14%, at 4,697.96; and the Nasdaq Composite added 63.73 points, or 0.4%, to 16,057.44.\nThe S&P 500 gyrated on Friday before slipping into negative territory, after a week in which retailers pushed it to a record finish the previous day.\nThe S&P consumer discretionary sector rose 0.3% to a closing peak for a second day in a row, after breaking its lifetime intraday high on Friday. This follows strong retail earnings this week and positive signs for holiday shopping.\nLowe's Companies rose 0.9% to its third successive record close after reporting third-quarter results on Wednesday. Etsy Inc, which posted earnings earlier this month, achieved the same closing feat after finishing up 1.4%.\n\"Out of the Q3 earnings, one of the trends we have seen is the resounding strength of the U.S. consumer,\" said Jessica Bemer, portfolio manager at Easterly Investment Partners.\n\"We've heard it all through this week from retailers talking about the consumer coming back into the store, enjoying the shopping experience and getting ready for the holidays. It makes sense but it was really validated during earnings season.\"\nProfit-taking in names which gained earlier in the week led to drops of between 2.9% and 8.8% in Macy's Inc, Kohls Corp and Gap Inc.\nThe information technology segment, up 0.8%, was the best performer on the S&P 500.\nIt was buoyed by Intuit Inc, which jumped 10.1% as brokerages lifted their price targets on the income tax software company after it beat quarterly estimates and raised forecasts.\nVolume on U.S. exchanges was 10.68 billion shares, compared with the 11.12 billion average for the full session over the last 20 trading days.\nThe S&P 500 posted 45 new 52-week highs and nine new lows; the Nasdaq Composite recorded 100 new highs and 309 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850094975,"gmtCreate":1634532151018,"gmtModify":1634532151258,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Ooo","listText":"Ooo","text":"Ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/850094975","repostId":"1185155570","repostType":4,"repost":{"id":"1185155570","kind":"news","pubTimestamp":1634511079,"share":"https://www.laohu8.com/m/news/1185155570?lang=&edition=full","pubTime":"2021-10-18 06:51","market":"us","language":"en","title":"Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1185155570","media":"Barrons","summary":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. ","content":"<p>Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights will include results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.</p>\n<p><img src=\"https://static.tigerbbs.com/685ba1e7f4763c12a3c0159fc2469ded\" tg-width=\"1878\" tg-height=\"2461\" width=\"100%\" height=\"auto\"></p>\n<p>Albertsons and State Street get the ball rolling on Monday.Procter & Gamble,Halliburton,and Johnson & Johnson are Tuesday morning’s highlights, followed by Netflix and United Airlines Holdings after the market closes.</p>\n<p>On Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&T, American Airlines Group,Southwest Airlines,and Chipotle Mexican Grill report on Thursday, then American Express,Schlumberger,and Honeywell International close the week on Friday.</p>\n<p>Economic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and IHS Markit’s Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.</p>\n<p>Other releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.</p>\n<p><b>Monday 10/18</b></p>\n<p><b>The Federal Reserve</b> releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.</p>\n<p>Albertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.</p>\n<p><b>Tuesday 10/19</b></p>\n<p><b>The Census Bureau</b> reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.</p>\n<p>Halliburton, Procter & Gamble, Johnson & Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.</p>\n<p><b>Wednesday 10/20</b></p>\n<p><b>The Federal Reserve</b> releases its beige book about current economic conditions across the central bank’s 12 districts.</p>\n<p>Abbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.</p>\n<p><b>Thursday 10/21</b></p>\n<p><b>The National Association</b> of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.</p>\n<p>Dow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.</p>\n<p><b>The Philadelphia Fed</b> diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.</p>\n<p><b>The Conference Board</b> releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.</p>\n<p><b>Friday 10/22</b></p>\n<p><b>IHS Markit releases</b> the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.</p>\n<p>Whirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-18 06:51 GMT+8 <a href=https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LUV":"西南航空","CMG":"墨式烧烤",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","IBM":"IBM","HAL":"哈里伯顿","TSLA":"特斯拉",".SPX":"S&P 500 Index","T":"美国电话电报","INTC":"英特尔","UAL":"联合大陆航空","AXP":"美国运通","NFLX":"奈飞","AAL":"美国航空"},"source_url":"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185155570","content_text":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights will include results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.\n\nAlbertsons and State Street get the ball rolling on Monday.Procter & Gamble,Halliburton,and Johnson & Johnson are Tuesday morning’s highlights, followed by Netflix and United Airlines Holdings after the market closes.\nOn Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&T, American Airlines Group,Southwest Airlines,and Chipotle Mexican Grill report on Thursday, then American Express,Schlumberger,and Honeywell International close the week on Friday.\nEconomic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and IHS Markit’s Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.\nOther releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.\nMonday 10/18\nThe Federal Reserve releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.\nAlbertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.\nTuesday 10/19\nThe Census Bureau reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.\nHalliburton, Procter & Gamble, Johnson & Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.\nWednesday 10/20\nThe Federal Reserve releases its beige book about current economic conditions across the central bank’s 12 districts.\nAbbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.\nThursday 10/21\nThe National Association of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.\nDow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.\nThe Philadelphia Fed diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.\nThe Conference Board releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.\nFriday 10/22\nIHS Markit releases the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.\nWhirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.","news_type":1},"isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":144808386,"gmtCreate":1626273692945,"gmtModify":1633928370759,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Ohno","listText":"Ohno","text":"Ohno","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/144808386","repostId":"2151511237","repostType":4,"repost":{"id":"2151511237","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626273009,"share":"https://www.laohu8.com/m/news/2151511237?lang=&edition=full","pubTime":"2021-07-14 22:30","market":"us","language":"en","title":"India bans Mastercard from issuing new cards in data storage row","url":"https://stock-news.laohu8.com/highlight/detail?id=2151511237","media":"Reuters","summary":"MUMBAI, July 14 (Reuters) - The Reserve Bank of India (RBI) on Wednesday indefinitely barred Masterc","content":"<p>MUMBAI, July 14 (Reuters) - The Reserve Bank of India (RBI) on Wednesday indefinitely barred Mastercard Inc from issuing new debit, credit or prepaid cards to domestic customers for violating data storage rules, dealing a blow to the U.S. company in a key market.</p>\n<p>In a notification, the RBI said Mastercard had not complied with data storage rules from 2018 that require foreign card networks to store Indian payments data locally so the regulator can have \"unfettered supervisory access\".</p>\n<p>\"Notwithstanding lapse of considerable time and adequate opportunities being given, the entity (Mastercard) has been found to be non-compliant with the directions,\" the RBI said.</p>\n<p>Mastercard did not immediately respond to a request for comment. The ban takes effect on July 22.</p>\n<p>The RBI's decision will not impact existing customers of Mastercard, and the company should advise all card issuing banks in India to comply with the order, the RBI added.</p>\n<p>The move comes less than three months after India's central bank barred American <a href=\"https://laohu8.com/S/EXPR\">Express</a> and Diners Club International, owned by Discover Financial Services , from issuing new cards due to similar violations.</p>\n<p>The RBI directive in 2018 sparked an aggressive lobbying effort from U.S. companies who said the rules would increase their infrastructure costs and hit their global fraud detection platforms, but the central bank did not relent.</p>\n<p>The order comes as companies such as Mastercard and <a href=\"https://laohu8.com/S/V\">Visa</a> also face growing competition from domestic payments network Rupay, which has been promoted by Prime Minister Narendra Modi.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>India bans Mastercard from issuing new cards in data storage row</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIndia bans Mastercard from issuing new cards in data storage row\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-14 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MUMBAI, July 14 (Reuters) - The Reserve Bank of India (RBI) on Wednesday indefinitely barred Mastercard Inc from issuing new debit, credit or prepaid cards to domestic customers for violating data storage rules, dealing a blow to the U.S. company in a key market.</p>\n<p>In a notification, the RBI said Mastercard had not complied with data storage rules from 2018 that require foreign card networks to store Indian payments data locally so the regulator can have \"unfettered supervisory access\".</p>\n<p>\"Notwithstanding lapse of considerable time and adequate opportunities being given, the entity (Mastercard) has been found to be non-compliant with the directions,\" the RBI said.</p>\n<p>Mastercard did not immediately respond to a request for comment. The ban takes effect on July 22.</p>\n<p>The RBI's decision will not impact existing customers of Mastercard, and the company should advise all card issuing banks in India to comply with the order, the RBI added.</p>\n<p>The move comes less than three months after India's central bank barred American <a href=\"https://laohu8.com/S/EXPR\">Express</a> and Diners Club International, owned by Discover Financial Services , from issuing new cards due to similar violations.</p>\n<p>The RBI directive in 2018 sparked an aggressive lobbying effort from U.S. companies who said the rules would increase their infrastructure costs and hit their global fraud detection platforms, but the central bank did not relent.</p>\n<p>The order comes as companies such as Mastercard and <a href=\"https://laohu8.com/S/V\">Visa</a> also face growing competition from domestic payments network Rupay, which has been promoted by Prime Minister Narendra Modi.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MA":"万事达","V":"Visa","DFS":"发现金融","AXP":"美国运通"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151511237","content_text":"MUMBAI, July 14 (Reuters) - The Reserve Bank of India (RBI) on Wednesday indefinitely barred Mastercard Inc from issuing new debit, credit or prepaid cards to domestic customers for violating data storage rules, dealing a blow to the U.S. company in a key market.\nIn a notification, the RBI said Mastercard had not complied with data storage rules from 2018 that require foreign card networks to store Indian payments data locally so the regulator can have \"unfettered supervisory access\".\n\"Notwithstanding lapse of considerable time and adequate opportunities being given, the entity (Mastercard) has been found to be non-compliant with the directions,\" the RBI said.\nMastercard did not immediately respond to a request for comment. The ban takes effect on July 22.\nThe RBI's decision will not impact existing customers of Mastercard, and the company should advise all card issuing banks in India to comply with the order, the RBI added.\nThe move comes less than three months after India's central bank barred American Express and Diners Club International, owned by Discover Financial Services , from issuing new cards due to similar violations.\nThe RBI directive in 2018 sparked an aggressive lobbying effort from U.S. companies who said the rules would increase their infrastructure costs and hit their global fraud detection platforms, but the central bank did not relent.\nThe order comes as companies such as Mastercard and Visa also face growing competition from domestic payments network Rupay, which has been promoted by Prime Minister Narendra Modi.","news_type":1},"isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":859325626,"gmtCreate":1634657176111,"gmtModify":1634657267557,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Ooo","listText":"Ooo","text":"Ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/859325626","repostId":"1183104478","repostType":4,"repost":{"id":"1183104478","kind":"news","pubTimestamp":1634654982,"share":"https://www.laohu8.com/m/news/1183104478?lang=&edition=full","pubTime":"2021-10-19 22:49","market":"us","language":"en","title":"Morgan Stanley’s Kushma Says Bond Yields Climbing Too Quickly","url":"https://stock-news.laohu8.com/highlight/detail?id=1183104478","media":"Bloomberg","summary":"The recent spike in Treasury yields is likely overdone as global demand for “risk-free” assets remai","content":"<p>The recent spike in Treasury yields is likely overdone as global demand for “risk-free” assets remains strong, according to Morgan Stanley Investment Management’s Michael Kushma.</p>\n<p>“Everyone is worried about tapering from the Fed, but the U.S. fiscal deficit should shrink dramatically next year,” Kushma, the firm’s chief investment officer for global fixed income, told Bloomberg TV’s Surveillance Tuesday. “I don’t see a supply-side issue on Treasuries right now. Treasuries are the world’s risk-free asset. That’s not going away. The level of U.S. yields relative to the rest of the world is also very high, meaning the U.S. is a high-yielding alternative.”</p>\n<p>Benchmark 10-year yields hovered near 1.61% on Tuesday. They reached 1.63% last week, the highest since mid-year.</p>\n<p>Markets globally are reckoning with an elevated pace of inflation that’s testing the Federal Reserve’s resolve to keep borrowing costs low until the labor-market recovery progresses further. The allocation to bonds tumbled to the lowest level ever as inflation woes drove expectations for higher rates, according to the latest Bank of America Corp. monthly fund manager survey, conducted in the week through Oct. 14.</p>\n<p>For Kushma, most countries are probably “overpredicting” how fast rates are going to rise.</p>\n<p>“The cyclical bounce in recovery next year will be strong. From a credit perspective, we’ll be fine,” Kushma noted. “We will have continued strong labor markets, strong inflationary pressures at the margin.” But he said, “there is no doubt that inflation is going to slow over the next 12 months.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley’s Kushma Says Bond Yields Climbing Too Quickly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley’s Kushma Says Bond Yields Climbing Too Quickly\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-19 22:49 GMT+8 <a href=https://finance.yahoo.com/news/morgan-stanley-kushma-says-bond-140757982.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent spike in Treasury yields is likely overdone as global demand for “risk-free” assets remains strong, according to Morgan Stanley Investment Management’s Michael Kushma.\n“Everyone is worried ...</p>\n\n<a href=\"https://finance.yahoo.com/news/morgan-stanley-kushma-says-bond-140757982.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MS":"摩根士丹利"},"source_url":"https://finance.yahoo.com/news/morgan-stanley-kushma-says-bond-140757982.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183104478","content_text":"The recent spike in Treasury yields is likely overdone as global demand for “risk-free” assets remains strong, according to Morgan Stanley Investment Management’s Michael Kushma.\n“Everyone is worried about tapering from the Fed, but the U.S. fiscal deficit should shrink dramatically next year,” Kushma, the firm’s chief investment officer for global fixed income, told Bloomberg TV’s Surveillance Tuesday. “I don’t see a supply-side issue on Treasuries right now. Treasuries are the world’s risk-free asset. That’s not going away. The level of U.S. yields relative to the rest of the world is also very high, meaning the U.S. is a high-yielding alternative.”\nBenchmark 10-year yields hovered near 1.61% on Tuesday. They reached 1.63% last week, the highest since mid-year.\nMarkets globally are reckoning with an elevated pace of inflation that’s testing the Federal Reserve’s resolve to keep borrowing costs low until the labor-market recovery progresses further. The allocation to bonds tumbled to the lowest level ever as inflation woes drove expectations for higher rates, according to the latest Bank of America Corp. monthly fund manager survey, conducted in the week through Oct. 14.\nFor Kushma, most countries are probably “overpredicting” how fast rates are going to rise.\n“The cyclical bounce in recovery next year will be strong. From a credit perspective, we’ll be fine,” Kushma noted. “We will have continued strong labor markets, strong inflationary pressures at the margin.” But he said, “there is no doubt that inflation is going to slow over the next 12 months.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":143440370,"gmtCreate":1625812448090,"gmtModify":1633937068526,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Gosh...","listText":"Gosh...","text":"Gosh...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/143440370","repostId":"2150320772","repostType":4,"repost":{"id":"2150320772","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625811863,"share":"https://www.laohu8.com/m/news/2150320772?lang=&edition=full","pubTime":"2021-07-09 14:24","market":"us","language":"en","title":"China's auto sales down 12.4% in June - industry association","url":"https://stock-news.laohu8.com/highlight/detail?id=2150320772","media":"Reuters","summary":"BEIJING, July 9 (Reuters) - Auto sales in China, the world's biggest car market, fell 12.4% in June ","content":"<p>BEIJING, July 9 (Reuters) - Auto sales in China, the world's biggest car market, fell 12.4% in June from the corresponding month a year earlier, industry data showed on Friday.</p>\n<p>Overall sales stood at 2.02 million vehicles in June, data from the China Association of Automobile Manufacturers (CAAM) showed.</p>\n<p>The country sold 12.89 million vehicles between January and June, up 25.6% from year-ago levels.</p>\n<p>Sales of new energy vehicles (NEVs) including battery-powered electric vehicles, plug-in petrol-electric hybrids, and hydrogen fuel-cell vehicles maintained their strong momentum, jumping 139.3%, with 256,000 units sold last month.</p>\n<p>NEV makers such as Nio Inc, Xpeng Inc, and BYD are expanding manufacturing capacity in China, encouraged by the government's promotion of greener vehicles to cut pollution.</p>\n<p>Tesla Inc sold 33,155 China-manufactured electric cars in June.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's auto sales down 12.4% in June - industry association</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's auto sales down 12.4% in June - industry association\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 14:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, July 9 (Reuters) - Auto sales in China, the world's biggest car market, fell 12.4% in June from the corresponding month a year earlier, industry data showed on Friday.</p>\n<p>Overall sales stood at 2.02 million vehicles in June, data from the China Association of Automobile Manufacturers (CAAM) showed.</p>\n<p>The country sold 12.89 million vehicles between January and June, up 25.6% from year-ago levels.</p>\n<p>Sales of new energy vehicles (NEVs) including battery-powered electric vehicles, plug-in petrol-electric hybrids, and hydrogen fuel-cell vehicles maintained their strong momentum, jumping 139.3%, with 256,000 units sold last month.</p>\n<p>NEV makers such as Nio Inc, Xpeng Inc, and BYD are expanding manufacturing capacity in China, encouraged by the government's promotion of greener vehicles to cut pollution.</p>\n<p>Tesla Inc sold 33,155 China-manufactured electric cars in June.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","NIO":"蔚来","09868":"小鹏汽车-W"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150320772","content_text":"BEIJING, July 9 (Reuters) - Auto sales in China, the world's biggest car market, fell 12.4% in June from the corresponding month a year earlier, industry data showed on Friday.\nOverall sales stood at 2.02 million vehicles in June, data from the China Association of Automobile Manufacturers (CAAM) showed.\nThe country sold 12.89 million vehicles between January and June, up 25.6% from year-ago levels.\nSales of new energy vehicles (NEVs) including battery-powered electric vehicles, plug-in petrol-electric hybrids, and hydrogen fuel-cell vehicles maintained their strong momentum, jumping 139.3%, with 256,000 units sold last month.\nNEV makers such as Nio Inc, Xpeng Inc, and BYD are expanding manufacturing capacity in China, encouraged by the government's promotion of greener vehicles to cut pollution.\nTesla Inc sold 33,155 China-manufactured electric cars in June.","news_type":1},"isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":602254203,"gmtCreate":1639032338716,"gmtModify":1639032338826,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602254203","repostId":"2190169579","repostType":4,"repost":{"id":"2190169579","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639001174,"share":"https://www.laohu8.com/m/news/2190169579?lang=&edition=full","pubTime":"2021-12-09 06:06","market":"us","language":"en","title":"Wall St closes higher as vaccine update feeds optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2190169579","media":"Reuters","summary":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third st","content":"<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St closes higher as vaccine update feeds optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St closes higher as vaccine update feeds optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-09 06:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QQQ":"纳指100ETF","BK4517":"邮轮概念","UDOW":"道指三倍做多ETF-ProShares","PFE":"辉瑞","QID":"纳指两倍做空ETF","TQQQ":"纳指三倍做多ETF","BK4142":"酒店、度假村与豪华游轮","DJX":"1/100道琼斯","NCLH":"挪威邮轮","SWK":"美国史丹利公司","BK4161":"工业机械","PSQ":"纳指反向ETF","DXD":"道指两倍做空ETF","QLD":"纳指两倍做多ETF","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4566":"资本集团","DDM":"道指两倍做多ETF",".DJI":"道琼斯","DOG":"道指反向ETF","CCL":"嘉年华邮轮","SQQQ":"纳指三倍做空ETF","BK4568":"美国抗疫概念",".IXIC":"NASDAQ Composite","BK4550":"红杉资本持仓","SDOW":"道指三倍做空ETF-ProShares",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190169579","content_text":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.\nPfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.\nInvestors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.\nMarkets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.\nIn a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.\nWhile Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.\nWith Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"\n\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.\nThe Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.\nThe S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.\n\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.\nSector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.\nWHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.\nSo-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.\nGoodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".\nStanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.\nOn U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606201331,"gmtCreate":1638880267101,"gmtModify":1638880267214,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Nicee","listText":"Nicee","text":"Nicee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606201331","repostId":"2189398466","repostType":4,"repost":{"id":"2189398466","kind":"highlight","pubTimestamp":1638880110,"share":"https://www.laohu8.com/m/news/2189398466?lang=&edition=full","pubTime":"2021-12-07 20:28","market":"us","language":"en","title":"3 High-Growth Stocks Wall Street Thinks Could Soar 30% or More","url":"https://stock-news.laohu8.com/highlight/detail?id=2189398466","media":"Motley Fool","summary":"Analyst estimates suggest the stock market isn't giving these stocks the attention they deserve.","content":"<p>When it rains, it pours. A market scorned for tech stocks, in general, has been particularly rough on the biotechnology industry and a slew of companies that provide software as a service (SaaS).</p>\n<p>Wall Street analysts who follow these companies don't think they've lost their sparkle. The average target on each <a href=\"https://laohu8.com/S/AONE.U\">one</a> is still at least 30% above their recent prices.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a3dc6b5af684b3586af06831b8c96c8\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p>If you're already holding these stocks in your portfolio, now could be a good time to average down. If you missed the boat the first time around, here's another chance to get in at a relatively low price.</p>\n<h2>1. Veeva Systems</h2>\n<p><b>Veeva Systems</b> (NYSE:VEEV) stock fell about 22% over the past month. Now, this stock is around 27% below the peak it reached over the summer.</p>\n<p>Wall Street analysts are expecting a swift rebound for Veeva Systems in 2022. The consensus price target for this stock represents a 30% premium over recent prices.</p>\n<p>Veeva Systems is a cloud service provider to the biopharmaceutical industry. Fiscal third-quarter earnings results came in slightly above expectations, but analysts on Wall Street have gotten used to this company beating estimates by a wide margin.</p>\n<p>A couple of quarters with less than amazing financial results hardly seem like a reason to avoid this well-positioned SaaS stock. The biopharmaceutical industry increasingly relies on Veeva Systems' suite of subscription-based services.</p>\n<p>Customer relationship management is just the tip of the spear for Veeva Systems. Its subscribers can also warehouse waves of data thrown off in the course of developing new drugs in a way that helps them meet the expectations of regulators all over the world.</p>\n<p>Despite the recent drop, Veeva Systems' stock isn't exactly cheap. The shares have been trading at around 68 times the company's earnings expectations for the year. With super sticky subscriber revenue, though, this stock has a good chance to grow into its valuation.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ae1bb868442e00c2b966f9357851d00c\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>2. Global-E Online</h2>\n<p>Shares of international e-commerce facilitator <b>Global-E Online</b> (NASDAQ:GLBE) shot up after its IPO this spring, but the gains didn't last long. The stock's down around 31% from the peak it reached in early September.</p>\n<p>The average analyst following Global-E Online expects it to bounce right back. The consensus price target suggests around 36% of upside ahead for this provider of end-to-end international e-commerce services.</p>\n<p>Despite the sell-off, Global-E Online stock still looks pricey at 32.6 times trailing sales. Expectations are high, but a recent partnership deal with <b>Shopify</b> (NASDAQ:SHOP) gives Global-E Online a chance to grow past its optimistic valuation.</p>\n<p>A majority of Shopify merchants operate out of North America, but they don't sell to countries on different continents nearly as often as they would like to. The tie-up gives Global-E Online access to around 1.7 million Shopify merchants eager to reach a larger audience.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d75544ca9267ab4ebb394449490deefc\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>3. Twist Bioscience</h2>\n<p><b>Twist Bioscience</b> (NASDAQ:TWST) is a DNA synthesis leader that has fallen around 40% over the past month. Investment bank analysts who follow the company think it can recover those losses soon. The consensus target for Twist Bioscience is around 38% higher than its recent price.</p>\n<p>At its peak this year, Twist Bioscience's market cap rose past $10 billion. During the company's fiscal year ended Sept. 30, 2021, total revenue reached just $132.3 million. That was an impressive 16% gain over the previous year, but hardly enough to justify such an enormous valuation.</p>\n<p>Copying a strand of DNA that already exists isn't nearly as difficult as it used to be. Accurately producing totally new bits of DNA code at scale, though, is usually prohibitively expensive. Twist Bioscience's proprietary DNA synthesis platform allows the company to synthesize DNA at a fraction of the cost of its nearest competitor, and its lead is expanding.</p>\n<p>Producing custom DNA strands to help drugmakers develop new drugs is Twist Bioscience's largest source of revenue at the moment, but it's probably just the tip of the iceberg. Twist Biosciences is doing for DNA synthesis what <b>Microsoft</b>'s Windows operating system did for personal computers in the 1990s.</p>\n<p>Since DNA is relatively stable over long periods of time, data storage is one potential new application. It's hard to know exactly what direction Twist Biosciences' customer base will expand in. We can be sure that patient investors who buy this high-growth stock now are in for an interesting ride.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 High-Growth Stocks Wall Street Thinks Could Soar 30% or More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 High-Growth Stocks Wall Street Thinks Could Soar 30% or More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 20:28 GMT+8 <a href=https://www.fool.com/investing/2021/12/07/3-high-growth-stocks-wall-street-thinks-could-soar/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When it rains, it pours. A market scorned for tech stocks, in general, has been particularly rough on the biotechnology industry and a slew of companies that provide software as a service (SaaS).\nWall...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/07/3-high-growth-stocks-wall-street-thinks-could-soar/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","BK4122":"互联网与直销零售","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4539":"次新股","BK4504":"桥水持仓","BK4528":"SaaS概念","GLBE":"Global-E Online Ltd.","VEEV":"Veeva Systems Inc.","BK4167":"医疗保健技术"},"source_url":"https://www.fool.com/investing/2021/12/07/3-high-growth-stocks-wall-street-thinks-could-soar/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189398466","content_text":"When it rains, it pours. A market scorned for tech stocks, in general, has been particularly rough on the biotechnology industry and a slew of companies that provide software as a service (SaaS).\nWall Street analysts who follow these companies don't think they've lost their sparkle. The average target on each one is still at least 30% above their recent prices.\nImage source: Getty Images.\nIf you're already holding these stocks in your portfolio, now could be a good time to average down. If you missed the boat the first time around, here's another chance to get in at a relatively low price.\n1. Veeva Systems\nVeeva Systems (NYSE:VEEV) stock fell about 22% over the past month. Now, this stock is around 27% below the peak it reached over the summer.\nWall Street analysts are expecting a swift rebound for Veeva Systems in 2022. The consensus price target for this stock represents a 30% premium over recent prices.\nVeeva Systems is a cloud service provider to the biopharmaceutical industry. Fiscal third-quarter earnings results came in slightly above expectations, but analysts on Wall Street have gotten used to this company beating estimates by a wide margin.\nA couple of quarters with less than amazing financial results hardly seem like a reason to avoid this well-positioned SaaS stock. The biopharmaceutical industry increasingly relies on Veeva Systems' suite of subscription-based services.\nCustomer relationship management is just the tip of the spear for Veeva Systems. Its subscribers can also warehouse waves of data thrown off in the course of developing new drugs in a way that helps them meet the expectations of regulators all over the world.\nDespite the recent drop, Veeva Systems' stock isn't exactly cheap. The shares have been trading at around 68 times the company's earnings expectations for the year. With super sticky subscriber revenue, though, this stock has a good chance to grow into its valuation.\nImage source: Getty Images.\n2. Global-E Online\nShares of international e-commerce facilitator Global-E Online (NASDAQ:GLBE) shot up after its IPO this spring, but the gains didn't last long. The stock's down around 31% from the peak it reached in early September.\nThe average analyst following Global-E Online expects it to bounce right back. The consensus price target suggests around 36% of upside ahead for this provider of end-to-end international e-commerce services.\nDespite the sell-off, Global-E Online stock still looks pricey at 32.6 times trailing sales. Expectations are high, but a recent partnership deal with Shopify (NASDAQ:SHOP) gives Global-E Online a chance to grow past its optimistic valuation.\nA majority of Shopify merchants operate out of North America, but they don't sell to countries on different continents nearly as often as they would like to. The tie-up gives Global-E Online access to around 1.7 million Shopify merchants eager to reach a larger audience.\nImage source: Getty Images.\n3. Twist Bioscience\nTwist Bioscience (NASDAQ:TWST) is a DNA synthesis leader that has fallen around 40% over the past month. Investment bank analysts who follow the company think it can recover those losses soon. The consensus target for Twist Bioscience is around 38% higher than its recent price.\nAt its peak this year, Twist Bioscience's market cap rose past $10 billion. During the company's fiscal year ended Sept. 30, 2021, total revenue reached just $132.3 million. That was an impressive 16% gain over the previous year, but hardly enough to justify such an enormous valuation.\nCopying a strand of DNA that already exists isn't nearly as difficult as it used to be. Accurately producing totally new bits of DNA code at scale, though, is usually prohibitively expensive. Twist Bioscience's proprietary DNA synthesis platform allows the company to synthesize DNA at a fraction of the cost of its nearest competitor, and its lead is expanding.\nProducing custom DNA strands to help drugmakers develop new drugs is Twist Bioscience's largest source of revenue at the moment, but it's probably just the tip of the iceberg. Twist Biosciences is doing for DNA synthesis what Microsoft's Windows operating system did for personal computers in the 1990s.\nSince DNA is relatively stable over long periods of time, data storage is one potential new application. It's hard to know exactly what direction Twist Biosciences' customer base will expand in. We can be sure that patient investors who buy this high-growth stock now are in for an interesting ride.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1094,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601213073,"gmtCreate":1638533968624,"gmtModify":1638533968736,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601213073","repostId":"1177709350","repostType":4,"isVote":1,"tweetType":1,"viewCount":817,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875557729,"gmtCreate":1637673658837,"gmtModify":1637673658902,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875557729","repostId":"2185381910","repostType":4,"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":835159617,"gmtCreate":1629696562639,"gmtModify":1631891571313,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/835159617","repostId":"2161272742","repostType":4,"repost":{"id":"2161272742","kind":"highlight","pubTimestamp":1629691020,"share":"https://www.laohu8.com/m/news/2161272742?lang=&edition=full","pubTime":"2021-08-23 11:57","market":"us","language":"en","title":"3 Warren Buffett Dividend Stocks Begging to Be Bought","url":"https://stock-news.laohu8.com/highlight/detail?id=2161272742","media":"Motley Fool","summary":"These Buffett-backed stocks could serve up huge wins for your portfolio.","content":"<p>Warren Buffett became <b>Berkshire Hathaway</b>'s CEO all the way back in 1965, a time when the company was valued at roughly $19 per share. The Oracle of Omaha steered the investment conglomerate to legendary success after taking over as its chief executive officer. Today, Berkshire's class A shares trade at roughly $429,700 per share, and the company's returns across Buffett's tenure are even more impressive if you take dividend payments into account.</p>\n<p>With that in mind, three Motley Fool contributors have identified three dividend-paying stocks in the Berkshire Hathaway portfolio: <b>Verizon Communications</b> (NYSE:VZ); <b>Mastercard</b>(NYSE:VZ); and <b>Apple </b>(NYSE:VZ). These stocks look poised to continue delivering big wins over the long term. Read on to see why our contributors think that these Buffett-backed, income-generating stocks have what it takes to be standouts in your portfolio.</p>\n<h2><b>Verizon is a dividend juggernaut</b></h2>\n<p><b>Jamal Carnette</b> <b>(Verizon):</b> Who says Warren Buffett isn't a tech investor? After eschewing the sector for years, Buffett has now invested billions in technology companies, including owning 3.8% of Verizon Communications. At current prices, Berskhire's position is worth nearly $9 billion.</p>\n<p>Verizon's dividend has historically been underappreciated. Despite its having a juicy 4.5% yield, many income investors favored the larger 7% payout provided by its telecom competitor <b>AT&T</b>. However, that's about to change.</p>\n<p>Earlier this year, AT&T announced it was spinning off its WarnerMedia division and merging it with <b>Discovery </b>with the split occurring next year. As a result, the company was cutting its dividend. While this move might unlock value for AT&T, it also makes Verizon relatively more attractive for income investors in the telecom space.</p>\n<p>Buffett is a value investor, and Verizon certainly fits the bill. The company currently trades at 10.5 times forward earnings versus 22.3 times for the <b>S&P 500</b>. Verizon's yield of 4.5% is three times the yield of the greater index, and investors are expecting another increase announcement in September, continuing the streak of raises that has occurred every year since 2006.</p>\n<p>Admittedly, Verizon stock has risks. Top-line growth has been difficult to come by, and revenue in 2020 was lower than it was in 2015. The company has significant exposure to landline telephone and cable television businesses, and a significant debt overhang, most of which comes from the $49 billion issuance it undertook to buy out <b>Vodafone</b>'s 45% stake of Verizon Wireless in 2014.</p>\n<p>Despite that, Verizon's dividend is safe. Last year, the company generated more than $20 billion in free cash flow, more than double dividend payouts. Verizon's predictable, subscription-based businesses will ensure investors can look forward to dividends (and increases) for years to come. Warren Buffett and Berkshire know a strong company when they see <a href=\"https://laohu8.com/S/AONE.U\">one</a>.</p>\n<h2>Don't let this payment giant's low yield -- or huge size -- keep you away</h2>\n<p><b>Jason Hall</b> <b>(Mastercard):</b> With a dividend yield south of 0.5% at recent prices, investors looking for yield often overlook Mastercard. Ironically, growth investors might <i>also</i> eschew the company, assuming that with a market cap above $351 billion, its growth days are over.</p>\n<p>I think investors in <i>either</i> camp are making a mistake to skip Mastercard. Simply put, this stalwart's scale and brand power have it lined up to ride a massive wave of digital-payments growth around the world in the decades ahead.</p>\n<p>Mastercard has a massive economic moat in its trusted, well-known payments network that gives it a massive network effect advantage. Having a relationship -- whether as a cardholder, accepting merchant, or a bank that issues Mastercard -- gives you access to the other two. And the more of each that is a Mastercard partner, the more of the others that want access. That's a killer advantage.</p>\n<p>This economic moat is why Mastercard's stock has consistently outperformed the S&P 500 on just about every three-, five-, and 10-year period since going public, and is likely to continue outperforming. It's also likely the reason why Mastercard is in the Berkshire Hathaway portfolio.</p>\n<p>One last thing: The yield may be low, but the dividend <i>growth </i>is incredible. Here's how much it's increased since being implemented, juicing Mastercard's total returns an extra 570%:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e18eba4fc8baaec5791cb8d23115229e\" tg-width=\"720\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>MA data by YCharts</span></p>\n<p>That's a <i>lot </i>of juice from a relatively low dividend yield, powered by incredible growth.</p>\n<h2><b>Investors can win with Berkshire's biggest stock holding </b></h2>\n<p><b>Keith Noonan (Apple): </b>The company has been on an incredible run. It's posted a total return of roughly 675% over the last decade, with gains spurred by strong sales for its hardware and impressive growth in the software and services space. In light of that gravity-defying performance, it's not unreasonable to wonder whether the tech giant still has room for big growth.</p>\n<p>Apple already has an eye-catching market capitalization of roughly $2.45 trillion, and it sits atop the list of the world's most valuable companies. While relative growth will be tougher to come by as the company continues to increase in size, Apple still has an unmatched position in the consumer electronics industry. Technology will only become increasingly important in the average person's daily life, and Apple is fantastically positioned to capitalize on some of the world's biggest emerging technology trends.</p>\n<p>The company's phones and tablets will play a huge role in ushering in the age of 5G networks, which will enable dramatically faster upload and download speeds that make new kinds of software applications possible. Apple is also likely to be a leader in the augmented reality (AR) space. Next-generation network technology will help pave the way for new AR hardware and software applications, and Apple's current leadership position in mobile and wearable computing suggests that the company is likely to be one of the biggest winners if augmented reality takes off.</p>\n<p>With the company's dividend yield coming in at roughly 0.6% despite years of strong payout growth, it might come as a surprise to hear that Apple's dividend posted a much greater yield at earlier dates. Consider that the stock yielded more than 2.6% for a stretch of time back in 2013. Apple has boosted its payout 132.5% since it began paying a dividend in 2012, but market-crushing capital appreciation has outpaced payout growth. Not to worry. The technology leader should be able to continue posting strong earnings growth and hiking its dividend payout, and long-term investors will likely see strong impressive returns from the stock.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Dividend Stocks Begging to Be Bought</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Dividend Stocks Begging to Be Bought\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-23 11:57 GMT+8 <a href=https://www.fool.com/investing/2021/08/22/3-warren-buffett-dividend-stocks-begging-to-be-bou/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett became Berkshire Hathaway's CEO all the way back in 1965, a time when the company was valued at roughly $19 per share. The Oracle of Omaha steered the investment conglomerate to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/22/3-warren-buffett-dividend-stocks-begging-to-be-bou/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VZ":"威瑞森","BRK.A":"伯克希尔","BRK.B":"伯克希尔B","AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2021/08/22/3-warren-buffett-dividend-stocks-begging-to-be-bou/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161272742","content_text":"Warren Buffett became Berkshire Hathaway's CEO all the way back in 1965, a time when the company was valued at roughly $19 per share. The Oracle of Omaha steered the investment conglomerate to legendary success after taking over as its chief executive officer. Today, Berkshire's class A shares trade at roughly $429,700 per share, and the company's returns across Buffett's tenure are even more impressive if you take dividend payments into account.\nWith that in mind, three Motley Fool contributors have identified three dividend-paying stocks in the Berkshire Hathaway portfolio: Verizon Communications (NYSE:VZ); Mastercard(NYSE:VZ); and Apple (NYSE:VZ). These stocks look poised to continue delivering big wins over the long term. Read on to see why our contributors think that these Buffett-backed, income-generating stocks have what it takes to be standouts in your portfolio.\nVerizon is a dividend juggernaut\nJamal Carnette (Verizon): Who says Warren Buffett isn't a tech investor? After eschewing the sector for years, Buffett has now invested billions in technology companies, including owning 3.8% of Verizon Communications. At current prices, Berskhire's position is worth nearly $9 billion.\nVerizon's dividend has historically been underappreciated. Despite its having a juicy 4.5% yield, many income investors favored the larger 7% payout provided by its telecom competitor AT&T. However, that's about to change.\nEarlier this year, AT&T announced it was spinning off its WarnerMedia division and merging it with Discovery with the split occurring next year. As a result, the company was cutting its dividend. While this move might unlock value for AT&T, it also makes Verizon relatively more attractive for income investors in the telecom space.\nBuffett is a value investor, and Verizon certainly fits the bill. The company currently trades at 10.5 times forward earnings versus 22.3 times for the S&P 500. Verizon's yield of 4.5% is three times the yield of the greater index, and investors are expecting another increase announcement in September, continuing the streak of raises that has occurred every year since 2006.\nAdmittedly, Verizon stock has risks. Top-line growth has been difficult to come by, and revenue in 2020 was lower than it was in 2015. The company has significant exposure to landline telephone and cable television businesses, and a significant debt overhang, most of which comes from the $49 billion issuance it undertook to buy out Vodafone's 45% stake of Verizon Wireless in 2014.\nDespite that, Verizon's dividend is safe. Last year, the company generated more than $20 billion in free cash flow, more than double dividend payouts. Verizon's predictable, subscription-based businesses will ensure investors can look forward to dividends (and increases) for years to come. Warren Buffett and Berkshire know a strong company when they see one.\nDon't let this payment giant's low yield -- or huge size -- keep you away\nJason Hall (Mastercard): With a dividend yield south of 0.5% at recent prices, investors looking for yield often overlook Mastercard. Ironically, growth investors might also eschew the company, assuming that with a market cap above $351 billion, its growth days are over.\nI think investors in either camp are making a mistake to skip Mastercard. Simply put, this stalwart's scale and brand power have it lined up to ride a massive wave of digital-payments growth around the world in the decades ahead.\nMastercard has a massive economic moat in its trusted, well-known payments network that gives it a massive network effect advantage. Having a relationship -- whether as a cardholder, accepting merchant, or a bank that issues Mastercard -- gives you access to the other two. And the more of each that is a Mastercard partner, the more of the others that want access. That's a killer advantage.\nThis economic moat is why Mastercard's stock has consistently outperformed the S&P 500 on just about every three-, five-, and 10-year period since going public, and is likely to continue outperforming. It's also likely the reason why Mastercard is in the Berkshire Hathaway portfolio.\nOne last thing: The yield may be low, but the dividend growth is incredible. Here's how much it's increased since being implemented, juicing Mastercard's total returns an extra 570%:\nMA data by YCharts\nThat's a lot of juice from a relatively low dividend yield, powered by incredible growth.\nInvestors can win with Berkshire's biggest stock holding \nKeith Noonan (Apple): The company has been on an incredible run. It's posted a total return of roughly 675% over the last decade, with gains spurred by strong sales for its hardware and impressive growth in the software and services space. In light of that gravity-defying performance, it's not unreasonable to wonder whether the tech giant still has room for big growth.\nApple already has an eye-catching market capitalization of roughly $2.45 trillion, and it sits atop the list of the world's most valuable companies. While relative growth will be tougher to come by as the company continues to increase in size, Apple still has an unmatched position in the consumer electronics industry. Technology will only become increasingly important in the average person's daily life, and Apple is fantastically positioned to capitalize on some of the world's biggest emerging technology trends.\nThe company's phones and tablets will play a huge role in ushering in the age of 5G networks, which will enable dramatically faster upload and download speeds that make new kinds of software applications possible. Apple is also likely to be a leader in the augmented reality (AR) space. Next-generation network technology will help pave the way for new AR hardware and software applications, and Apple's current leadership position in mobile and wearable computing suggests that the company is likely to be one of the biggest winners if augmented reality takes off.\nWith the company's dividend yield coming in at roughly 0.6% despite years of strong payout growth, it might come as a surprise to hear that Apple's dividend posted a much greater yield at earlier dates. Consider that the stock yielded more than 2.6% for a stretch of time back in 2013. Apple has boosted its payout 132.5% since it began paying a dividend in 2012, but market-crushing capital appreciation has outpaced payout growth. Not to worry. The technology leader should be able to continue posting strong earnings growth and hiking its dividend payout, and long-term investors will likely see strong impressive returns from the stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":126,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895791324,"gmtCreate":1628771508068,"gmtModify":1631893455789,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/895791324","repostId":"1129865099","repostType":4,"repost":{"id":"1129865099","kind":"news","pubTimestamp":1628771235,"share":"https://www.laohu8.com/m/news/1129865099?lang=&edition=full","pubTime":"2021-08-12 20:27","market":"us","language":"en","title":"Elon Musk Calls Renesas and Bosch’s Chip Supply ‘Problematic’","url":"https://stock-news.laohu8.com/highlight/detail?id=1129865099","media":"Bloomberg","summary":"Tesla Inc.’s Elon Musk griped that two of the world’s biggest auto-chip suppliers are inhibiting the","content":"<p>Tesla Inc.’s Elon Musk griped that two of the world’s biggest auto-chip suppliers are inhibiting the electric-car maker’s production.</p>\n<p>“We are operating under extreme supply chain limitations regarding certain ‘standard’ automotive chips,” Tesla’s chief executive officer wrote in a tweet Thursday, responding to a tweet from Ark Investment Management CEO Cathie Wood. “Most problematic by far are Renesas & Bosch.”</p>\n<p>Musk isn’t the first in the auto industry to point fingers at Japan’sRenesas Electronics Corp.and Germany’sRobert Bosch GmbHfor holding up vehicle output. Ford Motor Co.called outthefireat a Renesas factory north of Tokyo as a major risk to its production schedules earlier this year.Volkswagen AGheld talks with major suppliers including Bosch about possibly claiming damages related to the semiconductor shortage, a spokesperson told Reutersin January.</p>\n<p>Renesas said inearly Junethat its chip plant in Naka would resume full production by mid-month. Representatives for the company didn’t immediately respond to a request for comment.</p>\n<p>Bosch, which opened a 1 billion-euro ($1.2 billion)factorynear the city of Dresden in June, can’t escape the general shortage of semiconductor components caused by various factors, spokesperson Annett Fischer said.</p>\n<p>“In this tense situation, we are doing everything in our power to support our customers and are working flat out to keep up deliveries as much as possible,” Fischer wrote in an email. “Together with our customers and our suppliers, we have been working in task forces around the clock for weeks.”</p>\n<p>Musk was responding to a tweet from Ark Investment’s Wood, who was parsing Tesla’ssignificant dropin local deliveries of China-built vehicles in July. Wood, a long-time Tesla bull, wrote that China would like “local champions” to dominate EV sales in the country, but is pleased Tesla is exporting to Europe.</p>\n<p>“Tesla makes cars for export in first half of quarter & for local market in second half,” Musk replied.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk Calls Renesas and Bosch’s Chip Supply ‘Problematic’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk Calls Renesas and Bosch’s Chip Supply ‘Problematic’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-12 20:27 GMT+8 <a href=https://www.bloomberg.com/news/articles/2021-08-12/tesla-s-musk-calls-renesas-and-bosch-s-chip-supply-problematic><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla Inc.’s Elon Musk griped that two of the world’s biggest auto-chip suppliers are inhibiting the electric-car maker’s production.\n“We are operating under extreme supply chain limitations regarding...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-12/tesla-s-musk-calls-renesas-and-bosch-s-chip-supply-problematic\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.bloomberg.com/news/articles/2021-08-12/tesla-s-musk-calls-renesas-and-bosch-s-chip-supply-problematic","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129865099","content_text":"Tesla Inc.’s Elon Musk griped that two of the world’s biggest auto-chip suppliers are inhibiting the electric-car maker’s production.\n“We are operating under extreme supply chain limitations regarding certain ‘standard’ automotive chips,” Tesla’s chief executive officer wrote in a tweet Thursday, responding to a tweet from Ark Investment Management CEO Cathie Wood. “Most problematic by far are Renesas & Bosch.”\nMusk isn’t the first in the auto industry to point fingers at Japan’sRenesas Electronics Corp.and Germany’sRobert Bosch GmbHfor holding up vehicle output. Ford Motor Co.called outthefireat a Renesas factory north of Tokyo as a major risk to its production schedules earlier this year.Volkswagen AGheld talks with major suppliers including Bosch about possibly claiming damages related to the semiconductor shortage, a spokesperson told Reutersin January.\nRenesas said inearly Junethat its chip plant in Naka would resume full production by mid-month. Representatives for the company didn’t immediately respond to a request for comment.\nBosch, which opened a 1 billion-euro ($1.2 billion)factorynear the city of Dresden in June, can’t escape the general shortage of semiconductor components caused by various factors, spokesperson Annett Fischer said.\n“In this tense situation, we are doing everything in our power to support our customers and are working flat out to keep up deliveries as much as possible,” Fischer wrote in an email. “Together with our customers and our suppliers, we have been working in task forces around the clock for weeks.”\nMusk was responding to a tweet from Ark Investment’s Wood, who was parsing Tesla’ssignificant dropin local deliveries of China-built vehicles in July. Wood, a long-time Tesla bull, wrote that China would like “local champions” to dominate EV sales in the country, but is pleased Tesla is exporting to Europe.\n“Tesla makes cars for export in first half of quarter & for local market in second half,” Musk replied.","news_type":1},"isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893053158,"gmtCreate":1628223310474,"gmtModify":1631893455830,"author":{"id":"3582199304143416","authorId":"3582199304143416","name":"sgrs","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582199304143416","authorIdStr":"3582199304143416"},"themes":[],"htmlText":"Ooo","listText":"Ooo","text":"Ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/893053158","repostId":"1199377263","repostType":4,"repost":{"id":"1199377263","kind":"news","pubTimestamp":1628222564,"share":"https://www.laohu8.com/m/news/1199377263?lang=&edition=full","pubTime":"2021-08-06 12:02","market":"us","language":"en","title":"The S&P 500 looks strong — but these ‘internals’ are far less positive","url":"https://stock-news.laohu8.com/highlight/detail?id=1199377263","media":"MarketWatch","summary":"The S&P 500 index continues to accelerate to the upside. A new all-time closing high was registered ","content":"<p>The S&P 500 index continues to accelerate to the upside. A new all-time closing high was registered on Tuesday. Yet, the “internals” of the market remain in a far worse state. This has been the case for some time (since June 11, at least), and it may continue to be the case for a while longer.</p>\n<p>But as long as the S&P chart is positive and above support, a “core” long position is recommended.</p>\n<p>The first support level is now roughly 4370. That was the low on the two most recent days on which SPX sold off and then rebounded – July 27 and Tuesday (yes, the same day that SPX bounced back from that level and then closed at a new all-time high). Since it has been doubly tested, that makes it a viable support level. There is resistance at 4430, the all-time intraday high.</p>\n<p>You can see from the accompanying chart that SPX has been in a rather right trading since July 23 – between 4370 and 4430.</p>\n<p>A breakout from that range will be significant. If it were to break to the downside, that would be a negative for the SPX chart. Below there, a major support area exists at 4233, and it would likely be tested quickly after a break below 4370.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8fde9899a8fd1227a022dfe59858d4c5\" tg-width=\"699\" tg-height=\"523\" width=\"100%\" height=\"auto\"><span>LAWRENCE MCMILLAN</span></p>\n<p>So the SPX chart is still positive, but there is a McMillan Volatility Band (MVB) sell signal in place (green “S” on chart).</p>\n<p>Now let’s look at some of the indicators that encompass a larger number of stocks. You will see that they are far less positive. First are the equity-only put-call ratios. These have been rising for a month, meaning they have been on sell signals during that time. Put volume has been heavy, relative to call volume, and that is what is causing these ratios to rise. It looks like there is a slight “wiggle” in the standard ratio’s chart, but the computer analysis programs say that is not significant.</p>\n<p>The larger picture here is that as many stocks have been declining, option traders have been buying puts on those stocks, forcing these equity-only put-call ratios higher. As long as the ratios are rising, they will remain on sell signals.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/87099f2be31d9ce51b1b0c4708a9f046\" tg-width=\"699\" tg-height=\"535\" width=\"100%\" height=\"auto\"><span>LAWRENCE MCMILLAN</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6f08da61f702fd9abb483cd1d8f5b4ba\" tg-width=\"700\" tg-height=\"523\" width=\"100%\" height=\"auto\"><span>LAWRENCE MCMILLAN</span></p>\n<p>Market breadth (advances minus declines) has been woeful since mid-June. That is, most stocks are going down, even though SPX is going up. In fact, what is driving this market is a handful of large-cap NASDAQ stocks (the FAANG stocks plus Microsoft are the strongest stocks).</p>\n<p>Things have improved a little in the last couple of weeks, and so our breadth oscillators are on buy signals, but they are still in negative territory. Normally when SPX is making new all-time highs, the breadth oscillators are will into positive territory, reflecting a strong overall market. But that is not the case now.</p>\n<p>Moreover, cumulative breadth (the running total of daily advances minus declines) has not made a new all-time high since June 11. SPX has made a new closing or intraday high on 19 separate trading days since then. That is a huge, negative market divergence, but it alone is not a sell signal. Rather, it is a strong warning to be alert – to avoid complacency.</p>\n<p>New 52-week highs on the NYSE continue to lead new 52-week lows. Recently, there have been some isolated days where new lows exceeded new highs using NASDAQ or “stocks only” data, but not when using NYSE data. That means this indicator remains bullish for stocks. It would turn negative if NYSE new lows exceeded new highs and were sufficiently large, but that has not happened.</p>\n<p>There is a realized volatility sell signal in place, as well. That occurred when the S&P’s 20-day historical volatility first fell below 8% (in mid-June) and then later rose above 11% (in late July).</p>\n<p>Implied volatility, on the other hand, remains in a bullish state, as far the stock market is concerned. The VIX “spike peak” buy signal of July 20 remains in place. Moreover, the VIX 200-day moving average is still declining and is well above the price of VIX.There has been a slow “creep” upward by VIX, from 15 to 19 over the last month, but that doesn’t appear to be a significant change of trend.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e3501a851250cf90d4f08e0152a5d9a9\" tg-width=\"700\" tg-height=\"524\" width=\"100%\" height=\"auto\"><span>LAWRENCE MCMILLAN</span></p>\n<p>Finally, the construct of volatility derivatives remains positive for the stock market. The VIX futures are trading at a premium to VIX, and the term structures of those VIX futures and the CBOE Volatility Indices slope upward.</p>\n<p>The SPX chart is still positive. That is the most important fact. Until that changes, a long “core” position is recommended. Around that, one can trade confirmed signals – both buy and sell. A violation of the 4370 area by SPX would change things for the negative, but a breakout to new all-time highs above 4430 would reinforce the bullish case.</p>\n<p><b>New recommendation: Conditional SPX sell signal</b></p>\n<p>Based on the above article, we are going to lay out some parameters regarding taking a bearish position should SPX support be broken:</p>\n<p><b>IF SPX trades below 4370 and stays there for an hour,</b></p>\n<p><b>THEN buy 1 SPY Aug (27th) at-the-money put</b></p>\n<p><b> And sell 1 SPY Aug (27th) put with a striking price 25 points lower.</b></p>\n<p>In addition,</p>\n<p><b>IF SPX closes below 4370,</b></p>\n<p><b>THEN buy another bear spread:</b></p>\n<p><b> Buy 1 (more) SPY Aug (27th) at-the-money put</b></p>\n<p><b> And sell 1 (more) SPY Aug (27th) put with a striking price 25 points lower.</b></p>\n<p>Note that it is possible that the second condition (close below 4370) could occur without the first condition being satisfied (if SPX breaks below 4370 late in a trading day). If that is the case, then buy 2 of these spreads on the close.</p>\n<p>Finally, if these spreads are established, stop yourself out of all of these bear spreads on an SPX close above 4430.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The S&P 500 looks strong — but these ‘internals’ are far less positive</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe S&P 500 looks strong — but these ‘internals’ are far less positive\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-06 12:02 GMT+8 <a href=https://www.marketwatch.com/story/the-s-p-500-looks-strong-but-these-internals-are-far-less-positive-01628176855?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The S&P 500 index continues to accelerate to the upside. A new all-time closing high was registered on Tuesday. Yet, the “internals” of the market remain in a far worse state. This has been the case ...</p>\n\n<a href=\"https://www.marketwatch.com/story/the-s-p-500-looks-strong-but-these-internals-are-far-less-positive-01628176855?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/the-s-p-500-looks-strong-but-these-internals-are-far-less-positive-01628176855?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199377263","content_text":"The S&P 500 index continues to accelerate to the upside. A new all-time closing high was registered on Tuesday. Yet, the “internals” of the market remain in a far worse state. This has been the case for some time (since June 11, at least), and it may continue to be the case for a while longer.\nBut as long as the S&P chart is positive and above support, a “core” long position is recommended.\nThe first support level is now roughly 4370. That was the low on the two most recent days on which SPX sold off and then rebounded – July 27 and Tuesday (yes, the same day that SPX bounced back from that level and then closed at a new all-time high). Since it has been doubly tested, that makes it a viable support level. There is resistance at 4430, the all-time intraday high.\nYou can see from the accompanying chart that SPX has been in a rather right trading since July 23 – between 4370 and 4430.\nA breakout from that range will be significant. If it were to break to the downside, that would be a negative for the SPX chart. Below there, a major support area exists at 4233, and it would likely be tested quickly after a break below 4370.\nLAWRENCE MCMILLAN\nSo the SPX chart is still positive, but there is a McMillan Volatility Band (MVB) sell signal in place (green “S” on chart).\nNow let’s look at some of the indicators that encompass a larger number of stocks. You will see that they are far less positive. First are the equity-only put-call ratios. These have been rising for a month, meaning they have been on sell signals during that time. Put volume has been heavy, relative to call volume, and that is what is causing these ratios to rise. It looks like there is a slight “wiggle” in the standard ratio’s chart, but the computer analysis programs say that is not significant.\nThe larger picture here is that as many stocks have been declining, option traders have been buying puts on those stocks, forcing these equity-only put-call ratios higher. As long as the ratios are rising, they will remain on sell signals.\nLAWRENCE MCMILLAN\nLAWRENCE MCMILLAN\nMarket breadth (advances minus declines) has been woeful since mid-June. That is, most stocks are going down, even though SPX is going up. In fact, what is driving this market is a handful of large-cap NASDAQ stocks (the FAANG stocks plus Microsoft are the strongest stocks).\nThings have improved a little in the last couple of weeks, and so our breadth oscillators are on buy signals, but they are still in negative territory. Normally when SPX is making new all-time highs, the breadth oscillators are will into positive territory, reflecting a strong overall market. But that is not the case now.\nMoreover, cumulative breadth (the running total of daily advances minus declines) has not made a new all-time high since June 11. SPX has made a new closing or intraday high on 19 separate trading days since then. That is a huge, negative market divergence, but it alone is not a sell signal. Rather, it is a strong warning to be alert – to avoid complacency.\nNew 52-week highs on the NYSE continue to lead new 52-week lows. Recently, there have been some isolated days where new lows exceeded new highs using NASDAQ or “stocks only” data, but not when using NYSE data. That means this indicator remains bullish for stocks. It would turn negative if NYSE new lows exceeded new highs and were sufficiently large, but that has not happened.\nThere is a realized volatility sell signal in place, as well. That occurred when the S&P’s 20-day historical volatility first fell below 8% (in mid-June) and then later rose above 11% (in late July).\nImplied volatility, on the other hand, remains in a bullish state, as far the stock market is concerned. The VIX “spike peak” buy signal of July 20 remains in place. Moreover, the VIX 200-day moving average is still declining and is well above the price of VIX.There has been a slow “creep” upward by VIX, from 15 to 19 over the last month, but that doesn’t appear to be a significant change of trend.\nLAWRENCE MCMILLAN\nFinally, the construct of volatility derivatives remains positive for the stock market. The VIX futures are trading at a premium to VIX, and the term structures of those VIX futures and the CBOE Volatility Indices slope upward.\nThe SPX chart is still positive. That is the most important fact. Until that changes, a long “core” position is recommended. Around that, one can trade confirmed signals – both buy and sell. A violation of the 4370 area by SPX would change things for the negative, but a breakout to new all-time highs above 4430 would reinforce the bullish case.\nNew recommendation: Conditional SPX sell signal\nBased on the above article, we are going to lay out some parameters regarding taking a bearish position should SPX support be broken:\nIF SPX trades below 4370 and stays there for an hour,\nTHEN buy 1 SPY Aug (27th) at-the-money put\n And sell 1 SPY Aug (27th) put with a striking price 25 points lower.\nIn addition,\nIF SPX closes below 4370,\nTHEN buy another bear spread:\n Buy 1 (more) SPY Aug (27th) at-the-money put\n And sell 1 (more) SPY Aug (27th) put with a striking price 25 points lower.\nNote that it is possible that the second condition (close below 4370) could occur without the first condition being satisfied (if SPX breaks below 4370 late in a trading day). If that is the case, then buy 2 of these spreads on the close.\nFinally, if these spreads are established, stop yourself out of all of these bear spreads on an SPX close above 4430.","news_type":1},"isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}